ML20080N129
| ML20080N129 | |
| Person / Time | |
|---|---|
| Site: | Limerick  |
| Issue date: | 06/06/1994 |
| From: | Boyce R PECO ENERGY CO., (FORMERLY PHILADELPHIA ELECTRIC |
| To: | |
| Shared Package | |
| ML20080N087 | List: |
| References | |
| PROC-940606, NUDOCS 9503060158 | |
| Download: ML20080N129 (196) | |
Text
{{#Wiki_filter:----- ------- - e
+ i; y
v L
\
PECO t ENERGY i. j-Limerick t Generating Station
!(
k h
.{ '
j i. f 1 i' , 9503060158 950215 L PDR R ADOCK 05000352 PDR ___ -- i
m.. . 3947067420: pj-
- 'PORC YES-SOR. YES NOA NO I*
$0.59 YES RESP.MG R.' YES [
m , LIMERICK GENERATING STATION- . i-UNITS 1 AND 2 > OFFSITE DOSE CALCULATION MANUAL Revision 13 L PFCO ENERGY COMPANY l DOCKET NOS. 50-352 AND 50-353 J
,j , . . _ . . , . _
y,,,, ,,,,,,, l i
,l f
.ODCM;Rsv. 13 ,
, '5/94 Table of Contents Page-
' Part I - RADIOLOGICAL EFFLUENT CONTROLS l t
- 1. 0 ' DEFINITIONS 1 2.0 BASIS FOR EFFLUENT MONITORING CONTROLS. 6
^
2.1 : METEOROLOGICAL MONITORING INSTRUMENTATION 6-
- 2.2 MAPS. DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY
- FOR RADIOACTIVE GASEOUS AND LIQUID EFFLUENTS 6 y 2 .'3 ~ RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION .6 -l 2.3.1 Concentration- 9 ; 2.3.2 Dose 9 l 2.3.3 Liquid Radwaste Treatment System 10 e 2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION 10 2.4.1 Dose Rate 10 P ~ 2.4.2 Dose - Noble Gases 11-2.4.3 Dose - Iodine-131', Iodine-133, Tritium, and Radionuclides in Particulate Form 12 , 2.4.4- Ventilation Exhaust Treatment System 1L2 2.4.5 . Venting and Purging- 13 , 2.4.6 Total Dose 13 2.5 MONITORING PROGRAM 13. , 2.5.1 Land Use Census 14' 2.5.2 Interlaboratory Comparison Program 14 2.6 APPLICABILITY. 14 { , -j 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION-CONTROLS 16
'3.1 METEOROLOGICAL MONITORING INSTRUMENTATION 17
.!e e
. . - i
, . _ ~ , , , , . , ,
- l; , .. - ODCM-R$v. 13
~ '
es/ . ,
'_5/ 9 4 ,
1 1 Pagel s 3 ,
- 3.2 . RADIOACTIVE LIQUID EFFLUENT MONITORING INSTURMENTATION'- ' 21.
3.2.1- Radioactive Effluent Monitoring 4 -' : Instrumentation Controls 21.' 3'.'2.2: Concentration-- 24
- >3.2.3 Dose. 2 8 .-
3.2.4 Liquid Radwaste Treatment-System 29-
!3.3 GASEOUS EFFLUENTS -
3.3.1 Radioactive ~ Gaseous Effluent Motoring-Instrumentation '30: 3.3.2 SITE BOUNDARY Dose Rate ~35 3 .-3 . 3 - Dose - Noble Gases' 39 <
-{
-3.3.4 Dose ~.- Iodine-131, Iodine-133, Tritium, and i Radionuclides in Particulate Form. 40 l
3.3.5 Ventilation Exhaust. Treatment System 41 ,j 3.3.6 Venting or Purging' 42 3.3.7 Total Dose 43 3.4 ~ RADIOLOGICAL ENVIRONMENTAL MONITORING 3.4.1- Monitoring Program 44L ;l 3.4.2 Land Use Census 57' 3.4.3 Interlaboratory Comparison Program '58. 3.5 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING' REPORT 59 , 3 .' 6 SEMIANNUAL. RADIOACTIVE EFFLUENT RELEASE REPORT 60 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS 62~ t f.
-l 11 i i
y , ,
-ODCM Rsv.113
- 3 15/94 :i 4 LIMERICKLGENERATING STATION. $
OFFSITE DOSE CALCULATION MANUAL- 1 TABLE-CONTENTS Page Part II - CALCULATION METHODOLOGIES 1.0 LIQUID EFFLUENTS 63 1.1 RADIATION MONITORING INSTRUMENTATION AND' CONTROLS. 63 1.2 LIQUID EFFLUENT MONITOR-SETPOINT DETERMINATION 64 , t 1.2.1 Radwaste Discharge Monitor 64 1.2.2 Service Water Radiation Monitor 67 1.2.3 RHR Service Water Monitor 68 1.3 LIQUID EFFLUENT DOSE CALCULATIONS - 10 CFR 50 69 1.3.1 Member of the Public Dose - Liquid Effluents 69 1.4 LIQUID EFFLUENT DOSE PROJECTION 74 2.0 GASEOUS EFFLUENTS 75 , 2.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 75 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION 75 2.2.1 North Vent Noble Gas Effluent Monitors 77-2.2.2 South Vent Noble Gas' Effluent Monitors 79 2.2.3 Noble Gas Effluent Fractional Contribution 81 2.2.4 Noble Gas Effluent Default Setpoints 82 2.2.5 WRAM Noble Gas Effluent Monitor 86 2.3 GASEOUS EFFLUENT DOSE EVALUATIONS 91 2.3.1 Site Boundary. Dose Rate - Noble Gases 92
..w-2.3.2 Site Boundary Dose Rate - Radioiodine and Particulates 94 2.3.3 Noble Gas Air Dose 95 2.3.4 Radiciodine and Particulate Dose Calculations 10 CFR 50 96 111
8- ODCM'Rsv. 13
']E :5/94 Page
- 2.3.5.; Annual Dose. Evaluation' 4
199 2.4 . GASEOUS EFFLUENT DOSE' PROJECTION 102' 3.0 SPECIAL DOSE ANALYSIS -103
.3.1- TOTAL DOSES TO MEMBERS:OF THE PUBLIC 103'
~3. 2 DOSES DUE TO ACTIVITIES INSIDE THE SITE BOUNDARY- .104 10 C ..
' 4. 0 ' RADIOLOGICAL-ENVIRONMENTAL MONITORING PROGRAM' ,
4.1' SAMPLING PROGRAM- 106 4.2 INTERLABORATORY' COMPARISON PROGRAM 106' APPENDICES Appendix A - Technical Specification /ODCM- 159 ; Appendix B - Radiological Environmental Monitoring- 162 Program - Sample Type, Location and
. Analysis ,
t a s e I iv .
- t. ,.1 , .
J ,
-ODCM Rsv.n13 5/94L t
LIST.OFfTABLES.
..I 1.1: Surveillance Frequency: Notation I 3.1-1" Meteorological Monitoring Instrumentation I'3.1-2 Meteorological Monitoring' Instrumentation' Surveillance Requirements
- I 3.2-1 Radioactive Liquid' Effluent Monitoring-Instrumentation I 3.2-2 Radioactive Liquid? Effluent Monitoring Instrumentation Surveillance-Requirements I 3.2-3 Radioactive Liquid. Waste Sampling and Analysis Program I 3.3-l' Radioactive Gaseous. Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive'GaseousLWaste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program I"3.4-2 Reporting-Levels for Radioactivity. concentrations In
~ Environmental' Samples I 3.4-3 Detection Capabilities For Environmental Sample Analysis II 1.1 Ingestion' Individual Dose Factors (Daipj) For Liquid' Effluents' II 1.2 Assumptions Used-In Limerick Effluent Dose Evaluations II 2.1 Dose Factors for Noble Gases-II 2.2 Ingestion Individual Dose Factors (DFk,1,n) For Gaseous Effluent
-II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose
. Evaluation II 2.4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)
'A.1 Technical Specification /ODCM Matrix ,
B.1 Radiological Environmental Monitoring Program v
_ .- , . . - -- , . . _ ~ . - .
--I I
- ODCM Rsv.n13i 5/94:
%< LIST lOF: FIGURES s
Map Defining. Exclusion: Areas for; Radioactive t I1 2.2-la
-Gaseous and Liquid Effluents:
i sI 2.2-1b Map _ Defining 1 Low'PopulationfAreas for-Radioactive d
. Gaseous and Liquid' Effluents I: 3.1-1 Meteorological TowerLLocation: 1 IIJ1.3.1-1 -LGS Dilution vs River Flow (Outfall)
LII 1.3.1-2 LGS: Dilution vs~ River' Flow (Citizen's, Utility)
'II 1.3.1-31 LGS Dilution vs River Flow ~(Phoenixville) +
II 1.3.1-4 LGS Dilution vs River Flow (Philadelphia. Suburban)j j II 1.3.1-5 LGS Dilution vs: River Flow (Crew. Course) II 1-1 Liquid Effluent Flow Diagram II 2-1 ' Gaseous Effluent' Flow' Diagram - North Stack . II-2-2 Gaseous Effluent Flow Diagram - South Stack
'II 2-3 Gaseous' Effluent Flow Diagram.- Hot Maintenance Shop-
'B-1 Environmental Sampling LocationLon' Site.or'Near the Limerick Generating-Station B-2 Aquatic and Terrestrial. Environmental Sampling Location.
at' Intermediate Distances from the Limerick Generating-Station
- B-3 Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating s Station ,
B-4 Environmental Sampling Locations at Remote Distances-from the Limerick Generating Station- > i l' 9 vi 4 e
, - , . Y
. . . ~ - ,. . . . -. . . .
3 s -
- . y
, i... J PURPOSE
.Th e purpose of the Offsite Dose Calculation Manual.is'to establish-methodologies.and procedures for calculating doses to individuals in areas at and beyond the SITE BOUNDARY due to radioactive' effluents
'from Limerick Generating Station.
l 1 l l 1 PART I I RADIOLOGICAL EFFLUENT CONTROLS I l _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ .__ _ _ _ _ _ . _ _ _ _ _ _
3g ' WYi -
- ODCM'Rsv.- 13 JP
._ $lf ? s Pagafic o -
~5/94 f
up lll > g
?1'.0 DEFINITIONS b The followingLtermsLare taken1from: LGS Unit 1, Unit 2 Tech l Specs.. .
~1.1; ACTION M ACTION: sh'all be that part of af specification' which prescribes remedial measures required-under designated conditions.
$ -112 CHANNEL CALIBRATION 7
'A CHANNEL CALIBRATION shall be.the adjustment,:as necessary, of
< 'the. channel output such that it-responds withithe necessaryJ ;
range and accuracy to known values of the~ parameter which.the. channel monitors.- The CHANNEL CALIBRATION shall encompass the' entire-channelEincluding'the sensor and alarm and/or trip functions,:and shall'includenthe CHANNEL FUNCTION TEST.. The CHANNEL CALIBRATION may-be performed by any series of sequential, overlapping or total channel steps such that the entire channel-is calibrated. . 1.3 CHANNEL CHECK A CHANNEL CHECK shall be the qualitative assessment ofechanneli behavior during operation by-observation. This determination
-shall' include, where possible, comparison of:the channel indication and/or status with other' indications and/or status derived from independent instrument channels measuring the samel parameter. o 1.4 CHANNEL FUNCTIONAL TEST A CHANNEL FUNCTIONAL TEST shall be: ,
- a. Analog channels - the injection of a simulated signal, into the channel as close to the sensor.as practicable to verify OPERABILITY including alarm and/orl trip.
functions and' channel failure trips.
- b. Bistable channels - the injection of a simulated signal into the sensor to verify' OPERABILITY including alarm and/or trip functions.
The CHANNEL FUNCTIONAL TEST may be performed'by any series of sequential, overlapping or total channel steps such that the entire channel is tested. :
)
1 I I' - , _ . - _ . . , _ - ~. , _ . - __
m ,
- t -
, y --l ODCM Rsv. 13-
- -Pugs 2' 7 ,j : 5/ 94 '
1'. 5 CONTINUOUS SAMPLING
. .Per ASTM, Standard (1987) Section'II (WaterLand Environmental "
Technology),' Volume 11.03,' Article _D1356; tis ditined as" sampling without: interruptions'throughout an operation.org for'a predetermined' time." A' CONTINUOUS SAMPLE-is the opposite:
-of'a GRAB SAMPLE. Thertime period involved to secureL(shut- >
down)(ventilation orcre-establish. sampling:of.the' release 1 pathway shall': meet the intent of- CONTINUOUS ' SAMPLING.~ ,_ Consistent with industry standards, the_-time-allowance:shall not exceed 8 hours.
- 1.6 DOSE EOUIVATRNT T-131'
~
DOSE EQUIVALENT I-131 shall be that concentration;of I-131,- microcuries per gram, which.alone would produce the same thyroid dose as the quantity and isotopic mixture of-I-131, I-132, I-133, I-134- and ' I-135 actually- present. The? thyroid dose-conversion factors'used for this calculation shallibe those-listed in Table III of TID-14844, " Calculation of Distance Factors for Power and Test Reactor Sites." 1.7 FREQUENCY NOTATION The FREQUENCY NOTATIOR specified for the performance of. Surveillance Requirements shall; correspond to the intervals defined in Table I1.1. 1.8 MEMBER (S) OF'THE PUBLIC MEMBER (S) OF THE PUBLIC shall include all persons who'are not occupationally associated with the plant. This' category does not' include employees of'the utility, its contractors, or vendors. Alsofexcluded from-this-category are persons who enter the; site-toiservice' equipment'or to make deliveries.. This category does. include persons who use_ portions of the site. for recreational, occupational cnr other purposes not associated - with the plant. 1 1.9 OFFSITE DOSE CALCULATION MANUAL 1 i
, The OFFSITE DOSE CALCULATION MANUAL (ODCM)'shall contain the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and' liquid effluents, ~
in the calculation of gaseous and liquid effluent monitoring Alarm / Trip Setpoints, and in the conduct'of the Radiological Environmental Monitoring Program. .The ODCM shall also contain. (1) the Radioactive Effluents Controls and Radiological Environmental Monitoring Programs required by Technical Specification'6.8.4 and-(2) descriptions of the
, . - . . . - . . . ..~.- ~ .-.- . - . ~ ~ a. . ~~
4 I ((( / , .ODCM'R$v.'13:
- Pagar3 4 (l;; 5/94 Einformation:that should be1 included in'the: Annual. Radiological Environmental" Operating'and. Semi-annual' Radiological' Effluent Release. Reports requiredtby.Tecnnical-Specifications 6.9.1'.7
^
;, and 6.9.1.8. '
(3) description of meteorological monitoring 1 controls. -
'1.10' OPERABLE'- OPERABILITY ALsystem, subsystem,. train, component'or device shallibe OPERABLE'or'have OPERABILITY when it is capable of performing-its:specified functions (s)~and^when all necessary1 attendant' instrumentation, controls, electrical-power,. cooling or: seal water,:1ubrication or other auxiliary equipment that;are
. required: for the system, subsystem, . train, component or ' device to perform its function (s)'are_also. capable.of performing:their related support function (s).
1.11 OPERATIONAL CONDITION - CONDITION AnLOPERATIONAL CONDITION, 1.e., CONDITION,_shall be any one , inclusive. combination of mode switch position and average 1 reactor coolant-temperature as defined in the Technical. Specifications. 1.12 -PURGE - PURGING PURGE or~ PURGING shall be,the controlled process of discharging air'or gas from'a: confinement to. maintain: temperature,
. ~
pressure, humidity, concentration ~or other operating condition, in such a manner that' replacement air or_ gas is required to purify-the confinement. l
'l 1.13 RATED THERMAL POWER !
i 1 See current LGS' Tech ~ Spec definition.
.)
1.14- REPORTABLE EVENT ! l - A REPORTABLE EVENT shall befany.of'those conditions specified i in Section 50.73nof 10 CFR Part 50. 1.15 SITE BOUNDARY The SITE BOUNDARY shall be that line .aus defined in Figure I2.2 ' < 1a.
- .-- . . ll
ODCM Rhv.ll3;
^ ~ ?l: 1 Paga 4 F ' 5/ 9 4 -
ll: 1.16- ' SOURCE CHECK A. SOURCE CHECKishall be the. qualitative assessment of' channel L response when the channel sensor is exposed to a radioactive source. 1.17 THERMAL POWER , THERMAL POWER shall be the total reactor core heat transfer rate to the reactor coolant. , 1.18 UNRESTRICTED AREA An UNRESTRICTED AREA shall be.any area at or'beyond the SITE BOUNDARY access to which is not controlled by the-licensee'for- , purposes of protection of individuals from exposure to radiation and radioactive materials, or any are within the SITE BOUNDARY used for-residential quarters or for industrial, commercial, institutional, and/or recreational purposes. 1.19 VENTILATION EXHAUST TREATMENT SYSTEM A VENTILATION EXHAUST TREATMENT SYSTEM shall be any system designed and installed to reduce gaseous radiciodine or radioactive material in particulate form'in effluents 1by passing ventilation or vent exhaust gases through charcoal absorbers and/or HEPA filters,for the purpose;of removing iodines or particulates from the gaseous exhaust stream prior o to the release to the environment (such a system is not considered to have any effect on noble gas effluents). Engineered Safety Feature (ESF) atmospheric cleanup systems are not considered to be' VENTILATION EXHAUST TREATMENT SYSTEM components. 1.20 VENTING VENTING shall be the controlled process of discharging air or
- l gas from a confinement to maintain temperature, pressure, I humidity, concentration or other operating. condition, in such a j manner that replacement air or gas is not provided or required' !
during VENTING. Vent, used in system names, does not-imply a VENTING process.
)
i l l
's! :ODCM Rsv.~13 ? /' PIga 5 , is 5/94' L ,;
TABLE II.1 SURVEIT.TANCE-FREOUENCY-NOTATION NOTATION FREQUENCY S (Shift) At least once per-12_ hours._ F D (Daily). At least-once per 24 hours. W-(Weekly) At least once per 7. days. M (Monthly) At least once per.31 days. Q (Quarterly) At least once per 92 days. EUL (Semi-annual) At.least once per 184 days. A (Annual) At least once per 366' days. E At least once per 18 months-(550 days). R At least once per 24 months.(731 days). S/U Prior to each reactor startup. P Prior to each radioactive release. N.A. Not applicable. , t I 1 1 1 l l 1
rc .g '
< 'i t
- ([ 'ODCMLRiv. 13' Pngs 6 . '
1' y '
, 5/94 L2.0 BASIS FOR EFFLUENT MONITORING CONTROLS l2.1 METEOROLOGICAL INSTRUMENTATION y
~
.The. OPERABILITY of the meteorological monitoring . ..
instrumentation ensures that sufficient meteorologicalidataLis-available for-estimating potential radiation. doses'to the
.public as a result of routine:or accidental release'of:
radioactive-materials to the atmosphere. This capability is :
, required to evaluate'the need:for~ initiating measures to protect the health'and safety of the public. This .
instrumentation.is consistant with.the recommendations of a Regulatory Guide'1.23 "OnsiteIMeteorological: Programs,"= February, 1972. , Site data compiled since January'1972 providejcorrelation-
.between Elevation 1 (Tower 1).'and Elevation 1 (Tower 2), and:
between-Elevation 2(Tower 1) and Elevation;2.(Tower 2).' This. correlation serves as justification ~for.the use of the appropriate Tower 2< instrument as a back-up-to the Tower 1 r instrument as shown in Table I3.1-1 and Table I3.1-3. 2.2 MAPS DEFINING UNRESTRICTED AREAS-AND SITE BOUNDARY FOR' RADIOACTIVE ~ GASEOUS AND LIOUID EFFLUENTS Information regarding radioactive gaseous and liquid affluent's,. which will allow identification of structures and-release points'as well as definition of UNRESTRICTED' AREAS within the SITE BOUNDARY that are accessible to' MEMBER (S)10F THE PUBLIC,. shall be shown in Technical Specifications Figures 5.l.3-laLand
- 5.1.3-lb.
- The exclusion area and' low population. zone shall be~as shown in Figures I2.2-la and I2.2-1b.
! 2.3 ' RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION- T The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable,Jthe releases of radioactive i materials in liquid affluents:during actual or potential , releases of liquid effluents. 'The alarm / trip setpoints for i these instruments shall be' calculated in accordance with the-procedures in the ODC'" part LII to ' ensure that the alarm / trip will occur prior to exceeding the limits of'10 CFR Part 20. The OPERABILITY and use of.this instrumentation is consistent. with the requirements of General Design Criteria 60, 63, andL64~ of Appendix A to'1'O CFR Part 50. , a
ll ODCM Rev. 13 Paga 7 l 5/94 FIGURE I2.2-la EXCLUSION ZONE
=
'~cf o_;+ .. y ..
rieo~- ~= " & Tg:: g:
? . ;y;g.
= -
. ~ . . .-
' {L, / ~~~ ~~' :..% ' %,%;%%.f. s% :w.&. s s. ? / 's.wil.
-;,- ~~:~:. . .~.}%
. ~ . ..-.
gi, r j.
' - - N --
t ::.t:stcn W-A s-%.. . c '- %,','%~.
.r(
/
. l.'[
IjaX"b)'h(-f-(9'...-r.'//WuM
-' W
?,/U ,$\ b es W:: d ' t'A.i r5 . l-;g L j\ h.\n w tMAes k ,!h)irkkh (.
- f ' '
. q,n
--- r N -
a_ (l- 'k _./L 'b'i - g//= W
, /
- c.Wl'N. .: .:
g.=. : . c. ~ x sp. ,'q
- ~~
7"~ .y?,F~.:g5.3m'~ f.r - .=e M.t ?'. 's
*~ ' ..
O. - - CCv.'.;p+ . -
.j y; \.\ &.b ') ; S' %'hw,,,q, ' y/--Q . . .,: , . ./ >%,i'--~=~^n.~'"-='
1 l%ji dv-
. i ..
. r 'j s.y r .. . . . . . - -. . .
>;t. Q < .., .
.\i ..
,q.r.& =A . . .r = .> ; ~.s..~. '.'! g. C ';
.t - r s . ,./,g *'!V./' g /, y.f,c.:i- M '=
f j: s V .,,,.,s *N .1 . , r 7 ,r. - u ; .a - s ., *.
.. **u t \s,
' r'
\ .
$ / / 2 #~
M d'~~.c
.:.; $ ^'. p h, 'd. ' N,i'E'$dN=N 1-
$ . -=~ .:
h, *h;f$.h Mr,' d 1N 7.i?xX= $q'j(t, s:.h-s,>
. <-==' ' v iQ .! n , t. . \: ;-am s n: ag,'d -CE'As}yhp.iy.wp .g .
;y. af%*( :r- &;. .
uJ
+ e-%.s;. /- . -:= x
= --T;;a y W r
- vm..m. - /me#~~ ,n:
.r W'%>h'. ~- iW '
r?"~ IIG.CE.'kiY 'Is :-!' Y 'rN E'
?'k -
iy.\ {%-i
~
..=
f!(>, .'~-@?. I i[vh-- . 4* .nQ'".
- .-.D.pf;.'
==1. %w;p~Wb.,i gll.%,.,L. 3 i.l
. )n; S Q.
l'1 . s m . .
. - . r,:.--
=C v.---f.-sib..(..u./f. ;i /Q t 'g\ \ 1 c q ,- y .- .. s n %- <g) . ! w .
. ;-{.i
. i ' --
u
-Q.,.y.y- y - Q ;,,.y c'=q~.L:. g e.5.g.;. -
W p44X?&;@.'4-Q:'~%v%v Nge wr
% -k h}c;h. .. . ---
F@n f $. J N s f d T ? N I '\ i M .. hh Mi$(h4:sa fiiiiisd!FN;., T~J M h.'7.%%\ D.E b
$@/N>,'s.
d b, M 5-
i l ODCM Rev. 13 l Page 8 ; j 5/94 l FIGURE I2.2-lb LOW POPULATION ZONE
~
E LY4 /'a .~::.J
- J
""i -
,:',7 - .-
'; y,-.Y?%s .-- e.i o
.; 'j- '
n . y.~,_g::::
..l/ . . .N., /.-' *:r -rs: -/ q, .,
>p' /- :
/ - sh s e. ~! - --
- ='" .hl?$t[f**.,pr,.'%'iy.,/?,,F-
'f.
- 5. Q A :) .~- M'-?]. ~'-f ;.
f: n\kNYYy/r 7 2sjvs h./\r /-/g: f
/"_..'
r-rn,.).a .ae'q-m o-
/ r, y,g.s gf mf ~v.%r:,. w - -
c.
/Lbx
. , .C-), p . m: .o~
ffm.==@P m g,%u. g , Jit'e ,,;' cP 40 ='?. m79(ij < r~T ~: .<
- s n
// /_.,,. . .. r .~- 9
/ '
i.: .,v a. N,. .- t, . \, i.e,_/,/'"r'n .. .,.,:-- ./ </,A . / = / .,,i ri - 1 . u- -',. \ ? c,T:t; f
- ,: . - - :;8' -
/
t-s ., f. . g/ . _- -
'N$< ( - -
.1
_::, : z;:.
---r:G t ._ t;>.
3 e. . 5.- N,. -Y -- : ::~ : . T!/q. ;;4....:.:. W, 3-tE=.:.2:
.5 7.' . , ' < =% r i -
4 :- 4 -
~.-
, s L e'.
ls~~'T .. ,~:.: s.' f. .r.,.. vi,L - u
,.+.: $j"""*ul"
- $,1 I,s. W:-. .y m. :~-s.n=a'.yr,. ~. . -
~. /<',lre>:.
m* *m.@,1N 3 +_r'::~'r \ '. .\u% w*: a -
-v z
' ." j/ ~5.T. ..m, , e...,.n j N . .T\
' ' G4" ,,.
.s,'s F-- 2:::-/:: .-
I p \ kba- i '0-
' 'b, hWU:.Ek['h. , .:.M" .
.} , -u u" c\ <
\ ,, , q.
~~
3;- - 3. r , ,., --.i..
. r~.2 .?.a - l ,/
>. ~.,. , s. . . . //. . i,:. -
c;:a > r: -
~.~..
4 ..,:, m+et,.- , \... w .,\.'r . :- - :;n 4 , . " ,.. .;p:- - p '; .. .-Cc, /:
~ r ' -:_, ' - -p . ! - - *
. ::: Y'~' i .M .
Q s. h- - wM4- - .. Y-i M=:!.hve*-)w.p.f /- '..,i R, '
. kp,. ~' :h
. .: 4 M-Mf 'h-N.- . v .=. ~. s -
S W-M_;A' W ,:3 i' : '
"M~ ':~~ '- - s ~.n'W hfi\ 1Q'\ 5R k'bfg$. t',::s:f'~h's 5' l.'.' 0.k! / . ' $~ Nk[
W+-~ .: c% . gc. n s r;=y.E- *2 p9-v.9&C~ W%sf,jdd V8 % > K1%Qp t.,.?,c w %5 i 4 G N 5 - %:.. .r sc mw
===
w~.;h.3-4gs_.m A ww @M d +%s:rg;s, dM- - e c
- a. ,: s.
- rb q"'g,ess?-
_p'~'6 95 M;;gs .k\-@' ~#'s, . 2.6. -:- id' c#7s ';,Op -A&Q. :sh s .
,M'y, m..m..m .~.. ~,,,;,. / %Ww:..M e.,:f.t..h. 62:y;f .A
., , 2 .=r .
i,*
~ n. .... ~
v p>> i M s.. _ n . .. - - 56 -
]: -
A xs ' A- )
.: / ,
_ yg 3. ....
' .. x s
1 J Espc%gwed.yg%2rc%% E \
@. % p.. a . . a,.. - ~ '
u 2 M x h & x = n au C S +k x v .
m ~ y . mp x- - m - =,
, - . ~ . - . . ~ - - . -
j. 9; t t j
- w s g :-
,' ,J ,
r ODCMLRrd.113? l . m
- Pagn 9 l~
,1; ,l 5/94-4,
~ 2.3;1 CONCENTRATION
^
This_ control:is provided toJensure that the.concentrat' ion of 4
< -radioactive materials released incliquid waste effluents'to-UNRESTRICTED AREAS will be:less than'the concentration levels E ispecified in-10 CFR Part 20, Appendix B,LTable 7I, Column 2. . ,
This limitation provides additional assurance that-theElevels " t
'of: radioactive materials in' bodies' of ' water: in . UNRESTRICTED
- AREAS will-result'in exposures within-(1)'the Section1II.A '
? design objectives _of. Appendix I, 10 CFR-Part.50,-'to a MEMBER OF-THE_PUBLIC,-and '(2) the limits of 10'CFR 20.106(e)1to the population.: The concentration limits.for dissolved or entrained' noble gases are_ based upon the assumptionLthat Xe-135 '
.y is the controlling radioisotope and its.MPC11n air'was converted to an equivalent concentration in water using thel ., methods described in'the International? Commission on Radiological Protection (ICRP) ? Publication -2. The required detection capabilities for radioactive materials o in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD,' ' and other detection limits can be found in HASL Procedures
' Manual, HASL-300 (revised annually),. Currie, L.A., " Limits'for .
Qualitative-Detection and Quantitative' Determination -
~
Application to Radiochemistry,"; Anal. Chem. 40. '586-93 (1968). , and Hartwell J.K., " Detection' Limits for Radioanalytical-Countina Techniaues." Atlantic Richfield Hanford Comoany Recort ARH-SA-215 (June, 1975). 2.3.2 DOSE , This control is provided to implement the requirements of'
~
Sections II.A, III.A,;and IV.A of Appendix'I, 10'CFR Part 50. The control implements the. guides set forth in Section II.A of' ; Appendix I. The ACTION: statements provide'the required
~
operating flexibility and-at thelsame time implement 1the guides' set forth in Section~IV.A of-Appendix.I-to-assure that the ' releases of radioactive material;in liquid effluents willibe kept "as low as reasonably. achievable". Also, for freshEwater sites with drinking _ water supplies which can be potentially affected by plant operations,.there is-reasonable assurance , that the operation of the facility will_not' result in radionuclide concentrations in the finished drinking water that are in excess of'the requirements of 40.CFR'Rart 141.'"The dose; a calculation methodology and parameters in the ODCM implement the requirements in Section-III.A.of Appendix I that conformance with the guides of Appendix I be shown by L calculational' procedures based on models and data, such that l-the actual exposure of a MEMBER OF THE.PUBLIC through " p appropriate pathways is unlikely to be substantially underestimated. The equations specified in the ODCM for calculating the doses due to the-actual release rates of L radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, <
" Calculation of Annual Doses to Man from Routine Releases of j i
Reactor Effluents for the Purpose of Evaluating Compliance with l l-4 m i _. _ ._ - _- _.,2 _ _ _ _ , ,
,~ , . - +-. -. - -. .. .. . . . -. .- . - ~ . - .~
3 [h '
' ODCM! Rav.f13i o? :Pago 10 i"
l , 5/94:
-10: CFR f Part .- 50 ; Appendix I," Revision 11, October,11977 and LRegulatory' Guide 1.113, " Estimating =AquaticiDispersiont of .'
- Effluents from > Accidental: and Routine Reactor. Releases - for the l
/ ' Purpose of Implementing Appendix I,"' April",.,1977..
/ 2.'3.3- LIOUID RADWASTE TREATMENT SYSTEM The requirement'that.the-appropriate portions of this-system be used when specified provides assurance-that the-releases of' - ,< radioactive materials in liquid affluents.will belkept "as low , as-reasonably achievable".1 This specification implements- the T . requirements of 10 CFR 50.35a, General Design. Criterion 60 of 4 l Appendix-A to 10'CFR Part'50 and the design-objective.givenhin Section II.D of Appendix I~to 10 CFR Part 50. The specified:.
. limits governing the use of appropriate portions of the111guid; radwaste treatment-system were specified as a' suitable fraction.
of the' dose design objectives set forth in Section:II.A of-Appendix I, 10 CFR Part 50, for liquid _ effluents.
- - 2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION The radioactive gaseous affluent instrumentation.is providedLtot monitor and. control, as applicable, the-releases of radioactive materials in gaseous effluents during
- actual or: potential releases of gaseous effluents.- The: alarm / trip:setpointsifor:
these instruments shall:be calculated in accordance with the proceduresfin the ODCM to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20. The c OPERABILITY and use of this instrumentation >is consistent'with the requirements of General Design Criteria 60, 63, Land'64.of Appendix A to 10 CFR.Part 50. 2.4.1 DOSE RATE This control-is provided.to ensure that thefdose at any time ati and beyond the SITE BOUNDARY from gaseous. effluents from-the ,
' site will be within the annual dose limits of 10 CFR Part 20 to e UNRESTRICTED AREAS. .The annual l dose limits are the dose associated with the concentrations of 10 CFR Part 20, Appendix B, Table II, Column'I. .These limits'
- provide reasonable. assurance-that* radioactive material discharged in gaseous effluents will not result.in the exposure =
- of a MEMBER OF THE PUBLIC in an UNRESTRICTED' AREA, either ,
within or outside the SITE BOUNDARY, to annual average' concentrations exceeding the limits specified in Appendix B, Table II of 10 CFR Part 20 (10 CFR 20.106 (b) (1) ) . For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy factor for that MEMBER OF THE PUBLIC will usuallyfbe sufficiently~1ow to. compensate for any increase in the atmospheric diffusion factor for above that for the SITE BOUNDARY. Examples of calculations for such MEMBERS OF THE PUBLIC, with the appropriate occupancy factors,--are'given in the ODCM. The specified' release rate limits restrict, at all times, the corresponding gamma and beta dose: rates above background to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY to less than or equal to 500 mrems/ year to the total ,
.y .g . . --- .. . _ - . . __. ._, ._
- a. ,y gq c- -
p 1 j( ' M zODCM Rsv..-13 Pcgn111 .
-} - 5/94.
/ y F " body.orcto less than or equal;to 3000 mrams/ year to the skin i TheseLrelease rate' limits;also restrict, at,allLtimes,:the , corresponding thyroid ~ dose. ratefaboveLbackground"to a: child ~via
~
the inhalation pathway to.less1than or. equal to 1500 mrems/ year.. s This. Control applies to the release of radioactive" materials-in gaseous effluents from'all reactors at the site. The' required detection capability for-radioactive' materials in-gaseous. waste samples are tabulated in terms of the. lower limits of detection (LLDs). Detailed discussion'of the LLD,- and other. detection limits can be1found in HASL Procedures ,1 Manual, MASL-300 (revised annually),' Currie, L.A., "Limitsi for/
-Qualitative Detection and Quantitative, Determination - '
Application to Radiochemistry,". Anal. Chem. 40. 586-93'(1986). and Hartwell, J.K.. " Detection Limits for-Radioanalvtical. Countina Techniaues." Atlantic Richfield Hanford Company- , ReDort-ARH-SA-215 (June 1975). t 2.4.2 DOSE - NOBLE GASES This control ~is provided to implement the requirements of , Sections II.B, III.A, and IV.A of Appendix I, 10-CFR Part.50.- The control _ implements the guides _ set forth in,Section II.B of' ' Appendix I. .The ACTION: statements provide-theerequiredl . operating flexibility and-at the same time, implement'the; guides set forth in Section IV.A of Appendix!I to; assure;that the . . releases of radioactive material in gaseous effluents:will be l ~ kept:"as low as~ reasonably achievable". The Surveillance , Requirements implement the. requirements'in Section III.A of Appendix-I that conformance with the guidesLof Appendix I-be , shown by calculational-procedures based on appropriate. pathways s in unlikely to be substantiallyl underestimated. LThe dose'
. calculation established'in the ODCM for. calculating the doses. <
due to the actual. release. rates.of radioactive. noble gases-in-gaseous affluents are consistent withithe methodology.provided l in Regulatory Guide 1.109, " Calculation of Annual Doses to Man-from Routine Releases of Reactor Effluents for the-Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I,=" l ! Revision I, October 1977 and Regulatory Guide 1.111,_" Methods j ' for Estimating Atmospheric Transport and Dispersion of Gaseous .) Effluents in Routing Releases from Light-WaterfCooled j Reactors," Revision 1, July 1977?with. site specific. dispersion H curves and deposition iethodology. -The ODCM equations provided
' I > for determining the air doses at an.beyond_the SITE BOUNDARY
- are based-upon the historical average atmospheric conditions. p 1 4 i i 1 J
, ,- - - . . . . , , . . . _- -, , ., . - . .<w, - -
~ ^ " ' ^ " *~~ ^
T@s . Q. , - os i -
, *ll ODCM Rsv.H13L 1 Paga'12:
;lL -5/94?
s
'2.4;3 DOSE -' IODINE-131. IODINE-133, TRITIUM, AND-RADIONUCLIDES IN:
PARTICULATE FORM - W , This control is provided to implement'the requirementsLof " Sections.II.C,-III.A, and IV.A'of Appendix:I, 10 CFR'Part450. ; The controls-are the-guides set forth:in-Section II.C of: Appendix I. The ACTION statements provide the required- . . . . operating flexibility and at the same time implement lthe-guides set'forth in-Section IV.A of Appendix I.tofassure that the
- releases of radioactive materials in. gaseous effluents'will i be kept "as low as is reasonably. achievable."':The'ODCM' -
e calculational methods specified-in the Surveillance ~ .. .. Requirements: implement the' requirements!in Section III.A1of- ; . Appendix I be shown by calculational procedures. based'on models' and data, such that the actual exposure of.a MEMBER 1 0F THE PUBLIC through' appropriate pathways is unlikely to bel - substantially underestimated. The ODCM calculational methods for calculating the doses due to the actual-release rates of the subject materials are consistent with the methodology: provided in Regulatory Guide-1.109, Calculation ofLAnnual Doses ' to Man from Routine Releases of Reactor Effluents for thel Purpose of Evaluating Compliance with 10 CFR.Part'50, Appendix!
- I," Revision.I,. October 1977 and Regulatory, Guide.l.111,
" Methods'for Estimating Atmospheric Transport and Dispersion'of:
Gaseous Effluents in Routine Releases from' Light-Water-Cooled , Reactors," Revision;1,-July 1977,with. site specific dispersion' ' curves and deposition methodology. These. equations also provide for determining the actual. doses based upon the historical average atmospheric conditions. The' release rate-specifications for. iodine-131, iodine-133, tritium, and radionuclides ~1n particulate' form with half-lives greater than . 8 days are dependent on.the existing radionuclides pathways to man.in areas:at and beyond.the SITE BOUNDARY. :The pathways which were examined in the development of;these calculations I were: -(1) individual inhalation ~of: airborne radionuclides, (2)- J deposition of radionuclides onto green leafyivegetation with subsequent consumption by man, (3) deposition onto grassy areas where milk animals and meat-producing animals' graze with consumption of the milk and meat'by man, and (4) deposition on the ground with subsequent exposure of man. 2.4.4 VENTILATION EXHAUST TREATMENT SYSTEM-The requirement that the appropriate portions of this system'be-used, when specified, provides reasonable assurance that the - releases of radioactive materials in gaseous effluents will'be l kept "as low as is reasonably achievable." This control implements the requirements of 10 CFR 50.36a, General Design Criteria 60 of Appendix A to 10 CFR Part 50, and the design i objectives given in Section II.D of Appendix I to l 10 CFR Part 50. The specified limits governing the use i 1
i s - , ODCM Rsv. 13-f[ ]1 ' cPaga-13" , d 5/94 : b -of' appropriate portions of'the systems were specified. asia-
~
3
' suitable fraction of the. dose' design-objectives set"forth in' !
Section II.B and II.C~of Appendix I, 10 CFR Part 50,'for-gaseous effluents. J2.4.5' VENTING OR PURGING-V . .
~This contro1'provides reasonable assurance that-releases from drywell purging operations will not exceed the annual dose.
limits.of 10 CFR Part 20 for UNRESTRICTED AREAS. J i-t 2.4.6 TOTAL DOSE This control is provided to meet the dose" limitations ~of M - 40 CFR Part 190 that have~been incorporated into 10 CFR Part120 E by 46 CFR 18525. The control requires the preparation andL , submittal of a Special' Report whenever the calculated doses from plant radioactive effluents exceed twice the design .;' objective doses of Appendix I. For sites-containing up to four reactors, it is highly unlikely that the resultant dose to a . MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190, - if the individual reactors remain within the reporting requirement level. The Special Report will describe a course of action that should' 4 result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CER-Part 190 limits. For the. purposes-of the Special' Report,11t may be assumed thatLthe dose. commitment to the MEMBER OF THE'PUBLIC from other uranium fuel : cycle sources is negligible, with the exception that dose contributions from other nuclear fuel cycle facilities at the same site or within a radius of.5 miles must be considered. ~If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the-requirements of 40 CFR Part 190,:the'Special Reportiwith a request for a variance.(provided the release condition .
~;
resulting in violation of 40 CFR Part 190 have-not already been ; corrected), in accordance with'the. provisions'of 40 CFR 190.11' and 10 CFR 20.405c, is considered to be~a timely: request-and fulfills the requirements of 40 CFR Part.90-until NRC staff action is completed. An individual is;not considered a MEMBER OF THE PUBLIC during any period in which he/she is' engaged in I carrying out any operation that is part-of the' nuclear fuel . cycle. ; 1
-2.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM The Radiological Environmental Monitoring Program (REMP) required by this control provides representative measurements of radiation and of radioactive materials in those exposure pathways and for'those radionuclides that lead to the highest !i potential radiation exposures of MEMBER OF THE PUBLIC resulting from the station operation. This monitoring program implements Section IV.B.2 of Appendix I to 10 CFR Part 50 and thereby i supplements the. radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected
,. . - . _ _ m. _ , , , .
7~ ._. l
, q: ; :2
, ODCMLR3v.'13' 1 Paga!14
~
5/94" h on the basis of'theLeffluent^ measurements-and modeling_of.the environmental exposureEpathways. The required detection. capabilities.for environmental sample' - L analyses areftabulated in terms of,the lower-limits.of-detection'(LLDs). The LLDs required by Table I3.4-3'are. , j i
; considered optimum for routine environmental measurements in :
industrial-laboratories.- It should be recognizedithatzthe1LLD l- 1s. defined as.an a oriori (before the fact) limit representing. the capability of a measurement system and not-an after-the ; fact limitifor a particular measurement 3 Detailed ~ discussion of the LLD, and~other detection limits, can- l C :be found in HASL' Procedures Manual, HASL-300 (revised . annually);' Currie L.A., " Limits for-Qualitative Detection:and ,
' Quantitative' Determination cApplication to Radiochemistry,"
J.K.,'" Detection Anal. Chem.'40, 586-93-(1968). and Hartwell, Limits for Radionnalytical Countina Techniaues." Atlantic Richfield Hanford Connany Renort ARH-SA-215 (June ' 1975) . l 2.5.1 LAND USE CENSUS
~
, This control'is provided to ensure that changes'in'the.use'of-areas at and beyond the SITE BOUNDARY 'are -identified: and .thatl . modifications to the monitoring program are made.if: required'byr
.the results of the census. The.best informationifrom the: door -
g' to-door survey, aerial' survey or consulting with' local; . , agricultural authorities or any combination ofithese-methods-shall be:used. -This census < satisfies'the requirements 1 of- j' Restricting Section IV.B.3 of. Appendix I'to 10'CFR Part 50.
.the census to-gardens of greater than 500 squareLfeet provides t
~
i
' assurance that significant exposure pathways via: leafy.. j vegetables will'be identified and monitored since a garden of j
this size:is-the minimum required to produce the quantityc(26 , Xg/ year) of leafy vegetables assumed in Regulatory' Guide:1.109 's for consumption by a. child. To" determine this minimum' garden: ' size, the.following assumptions were used: .(1)1that20% offthe garden was used for growing broad leafy'vegetationi(i.el similar to lettuce.and cabbage), Land (2) atvegetation. yield of. 2 kg/ Square meter.' 2.5.2 INTERLABORATORY COMPARISON PROGRAM . The requirement for participation in an Interlaboratory , , Comparison Program ensures that' independent checks on the precision and accuracy.of.the measurements of radioactive material in' environmental sample matrices are performedLas part' of the quality assurance program for environmental. monitoring in order to demonstrate that the results are reasonably valid for the purpose of~Section IV.B.2 of Appendix I to 10 CFR Part
- 50. ,
7 2.6 APPLICABILITY # 2.6.1 Compliance with the controls contained in the succeeding ; controls section is required during the' OPERATIONAL CONDITIONS
~. >
gn; *L. l[y ODCM - Riv. : .-13 $ i Pagazl5; 4
-(l] -5/94- .;
y sor other conditions _specified'therein; except that uponLfailure to meet the controls, the associated ACTION requirementsLahall-be met. 2.6.2 NonLcompliance'with afcontrol shall-' exist when the requirements : of the control and associated ACTION requirements are not' 7 performed within'the specified time' intervals.. If'the. control 1 - is restored prior to= expiration of the specified time- ' intervals,. completion of the ACTION requirements is not'_ . required.
~i
-2.6.3 There'are no actions.in the:ODCM which would require an operational. condition change.
2.6.4 There are no restrictions.on-changing operating conditions in any of the controls on the.ODCM. 2.6.5 Surveillance Requirements shall be met during the~ OPERATIONAL CONDITIONS or'other conditions specified for individual controls unless otherwise stated in'an individual Surveillance. Requirement. ; 2.6'6- . Each Surveillance 1 Requirement shall'be performed within.the specified interval with a maximum allowable. extension not to , exceed-25%lof the surveillance-interval. 2.6.7 ' Failure to perform a Surveillance Requirement within the . allowed surveillance: interval defined by' control 216.6,;shall, l constitute. noncompliance with'the-OPERABILITY requirementsifor n a control. The time limits.of the ACTION requirements are! , applicable at the time it'is identified that a Surveillance Requirement has not been performed. The ACTION requirements 1 ; may be delayed _for up to 24 hours to permit the completionfof-the surveillance when the allcwable outage 1 time limits of the ACTION requirements are less than'24 hours. Surveillance . requirements do not have to be performed on inoperable i" equipment. i
# The associated bases from the LGS Technical Specifications -
applies to this section.
)
E , I h
- , , - u__ __ .__ -m . _ _ _ _ _ _
, , . . . -- - ~ _
(l}
~
-ODCM.Rsv.r13' Pags 16
- 5/ 94 ,
4 u . l:f .
?3.0- METEOROLOGICAL MONITORIhG INSTRUMENTATION ,
CONTROIS
- 3 .1' The meteorological monitoring instrumentation channels shown in-
^ Table'I3.1-1Lshall~be OPERABLE.-
APPLICABILITY:-At all' times. , ACTION: -t With less than the minimum required instrumentation
' channels. operable.for more than 71 days, prepare and submit a Special Report to the Commission pursuant 7to .
LGS. Technical Specification 6.9.2.within the nextl10 days outlining; the ~cause of :the ' malfunction and the < plans for restoring the instrumentation to OPERABLE ' status.- t SURVEILLANCE REQUIREMENTS
- . 3.1-1 Each of the above required meteorological monitoring
- instrumentation channels.shall be demonstrated OPERABLE by the; performance of the CHANNEL' CHECK-and CHANNEL . .
. CALIBRATION operations at.the frequencies shownfin~ Table-I3.1-2. ,
4 i I
m . . _ . . .-. . _ __ JS ODCM REv. 131
- Pcgn 17:
.=
l; 5/94 TABLE 13.1-1 METEOROLOGICAL MONITORING INSTRUMENTATION ^ MINIMUM Tower 1 Tower 2 INSTRUMENT
. INSTRUMENT (Primary) (Backup) OPERABLE.
fl.- Wind Speed
- a. Elevation 1 30 feet 159 feet .1
- b. Elevation 2 175 feet 304 feet 1
~2. Wind Direction
' 159 feet 1
- a. Elevation 1 30 feet.
- b. Elevation 2 175 feet 304 feet 1 f- -3. Air Temperature Difference (AT)
- a. Elevations 266 feet-~ 300 feet-26 feet 26 feet 1 TABLE 13.1-2 METEOROLOGICAL MONITORING INSTRUMENTATION SURVEIT.TANCE REOUIREMENTS Channel Channel INSTRUMENT Check CALIBRATION
- 1. Wind Speed
- a. Elevation 1 (Tower 1 and Tower 2) D SA
- b. Elevation 2 (Tower 1 and' Tower 2) D SA
- 2. Wind Direction a.-Elevation 1 (Tower 1 and Tower 2) D SA.
- b. Elevation 2 (Tower 1 and Tower 2) D SA
- 3. Air Temperature Difference (AT)
- a. Elevations 266 - 26 ft (Tower 1) D SA
- b. Elevations 300 - 26 ft (Tower 2) .D SA 4
NOTE: The. meteorological towers shall be located as shown on Figure I3.1-1. For backup sources of data retrieval, refer to' Table I3.1-3.
(_
- L_
L' W
,~
j ODCM R:v."13 y Page.18' l 5/94. i- .. TABLE I3.1-3 l METEOROLOGICAL TOWER DATA RETRIEVAL l INSTRUMENT TOWER 1 TOWER 2 DATA IDGGER DATA Strip Chart # Strip Chart # RM-21A Channel # I Wind Speed. 1 (TWR1)
- c. Elev. 1 XR-MS-012C XR-MS-020B RM-21A 14 (TWR2)
Wind Speed _ _ 5.(TWR1) , b. Elev. 2 XR-MS-012B XR-MS-020A RM-21A 21 (TWR2) Wind Dir. 0 (TWR1) - ' I a. Elev. 1 XR-MS-012C XR-MS-020B LRM-21A 13 (TWR2) l Wind Dir. . 4.(TWR1)
- b. Elev.-2 XR-MS-012B XR-MS-020A RM-21A 20 (TWR2). ,
l Multi-pt Rec # Multi-pt Rec # I DELTA T. XR-MS-091 XR-MS-092 7 (TWR1) l Point 2 Point 2 RM-21A- 23 (TWR2)- l. l PRIMARY OPTION: H DATA-IS UNAVAILABLE FOR TOWER l'(Strip Chart ##s XR-MS-012C,.XR-MS-012B, Multi-Point' l_ Recorder #XR-MS-Ol' point'2),.. l THEN verify corresponding data'available on Tower 2 (Strip Chart #'s XR-MS-020A,;XR-MS-020B,: 1 Multi-Point Recorder iXR-MS-092 point 2). - SECONDARY OPTION:
.H data is not'available from Strip Charts.or Multi-Point. Recorders,
~~
THEN verify data on RM-21A. TERTIARY OPTION: H'RM-21A.is not available, l THEN verify. data on Data Logger (corresponding channel numbers)~. 1 4 l i h
'k
.n. ,, ,. , -
,- - .w,. ,, .- ,
m , -) 1 a . . . 1
;ODCM Rav. 13' yl _ ,
- 9. 7
, jPaget19
- i~ ' ' : 5/94 :
8l Ficrure 13.1-1
. Meteorological Tower Location- pg-y,\ \ ', MC'Oh yM.yggg4Svi-MM -
gi p y y::t m_.L b.u..r~ .___ , %..r . F ' 42.. W... n.1 o : y
. .. x.
t a*".
. - , p *. =.* -
V~~:0:BtfMitil
-,...,4'.
.Jr .
'l*.
6 .
,3
- i.
, '4"
# 11 "Nf
!D.'. 9 ,' _
~h
\ . i,ts( 4.k, ./ W;.e.glrk,**h,b_=a .1~*g s
M, s%. , A .
\, \, -
..,,<....vgf.,- Q
;. E...,. .
. .( .M ./.( M .-:. ...
ic .s \t i \~ V 14 . * /. ) ~# . M i sy g i s
.%v .s.g. s %.,s,p.,,
c. r - li ie r v
- g. ':K v.. . c .x. s
'A\ y%\ h.hSD..W Jo.O_sh!M s
- ') u
~
'. 4. N Y,b, psgy. . s.;,t si ha E.f4, -
~ E.M. .. t.-+f i, \i e um c-<fmd T T'K _N ~ m m .
3 .
,. w\
Y
;,g ;-
1x k~ . _I _'._ m .\ gi "_.;c
' :e-- m==w!T, _ o--
_.i.*e yw_.3try!.
.w. sw,. >
v.&s..w .:,e e w. w. 8 - V\ W. Mis _E F3'd/@je.',' b i*s!sN
,h, h -j; lMETIOROLOG1til \
i , 3- g !) .h 5_- -500T
- e. .~i., Tev.. e? .
\ u . w. _
l
" \Wt9C'-- P.Q. "/ I * \ )\
\ _.%fffC Wik D- - MYi%W'.;msm.Y
. 4, , r- -.f
- 0.9 5.
,,y. <<,< g. , :: q y
h-.:d..: vx bcx p;.i ..i.,
" s: ..4
- s. - 1 l wc ..w,.v rewc t , .c A '
qr u-- 3 . a a
.s ::~ sw s. . . .s; i
M. . r. g 1 t ,s -Q. .q.yc. e <--
- q u.s.Y..w ;. .c
., i s . , .-
- - Q w. s.c'i .3 e. -
.p(,%p..u.?a ._
; %.g
- . t -.
- ) 1 , /, ,.
4
., K .. , iS=i;L'~- .Y N. *
- s. ;';~
; =p) 'it.
, .Y.k.'%' Nh ] L+ .-3
~~~~
*&:4.'?'. ,.
.U -l' f ~3\"7 s q '.Q-. T%, ' ' . 'r.'% ..' .~.": : ?%A k'v.3.--
' i, M m.h-.f
_- 'i G: .Q 1 i i e 4
""F* '#"- "u n y .,-,,_.,,_,g5g_,,
-,.,w, , ,,- m
,ny .- n . - - . - - - -. . .
!M :1 _-ODCM"Riv. 13 :1 f.. Pago:20- l
;j 5/94? j 3.2' RADIOACTIVE LIOUID' EFFLUENT MONITORING INSTRUMENTATION CONTROLS 3.2.1 ~Thelradioactivefliquid effluent monitoring instrumentation,
, channels:shown in Table I3.2-1 shall'be OPERABLZ'with their' .
' alarm / trip setpoints set to ensure that control.I3.2.2 is not
~
' exceeded. .The alarm /setpoints* of these channels shallibe
. determined and adjusted in .accordance: with the methodology and '
. parameters in.the-ODCM - Part II,.Section 1.2. 1 APPLICABILITY: At all? times.' '- ACTION: + 4
- a. .
With a' radioactive liqaid affluent monitoring instrumentation' l . channel alarm / trip setpoint -less conservative than required: , by the-above control, immediately; suspend-the: release of. b r&licactiveEliquid effluents monitored by:the'affected' channel, and declare the-channel inoperable ~. ;
- b. With less than the minimum number lof radioactive' liquid effluent monitoring; instrumentation' channels OPERABLE,1take the ACTION shown in Table I3.2-1. Restore-the inoperable ._
instrumentation'to' OPERABLE status within,the. time-specifiedc in the ACTION or-explain.in the:next Semiannual' Radioactive Effluent Release Report whyLthis inoperability wasLnot.. corrected within the time specified. SURVEILIANCE REQUIREMENTS 3.2.1-1 Each radioactive liquid effluent; monitoring instrumentation channel shall befdemonstrated OPERABLEL by performance:of the CHANNEL-CHECK,-SOURCE CHECK, ~' l CHANNEL, CALIBRATION and-CHANNEL FUNCTIONAL TEST-performance at the. frequencies shownsin Table I3.2-2.. W
- Excluding the flow rate measuring devices'which are not
determined and adjusted-in accordance with the.ODCM.
I 4 . 4 4
W
, ]j ODCM Rsv. 13 gg, .
Paga 21-M
.[ -5/94-
' TABLE I3.'2-1.
RADIOACTIVE LIOUID ' EFFLUENT ' MONITORING INSTRUMENTATICE :
I MINIMUM:
CHANNELS: INSTRUMENT OPERABLE ACTION
- 1. Gross Radioactivity Monitors Providing Automatic Termination.of Release ;
a.- Liquid Radwaste Effluent Line 1- _100
, b. Jy/B RHR Service Water: Effluent Line 1/ loop: 101 ;
- 2. Gross Radioactivity Monitors Not Providing' Automatic Termination of Release ,
- a. Service Water Effluent Line 1 :101~ '
- 3. Flow Rate Measurement Devices
- a. Liquid _Radwaste Effluent Line 1 1102
- b. Discharge Line 1- 102' .
ACTION STATEMENTS Action 100- With less than the Minimum Required-Channels operable,- effluent releases may continue for up toJ14 days provided; .# that prior to' initiating.a release:' _
- a. At least two independent samples are analyzed in; accordance with Table I3.2-3, and . ,
- b. At least two technically qualified members of thel '
facility staff independently verify the release rate calculations and discharge line valving;. _ Otherwise, suspend release of? radioactive effluents 1via ! this pathway. ] Action 101- With less than the Minimum Required Channels operable,- ' l effluent releases via this pathway may continue'for up.to 30' days provided that, at least once per 8 hours, grab samples are collected and analyzed for radioactivity by l gamma isotopic analysis-(Principal Gamma' Emitters, I-131, ' and Dissolved / Entrained Gases) as'a Lower Limit-of~ Detection as specified in Table I3'.2-3'orfgross ~ radioactivity'(beta _and gamma). Gross Beta is-analyzed; at an LLD of at.least 1N7 microcurie /ml. : Gross Gamma.is analyzed at an LLD of at least SN7 microcurie /ml.
- Action 102- With less than the-Minimum Required Channels-operable, j effluent releases via this pathway may continue for:up to a 30 days provided the flow rate is estimated at.least once ;
per 4 hours during actual releases. Pump curves i generated in situation may be used to estimate flow. H l i i i
_ g. .
~ y+
^
fi j u . a L
~
l l ~ODCM Rev.- 13 &. Page-224 l 5/94 - l l: TABLE I3.2-2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE'REQU'IREnENTS-
.CHANNELi CHANNEL SOURCEL CHANNEL F UNCTIONAL~
INSTRUMENT CHECK CHECK ' CALIPRATION TEST I' 1. Gross Radioactivity Monitors Providing Automatic Termination of. Release-
- a. Liquid Radwaste Effluent Line- P P R(3) - Q (1) : '
- b. RHR' Service Water System Effluent Line D M- ' R(3). ~ Q(1) _
I L
- 2. Grcss Radioactivity Monitored Not Providing Automatic Termination of Release '
- a. Service Water System Effluent Line- D M R(3) L Q (2')
- 3. Flow' Rate-Measurement. Devices i
- a. Liquid Radwaste' Effluent Line D(4) N.A. ~ R- .-
Q
- b. Discharge lLine D(4) N.A. R -Q i
l-i 4.
. ~- -
~ . - s. , . , _ , . . 4 -, . . + - -
/ + + + v + - - A-:- ----z - - - - - - -
j' , ODCM Rsv. 13- .
' Prga 23
, l 5/94'
@ABLE T3.2-2'(Continued) 7-TABLE NOTATIONS
-(l) . The CHANNEL FUNCTIONAL TEST shall also demonstrate that-automatic isolation of this pathway _and control room alarm-
" J annunciation will' occur if any of the following conditions-exists:
- 1. Instrument indicates-measured levels above the-alarm / trip setpoint. "
2.- Circuit failure.
- 3. Instrument indicates a downscale failure. '
(2) The CHANNEL FUNCTIONAL TEST shall-also demonstrate'that control room alarm annunciation' occurs if any of the . following conditions exists:
- 1. Instrument' indicates measured levels'above the alarm-setpoint.
- 2. Circuit. failure.
- 3. Instrument indicates a downscale' failure.
(3) The initial CHANNEL CALIBRATION shall be performed using reference standards certified by the National Institute af. , Standards and Technology. (NIST) obtained :from suppliers that . '
. participate in measurement assurance activities with:NIST.
These standards shall permit calibrating the system over it's-intended-range'of energy.'and measurements range. .For-subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be-used. , (4) CHANNEL CHECK shall consist of verifying indication of' flow; , during periods of release. CHANNEL CHECK shall be made at-least once per 24 hours on days on which batch releases are made.
- }
w 4 a 4 1
)
~
~
'. l. ODCM rov. 13 '
Pcgn:24: 5/94; l-CONCENTRATION CONTROLS J3.2.2 -The concentration ~of radioactive material; released in
' liquid.offluents to UNRESTRICTED AREAS (see Figure.I2.2-la,b) shall'be limited-to the concentrations'specified in.
10 CFR Part 20, Appendix B, Table II,-Column-2-for,
, radionuclides other than' dissolved or entrained nobles
~
gases.. - For dissolved or entrained noble gases, the- ' concentration shall be limited-to.2E-4 microcuries/ml total-activity. APPLICABILITY: . At all times. , ACTION: With the concentration'of radioactive material released in liquid effluents to' UNRESTRICTED AREAS exceeding'the above limits, immediately restore ~the concentration to within the above limits or terminate the release.- SURVEILLANCE REQUIREMENTS 3.2.2-1 Radioactive'liqpid wastas shall be sampled and-analyzed according to the: sampling and analysis
- program-of Table I3.2-3.
3.2.2-2. The results of the radioactivity analyses shall
'be used in accordance with the methodology.and-
. parameters in the ODCM Part II. Section 1.3 to +
assure that the concentrations at the point of. release are maintained within the' limits of Control I3'.2.2. , i 5 i . I y y-
If ODCM Rnv. 13 l Page 25 l 5/94 TABLE I3.2-3 RADIOACTIVE LIOUID WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum Type of of Detection Liquid Release Sampling Analysis Activity (LLD)* Type Frequency Frequency Analysis (uCi/M1) A. Batch Waste P P Principal Gamma 5E-7 Release Each Batch Each Batch Emitters
- Tanks b I-131 1E-6
- 1. Floor or P M Dissolved and 1E-5 Equip. Drain One Batch /M Entrained Gases Sample Tanks (Gamma Emitters)
- 2. Laundry P M H-3 1E-5 Drain Sample Each Batch Composite d Tank Gross Alpha 1E-7 P Q Sr-89, Sr-90 SE-8 Each Batch Composite d Fe-55 1E-6 B. Continuous W W Principal Gamma SE-7 Release' Grab Sample Emitters
- I-131 1E-6
- 1. RHR Service W W Dissolved and 1E-5 Water System Grab Sample Entrained Gases Effluent Line f (Gamma Emitters)
- 2. Service Water W M H-3 1E-5 System Grab Sample Composite d Effluent Line f Gross Alpha 1E-7 W Q Sr-89. Sr-90 SE-8 d
Grab Sample Composite Fe-55 1E-6 I l I 5
p-ODCM:Rsv.~13-
. s Jf Pago 26
.m^
't 5/94 -
mg 7 TABLE-I3.2-3'(Continued)- TABLE NOTATIONS
- a. The LLD>is defined as.the smallest concentration ofLradioactive-material'in-a sample that will yield a net count, above system background,.that will be detected with195%Jprobability with only. r 154 probability of falsely concluding that'a blankiobservationc represents a1"real" signal.-
o For a> measurement system, which mayrinclude1 radiochemical separation:- 2 . 71. + 4 . 66s, (1-exp (-A A t )2 ) - LLD - E 1/ 2.22E6
- Y exp (-AAt,) ( AAt2) .
Where: LLD is the a criori lower limit of detection as defined above ( as microcuries per unit mass or volume), s, is the standard deviation of the background ' counting rate -or - ; of the counting rate of blank sample as appropriate (as' counts per minute), E is the counting efficiency, as counts per disintegration, V is the sample size, in units of mass or volume, N 4 2.22E6 is the number of~ disintegrations per_ minute per microcurie, j l Y is the fractional radiochemical' yield, when applicable, .j ^ A is the radioactive decay constantLfor the particular $ radionuclide, and , At i for the plant effluents is - the elapsed time between the end-of the sample collection and the time of counting. ; At2 for the plant effluents is the elapsed time between tdue end- r', of the sample collection and the_ start of sample collection.. d' Typical values of E, V, Y, and At should be used in: calculation. ; e It should be recognized that the LLD is defined as an a criori-(before the fact) limit representing the capability'of a measurement. system-and not as an after the fact limit 1for a particular measurement. Y s
l> :ODCM Rsv.. 13 Paga-27
.l 5/94. -;
4 TABLE 13.2-3 (Continued) TABLE NOTATIONS Eb . A batch release is the discharge of liquid. wastes of a discrete ., volume. Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed to assure representative sampling.
- c. The principal gamma emitters for which the'LLD specification applies-include-the following radionuclides: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141 and-Ce-144.- This list does not mean that only these nuclides are to be considered.-
Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the-Semiannual Radioactive Effluent-Release Report pursuant to Control 3.6.
.d. The te::m " Composite- Sample" means a combination of individual.
samples obtained at regular intervals over a time period. Either
-the volume of each individual sample is proportional to discharge:
flow rates, or the sampling interval (for constant volume samples) is proportional to flow-rates over the time period used to produce the composite.
- e. A continuous release is the discharge of liquid wastes.of nondiscrete volume, from a Volume of a system that.has an input flow during the continuous release.
- f. Whenever effluent releases are in excess of the monitor's setpoint.
k
7,. - .. . . .. . . -~ -- - - . . dM'^ W ODCM Rav. 13- j
- . l[ _
; .-g 'Pcga 28
- j. -5/94
~ ** Dose 1
CONTROLS ] l
'3.2.3 The dose'or dose commitment:to a MEMBER OF THE-PUBLIC:from< -
radioactive materials in liquid affluents released-from the
' site to' UNRESTRICTED AREAS'(See' Figure._I2.2-la).shall~be- '
limited:
- a. During any calendar quarter to'less than or equal to.
-3 mrems to'the-total body and to lesssthan or. equal tol 10'erems:.to any organ, and f
~b. During any calendar' year.to less than or equal lto 6 ;
arems;to the total body and to less than or equal..to 20 mreas to-any organ. APPLICABILITY:- At all times.. .. E ACTION: With-the calculated dose from the release of--- . radioactive' materials in liquid effluents' exceeding any of the above limits,-prepara and submit to the
-Commission within 30 days,Rpursuant to Technical Specification 6'.9.2, a Speciali Report: which ~ identifies :
the -cause(s) for exceeding' the' limit (s) 'and : defines the corrective actions-that:have beenitaken to reduce the releases and the proposed corrective actions to be ., taken to assure that subsequent-releases'will.be.in* compliance with the above limits. This.Special: Report ; shall1also include'the radiological' impact on finished: drinking water supplies at the nearest downstream; drinking water source. SURVEILLANCE REQUIREMENTS . 3.2.3-1 Cumulative dose contributions'from liquid-effluents. for the current calendar quarter and the current' . E, calendar year shall be determined using ST-0-104-878-0 at least once per 31-days. [ 2 S 1 v - w mv,-d--- ,- - - , , _ _ _ , - - - . _ _ _ -
W l l.
.ODCM Rtv. 13'
. l P0g3 29
" - j' 5/94 LIOUID RADWASTE TREATMENT SYSTEM CONTROLS 3.2.4 The liquid radwaste treatment system shall be IN SERVICE and appropriate portions of the system shall be used to reduce the radioactive materials in liquid waste. prior to their discharge when the projected doses due to the liquid effluent, from'the site, to UNRESTRICTED AREAS (See Figure I2.2-la) would exceed 0.06 mrem to the total body or 0.2 mrem to any organ.
in a 31-day period. APPLICABILITY: At all times. ACTION: q
- a. With radioactive liquid waste being discharged without treatment or in excess of.the above limits, pursuant to Technical Specification'6.9.2, prepare a Special Report which includes the following information:
- 1. Explanation of what liquid radwaste was being discharged without treatment, identification-of any inoperable equipment or subsystems, and the reason for the inoperability.
- 2. Action (s) taken to restore the inoperable equipment to OPERABLE. status, and
- 3. Summary description of action (s) taken to prevent a recurrence,
- b. Submit report to Commission within 30 days.
SURVEILLANCE REOUIREMENTS 3.2.4-1 Dose due to liquid releases from the site to UNRESTRICTED AREAS shall be projected at least once per 31 days using ST-0-104-878-0. 9 4
n -
] ODCM:RLv.'13<
Pago-30 :J i gf clt ' c5/94 ;)
-l 3.3 RADIOACTIVE GASEOUS EFFLUENT' MONITORING INSTRUMENTATION CONTROLS 3.3.1 The-radioactive gaseous effluents monitoring' instrumentation channels in! Table I3.3-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that the limits of ODCM Control Part I Section 3.3.2 are not exceeded. .Thefalarm/ trip setpoints of'the applicable channels shall-be determined in accordance with the methodology and~ parameters in the ODCM O ^
Part'II,.Section 2.2. APPLICABILITY: As shown in Table I3.3-1.- AC RQH:
- a. With a radioactive gaseous affluent monitoring instrumentation channel alarm / trip setpointsfless -
conservative than. required by'Part II Section 2.2i . immediately suspend the release of radioactive gaseous effluents monitored-by the affected. channel or declare. the channel inoperable. With less than.the minimum number of radioactive b. gaseous effluent monitoring instrumentation. channels-OPERABLE, take the ACTION shown in Table:I3.3-1. Restore the inoperable instrumentation to' OPERABLE i . status within the time specified in the ACTION. If-the inoperable instrumentation is not. restored within. the time specified in the ACTION statement: create an AR-in PIMS to ensure an explanation is written by the responsible System Engineer and is included in SAERR l by the HP Effluent Physicist.- ^ SURVEILLANCE REQUIREMENTS 3.3.1-1 Fach radioactive gaseous effluent monitoring . , instrumentation' channel shall be'demonstratedf0PERABLE 4 by performance of the CHANNEL' CHECK, SOURCE CHECK, CHANNEL CALIBRATION AND CHANNEL FUNCTIONAL TEST F operations at the frequencies shown-in Table I3.3-2. t 4 P 1 : L >
8 ODCM RSv.J13S k.- Prgs 31 ' $W:9 5/94' l
~
TABLE I3.3-1 -
~
M OACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION-MINIMUM CHANNELS' INSTRUMENT ' OPERABLE APPLICABILITY ACTION g SOUTH STACK CFFLUENT MONITORING SYSTEM
-a.-Noble Gas Activity Monitor l' *- 111
- b. Iodine Sampler 1 *- 112
- c. Particulate sempler. 1
- 112 9
- d. Effluent' System Flow Rate Monitor 1- * -113
- e. Sampler Flow Rate Monitor 1 * '113 NORTH STACK EFFLUENT MONITORING SYSTEM #
- a. Noble Gas Activity Monitor 1 *. ~ 114 ,
-b. Iodine' Sampler 1
- 112
- c. Particulate Sampler 1 *- 112 .;
- d. Effluent System Flow Rate Monitor 1
- 113
- e. Sampler Flow Rate Monitor 1
- 113:
i HOT MAINTENANCE.SNOP VENTIIATION EXHAUST RADIATION MONITOR
- a. Iodine. Sampler 1- ** 112 i b.' Particulate' Sampler . _
1- ** 112' c.. Effluent-System' Flow Rate Monitor 1 ** 113
- d. Sampler Flow Rate' Monitor l' **- 113 i The (A or B) North Stack Normal Range Radiation: Monitors OR the Wide' Range Accident. ,
i Monitor (Low Range) may;be used to satisfy requirements for the North Stack Effluent Monitoring l" System. ~ NOTE: With. regard to~ Actions Ill -i112,-113, and 114;Jwith less than:the; minimum Required Channels-operable for greaterithan 30 days prepare and submit ~a Special: Report to.the Effluent ~ Physicist within thelnext-10. days ~ outlining the cause of.the malfunction and the plans for restoring:the: instruments toLOPERABLE Status. . Sampling sha!.1 continue until-the minimum channel operability. requirement.is met.
-* At all' times..
** . During operation of the hot' maintenance : shop ventilat! ion system.-
- j. 3
. ~ . . - . __. . . . - .__ .
+e . .
' ' F ODCM Rav. 13 '
.Paga 32.
-[ 5/94 y
TABLE I3.3-1(Continuedi TABLE NOTATIONS
~
ACTION STATEMENTS .
~
ACTION 111- - .With less than the minimum Required Channels (SS. Noble Gas). OPERABLE, affluent. releases-via.this; pathway. may continue for'up to 30 days provided: grab samples'are_taken per ST-5-026-580-*- at least once per_8: hours and these samples are: .; analyzed for gross activity within'24 hours.- ACTION 112* - With less than the: minimum Required Channels (Iodine & Parts) OPERABLE, effluent releases.via this pathway.
- may' continue'for up to 30-days provided '
samples are continuously collected with
-auxiliary sampling equipment per St-5-076-815-*, ST-5-076-820-* as required in '
Table I3.3-3. II the Sample Pump is. operable, a' particulate and iodine' sample can be obtained;'
= &HD the Minimum. Channels Operable-requirements are satisfied.
I ACTION 113* - With:less than the minimum' Required' Channels I (Eff. & Supl. OPERABLE, effluent releases'via NS', SS or HMS Flow Rate) may. continue for up to 30 days _provided the flow- rate iis estimated by adding the nominal - flow rates indicated in P&ID M-26 for eacn: in-service fan. This shall be documented-in the MCR operations ShiftjLog at-least once par'4 hours.
- ACTION 114 - With less than the minimum Required Channels (NS Noble Gas) OPERABLE,' effluent releases via this pathway may continue for up to 30Ldays-provided grab a samples are taken per-ST-5-026-580-0 at least once per 8 hours and these samples are, analyzed for gross activity.within 24_ hours.
The Mechanical Vacuum Pumps mayinot be-
- operated during this LCO.
- If release _ point is the Hot Maintenance Shop,.
Then' secure ventilation because no'means exist to alternately. sample the ventilation. 5 4 5 s 1 4 < - eq n -
-m~ - n,- , , , , - . . , , -_--._--_-_.__._.__._____L
~~
- J -
- j. ODCM'Rsv.'13- -
Page 33 ' 8
.5/94 -n
- ! {
- TABLE I3.3-2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS
. ~ ~ ~ CHANNEL MODES IN WHICH-CHANNEL SOURCE CHANNEL' FUNCT. SURVEILLANCE INSTRUMENT CHECK CHECK CALIBR. TEST IS REQUIRED . 1. SOUTH STACK EFFLUENT MONITORING SYSTEM * - a. Noble Gas Activity Monitor
~
D . M R(2) Q(1) 1 N.A. N.A. N.A.
- j b. Iodine Sampler 'W(3) *
- c. Particulate Sampler. W(3) 'N.A. N.A. N.A.
j d. Effluent' System' Flow Rate-Monitor D N.A. R Q.
- e. Sampler Flow Rate Monitor' D N.A. R Q :
I 2. NORTH STACK EFFLUENT MONITORING SYSTEM #
- j a. Noble Gas Activity-Monitor D- M R'(2) Q(1)
N.A. 'N.A. N.A. * >
- b. Iodine Sampler-W(3) *
- c. Particulate Sampler W(3) N.A. N.A. N.A.
~*
F .d. Effluent System Flow Rate-Monitor D N.A. R Q ,
- e. Sampler. Flow Rate Monitor D N.A. R Q ..
- 3. HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR N.A. N.A. N.A. '**
a.' Iodine' Sampler W(3)
- b. Particulate Sampler N.A. N.A. **
W(3) N . A . --
- c. Effluent System. Flow Rate. Monitor D' " N.A. R Q **
- d. Sampler Flow Rate Monitor. D. N. A. - R Q. **
~ ~
I
# Wide Range Accident Monitor;(WRAM) surveillance'.is specified in Technical-Specification:4.3.7.5.
- At all times.
** During operation'of the hot maintenance-shop ventilation exhaust' system.
~]
[ ODCM Rav.~13-Pcgn 34 l 5/94 TABLE I3.3-2(Continued) TABLE NOTATIONS (1) The CHANNEL FUNCTIONAL TEST shall.also demonstrate that control room alarm annunciation occurs'if any of.the following conditions exists:
- 1. Instruments indicate measured levels above the alarm / trip setpoint.
- 2. Circuit-failure..
- 3. Instrument. indicates a downscale failure.
- 4. Instrument' controls not set in operate mode.
(2) The initial CHANNEL CALIBRATION'shall be performed using one or more.of.the_ reference standards certified by the National Institute of Standards and Testing (NIST) or using standards that have been obtained from suppliers that-participate in measurement assurance activities-with NIST. These. standards shall permit calibrating the system over' its intended range of energy and measurement. range.1 For subsequent CHANNEL CALIBRATION, sources that are traceable to the initial calibration shall be used. (3) The iodine cartridges and particulate filters will be. changed and analyzed at least once per-7' days. l
-= . . - . . , . . . . .. . . ..
[jI ODCM Rev.'13'
~
Pagn=35 g ~ 5/94; Jl GASEOUS EFFLUENTS . CONTROLS
'3.3.2:The' dose rate due to radioactive materials' released-in gaseous effluents'from the site to areas at or beyond the SITE BOUNDARY -(See Figure I2.2-la) .shall be limited to:
a.- For noble gases:- less than or' equal.to.500 mrems/yr.to the total body and.less than or. equal to-3000 mrams/yr to the skin, and
- b. For iodine-131,- iodine-133, tritium, and-for all >
radionuclides in particulate form with half-lives-greater.than 8 days: less than or equal'to 1500 mrams/yr to any organ. -(Inhalation pathways only.) APPLICABILITY:' At all times. ACTION: With the dose rate (s) exceeding the above limits, immediately restore the release rate to within the above limits. SURVEILLANCE REOUIREMENTS 3.3.2-1 The dose rate due to-noble gases in gaseous effluents'shall be determined to be within the , above limits using ST-0-104-879-0. When North or South Stack. Noble Gas setpoints are exceeded, the Common Dose Model computer program is used to .* determine dose rates due to Noble Gases. 3.3.2-2 The dose rate due.to iodine-131,' iodine-133, tritium, and all radionuclides in particulate' form with half-lives greater than 8 days ~in gaseous. " effluents shall be determined to be within the' above limits using ST-0-104-879-0 by obtaining representative samples and performing analyses in accordance with-the sampling and analysis program specified in Table I3.3-3. A= . _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ - _ _ _ _ _ . - .- . - %. -,m ,m. - . w
L...>, , _ l? g.- L.
.}
K~ O D C M R s v .,-- _' 1 3 - 'I Pags.36) ' w ' ] @[ T - 5/94; T TABLE'I3.3-3 1
~
RADIOACTIVE CAEEOUS WASTE SAMPLING AND ANALYSIS PROGRAM-Lower Limit Miriimum TypeLof .of Detection .
. Gaseous Release Sampling' Analysis Activityi :(LLD)*
Type Frequency' Frequency ; Analysis (uci/M1)
<r A. Containment .
P. P . Principal Gamma; : 1E-4 ; , Purge Each Batch Each Purge- Emitters'; f - Release- ' Grab.Supl. . B. North Stack / Continuousd Q Gross Alpha ~ 1E-11' South. Stack- (Comp. Part. Sr-89, Sr 1E-11 Sample Mb ' Grab Supl. Mb Noble Gas. '1E-4 " H-3 1E-6 continuousd W'~ Char. Sapl. I-131 1E-12L I-133- 1E .; Part. Supl.. Principal. Gamma _ Emitters . 1E-11' , Continuousd Continuous- ' Noble. Gas Noble Gas 'Betalor Gamma ^ '1E-6
-Monitor- .(Based:on- >
- Xe- 13 3 ) -
q C. Hot Mainten. Continuous d Q Gross Alpha- 1E-11 Comp. Part.- Sr-89, Sr-90: .1E-11 ' Supl. continuousd W* ; Char. Supl.. I-131- ' 1E-12 L I-133 1E-10= Part. Supl. Principal ~ Gamma Emitters 1E -11 : 1
;31
_ _ . . . - _. _ _ .. .m _ .. k k h ODCM R3v. 13 (, m _ [ :
-Paga 37 1 ,
d :, 5/94
. TABLE I3.3-3 / Continued)
TABLE NOTATIONS
' a. ~ The LLD is defined, as the smallest. concentration:of radioactive material?in a sample that;will. yield a' net count,_
above system. background,;that will be detected.with 95%'
' probability with only 5% probability of= falsely: concluding that a-blank observationLrepresents a "real" signal. It should be recognized that the LLD.is: defined.as an a nriori '
- (before the fact)l limit-representing the capability of a-measurement system and not as an.after the fact-limit for a particW r.r measurement.
For a particular measurement system, (which'may include radiochemical separation): I 2.71 + 4. 66s, (1-exp(-A At2 ) ) - E V
- 2.22E6
- Y exp (-AAt,) ( AAt a)-
Where: LLD is the a oriori lower limit of detection as defined 1above . (uCi/cc or uCi/mL) , s, is the standard deviation .of the background _ counting rate or of the counting-rate of blank-sample as appropriate (as cpm), shall be based on.the actual = observed variance of the background countin'g rate or of the counting rate of the' blank samples (as appropriate) rather than on an unverified-theoretically predicted variance. j E is the counting efficiency, as cpdis, , V is the sample size, in units'of cc or al, 2.22E6 is the number'of dpm/uci Y is the fractional radiochemical. yield, when applicable, A is the radioactive decay. constant for the particular radionuclide, and At3 for the plant effluents is the elapsed time between the. and of the sample collection and the-time of counting. At7 for the plant effluents is the elapsed time between the , and of the sample. collection and.the start of sample
. collection.
Typical values of E, V, Y and At should be used in calculation. l
,g ., .. - ~_ ~ . - .
. - - ~ - . , . . - . - . .. ..
SGl9 ' DCM~Rav. 131 O P P a g a .3 8 '. y ]' 5/94 -Mg; TABLE T3.3-3 (Continued) , a TABLE NOTATIONS ,
- b. . Sampling and-analyses-shall1also be performed.following,
, , shutdown,.startup,.or a THERMAL 1 POWER change exceeding 15% of; - 'the RATED THERMAL POWER'within a 1-hour.perioo using.:
1RT-5-000-876-*. This. requirement does.not apply if (1) analysis show that.the DOSE = EQUIVALENT I-131 concentration in the~ primary-coolant has not increased more than a factore of 3;
, and-(2)"the mainLcondenserloffgas-pre-treatment radioactivity monitor:shows-that affluent activity has not increased more' than a factor of 3.
? ~ _cr '.
- c. Samples shall.be. changed at least once per 7 days and. analyses shall be completed within 48 hours after-changing, orLafter' removal'from sampler.- Sampling shall~also:be' performed at least once'per 24 hours for at least17 daysffollowing each shutdown, startup or THERMAL' POWER change exceeding:15% of-
, RATED THERMAL' POWER in l' hour and analyses completed with 18. 1 hours of changing., When samples collected.for~24 hours ~are analyzed, the corresponding LLDs:may be increased.by a-factor of_10. This' requirement does.not' apply if: (1)' analysis shows: that the DOSE EQUIVALENT I-131' concentration in the primary coolant has not increased more.than a. factor of,3; and (2) thef . noble gas monitor showsuthat effluent activity has not increased more than a factor of 3.
- d. The ratio of the sample flow rate to the-sampled stream flow:
rate shall be known for the time period. covered-by.each dose or dose rate calculation made in accordance'with controls j 3.3.2, 3.3.3, and 3.3.4.. The principal. gamma emitters:for which the LLD; specification ? j e. applies include the_following radionuclides: Kr-87, Kr-88, Xe ' 133, Xe-133m, Xe-135, Xe-135m and Xe-138 fsr gaseous' emissions-and Mn-54, Fe-59, Co-58, Co-60,.Zn-65, Mo-19, I-131,._.Cs-124,_ Cs-137, Ce-141 and Ce-144 for particulate ' amissions. This ~ list does not mean1that only these nuclide s are nto -be considered. Other gamma peaks which are identifiable, together with the above nuclides,-shall-also1be' analyzed and L reported in the Semiannual Radioactive Effluent Release l: Report, pursuant to Control 3.6
- f. Under the provisions of footnote e. above, only noble gases need to be-considered. ,
L g. Required for the hot maintenance shop ventilation' exhaust only during operation of the hot maintenance-shop ventilation exhaust system. , I y
.a b .
, . . , . . . - -. . . -..~ - - . - - .- . ,
, e,
_ 'l(
- > ODCM R3v. 13i .
Paga'39 l 5/94
' J2QSE ' NOBLE GASES CONTROLS
- 3.3.3- The air dose due to noble gases released in gaseous effluents, ,
from the site _to areas atland beyond the SITE. BOUNDARY (See ~ Figure I2.2-la) shall be limited to the following:
- a. During any calendar' quarter: . less.than or equal to 10 mrads for gamma radiation and less than or equal to 20 mrads forfbeta radiation, and
- b. During any calendar' year: ' less'than or. equal to l 20'mrads for gamma radiation and less than-or equal to-40-arads for beta radiation.
. APPLICABILITY: At all times.
ACTION: i a. With the calculated air dose from' radioactive noble gases in' gaseous effluents exceeding any of.;the'above - limits, prepare and submit to the Commission within 30 days, pursuant:to Technical Specification 6.9.2, a-Special Report which identifies the cause(s) for i exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will'be'in compliance ; with the above limits. , ~ SURVEILLANCE REQUIREMENTS 3.3.3-1 Cumulative dose contributions for the current quarter. and current calendar-year for noble gases shall be- , determined usin? ST-0-104-879-0,.ST-0-104-881-0, t. ST-0-104-883-0 every 31. days. t g k
- k n I
w--3 2 c - ~ - - --v,- q - _m a w --e,%-e. --ww., .-w. ..w--- , _ m =c. w w.-,ci-w,w_ e
. .. . - -_.- __ ,. _ - _ . . ~ .. _ ._ -. .
D-;. , aqh '
.ODCM Rev. '
+
f Paga.407
+
p ,
.5/94-V v DOSE - IODINE'- 133. TRITIUM. AND RADIONUCLIDES IN PARTICULATE FORM m
CONTROLS 13 i3.4~ -The" dose to alMEMBER OF THE PUBLIC from iodine-131,.' iodine- '
-133,-tritium?and all radionuclides in particulate form-with-
. half-lives greater than 8 days in~ gaseous affluents ~ released:
from the site to areas.at-or beyond-the SITE BOUNDARY.(See-Figure'I2.2-la) shall'be limited'to the following: -
- a. 'During any calendar quarter: -less than or equal to'
- 15 arems to any organ'and,
- b. During any calendartyear:- less than or equal to. ,
30 mreas to any organ. APPLICABILITY: At all times. ACTION: 4
- a. With the-calculated' dose'from the release of iodine '
131, iodine-l'33, tritium and all radionuclides'in'
-particulate form with half-lives greater than'8 days 1 in gaseous effluents exceeding any of-the above ,
-limits, prepara and submit.to.the Commission within 30-days,_ pursuant to Technical. Specification 6.9.2, a i Special Report which identifies the cause(s) for exceeding the limit and defines the corrective actions i' that'have been taken to reduce the releases and.the
. proposed corrective actions to-be taken to1 assure that.
subsequent releases will be in compliance with the above limits. SURVEILLANCE REOUIREMENTS i 3.3.4-1 Cumulative dose contributions for the current calendar ~ j- quarter and current calendar yearifor iodine-131,
- iodine-133, tritium and radionuclides-in' particulate '
form with half-lives greater than 8' days,shall lum-F determined using ST-0-104-879-0 once per 31; days. t E y
~
k f ODCM-R$v. 13-
'~
Pago;41. ll' ;5/94 VENTILATION EXHAUST TREATMENT SYSTEM CONTROLS 3'.3.5~ The VENTILATION EXHAUST TREATMENT SYSTEM shall be IN SERVICE-and appropriate portions of the system shall be used to reduce radioactive material 11n gaseous waste: prior to their discharge when the' projected doses due to gaseous affluent' releases, from- <
'the site.to areas at and.beyond the SITE BOUNDARY (See Figure
.I2.2-la) when^ averaged'over 31 days would exceed 0.6 mrem.to
, any organ in a 31-day period. APPLICABILITY: At all times. ACTION: , M
- a. With gaseous waste being. discharged without' treatment,-or in excess of the above-limits, prepare and submit to the Commission-within 30 days, pursuant to Technical _ .
Specification 6.9.2, a Special Report which includes the following information:
- 1. ' Explanation of why gaseous radwaste was-being discharged without treatment, identification of any.
inoperable equipment or subsystems, and the reason for < the inoperability..
- 2. Action (s) taken to restore the inoperable equipment to OPERABLE status, and <
- 3. Summary description of action (s) taken to prevent a recurrence.
SURVEILLANCE REQUIREMENTS 3.3.5-1 Doses due to gaseous releases'from the site-to areas at and beyond the SITE BOUNDARY shall be projected at least once per.31 days using ST-0-104-879-0. 4 4
-+ - , ,m, . - , - _ ,.. . . . . . - .
~l 'ODCM R$v. 13 Pagn 42 N l 5/94
~
VENTING OR PURGING CONTROLS l 3.3.6 The VENTING or PURGING of the Mark II containment shall be I through the standby gas treatment system. APPLICABILITY: Whenever the containment is vented or purged.* ACTION: With the requirements of the above specification not a. satisfied, suspend all VENTING and PURGING of the containment. SURVEILLANCE REOUIREMENTS 3.3.6-1 The containment shall be determined to be aligned for VENTING or PURGING through the standby gas treatment system within 4 hours prior to start of and at~least once per 12 hours during VENTING or PURGING of the containment. 3.3.6-2 Prior to use of the purge system through the' standby gas treatment system assure that:
- a. Both standby gas treatment system trains.are OPERABLE whenever the purge system is in use, and
- b. Whenever the purge system is in use during OPERATIONAL CONDITION 1 or 2 or 3, only one of the standby gas treatment system trains shall be used to prevent daLage to both trains should a LOCA occur (LCO 3.6.5.3 ACTION a applies during this configuration).
- Except after Containment is deinerted and purged while the reactor is in OPCON 4 or 5 QB for the one inch /two inch vent valves to the Reactor.
Enclosure Equipment Compartment Exhaust Filters when used for containment pressure control and nitrogen make-up operations.
~ , _ 7
ODCM R$v. 13 l Pago 43 [ 5/94 RADIOACTIVE EFFLUENTS TOTAL DOSE CONTROLS 3.3.7 The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from uranium fuel cycle sources shall be limited to less than or equal to 25 mrems to the total body or any-organ, except the thyroid, which shall be limited to less than or equal to 75 mrems. APPLICABILITY: At all times. ACTION:
- a. With the calculated doses from the release of radioactive materials in liquid or gaseous effluents exceeding twice the limits of ODCM Controls I3.2.3.a, I3.2.3.b, I3.3.3.a, I3.3.3.b, I3.3.4.a or I3.3.4.b, calculations shall be made including direct radiation contributions from the reactor units and from outside storage tanks to determine whether the above limits of ODCM Control 3.3.7 have been exceeded. If such is the case, prepare and submit-to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report that defines the corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding the above limits and includes the schedule for achieving conformance with the above limits.
This Special Report, as defined in 10 CFR 20.405c, shall include an analysis that estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from the uranium fuel cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes the release (s) covered by this report. It shall also describe levels of radiation and concentration of radioactive material involved, and the cause of the exposure levels or concentrations. If the estimated dose (s) exceeds the above limits, and if the release condition resulting in violation 40 CFR Part 190 has not already been corrected, the Special Report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190. Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete. SURVEILLAllCE REQUIREMENTS 3.3.7-1 Cumulative dose contributions from liquid and gaseous effluents shall be determined using ST-0-104-878-0, ST-0-104-879-0. 3.3.7-2 If the cumulative dose contributions exceed the limits defined in 3.3.7a, Cumulative dose contribution from direct radiation from unit operation shall be determined using S2-0-104-878-0, ST-0-104-879-0.
E
- l- -
il~ :ODCM Rav.-13 Pags'44 m. m _l, 5/94 3.4 RADIOIDGICAL ENVIRONMENTAL MONITORING PROGRAM (REMP) CONTROLS
-3.4.1 The monitoring program shall be conducted as specified in' Table I3.4-1.-
g' APPLICABILITY: At all times. ACTION: ~
- a. With the' radiological environmental monitoring programi c not being conducted as specified in Table I3.4-1,~ j
_ prepare and submit.to the' Commission, in the: Annual-H Radiological Environmental'. Operating. Report per'ODCM' 1 Control.3.5, a description of;the reasons for not conducting the program.as required and'the plans for preventing a. recurrence.
- b. With the level of radioactivity. as the: result of -plant . ,
effluents in an environmental sampling medium at.a specified-location exceeding the_ reporting levels of Table I3.4-2 when averaged over any_ calendar quarter,. prepare and submit to,the Commission within-30 days, pursuant to Technical specification 6.9.2, a.Special Report that identifies the cause(s) -for. exceeding the r limit (s) and' defines the corrective actions to be'taken~- to reduce radioactive affluents so that the potential annual dose to a MEMBER OF-THE PUBLIC is less than the , calendar year limits of ODCM Controls I3.2.3,.I3.3.3 and I3.3.4. When more'than one of the radionuclides in Table I3.4-2 are detected in the sampling medium, this ' report shall be submitted if: concentration -(1) , concent' ration - (2 )' . ,,,g,o reporting level (1) -reporting level (2) , When radionuclides other than those in Table I3.4-2 are detected and are the-result of plant effluents, this report shall be submitted if the potential annual dose to a MEMBER OF THE PUBLIC is equal to .or greater. than the calendar year limits of ODCM Controls I3.2.3, I3.3.3 and I3.3.4. This report is not_ required.if the; measured level of radioactivity was not the result'of plant effluents; however; in such'an event,.the condition shall be reported and_ described-in the Annual Radiological Environmental- Operating Report. - 4
+
T e 1
--* -- ---.----r-- - , , , - , , , . - ,,
ODCM RLv. 13 I'
'l Pcg2 45.
6 ; j L. E ' 5/94
. RADIOLOGICAL ENVIRONMENTAL ~ MONITORING (Continued)
- c. With milk or fresh leafy vegetable samples unavailable from one or more1of the sample locations required by Table I3.4-1, identify locations for obtaining j '
replacement. samples and add them to the radiological environmental monitoring program within 30 days. The specific locations from which samples were. unavailable may then be deleted-from the monitoring program. Pursuant to Technical Specification 6.14, submit as a- 'l part of or concurrent with the Semiannual Radioactive Effluent Release Report, a complete, legible copy of .; the entire ODCM, including a revised figure (s) and- I
. table for the ODCM reflecting the new location (s). )
SURVEITTANCE REOUIREMENTS 3.4.1-1 The radiological environmental monitoring samples shall be collected (using ST-0-104-800-0) pursuant to Table 13.4-1 from the specific locations given in the table and figure (s) in the ODCM and shall be analyzed pursuant.to the requirements of Table I3,4-1, the. l detection capabilities required by-the. Table I3.4-3. l l l P
-'^
/*
!'-A *\ *,a l ODCM Rev. 13 ~[
4
.Page'46 l 5/94 -
TABLE I3.4-1 -
. cd^
RADIOIDGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE - J EXPOSURE PATHWAY SAMPLES AND- SAMPLING AND TYPE AND FREQUENCY' AND/OR SAMPLE SAMPLE ' IDCATION(*) ' COLLECTION FREQ.- -OF ANALYSIS . i
- 1. DIRECT RADIATION *) 40 routine monitoring stations At least Quarterly. Gamma dose _at least -
either with two or more dosi- quarterly. -
' meters or with one instrument,for
- measuring and' recording dose t
- rate continuously placed as follows
- '
(1) An' inner ring of stations, ! one in each meteorological sector,'in the general area of I the SITE BOUNDARY: .(2) An outer' ring of stations, one in each l meteorological. sector, in the
- 3-9' mile range from the site; 1
-(3)' The balance of the stations i placed.in special interest' areas such as population centers,.
nearby. residences,. schools and in- c.I' 1 or 2 areas-to serve as control stations.
-- i i
I t g ie 4 -
# ,,+,c _ . m _e .___ <_ _ _ . _ __. , . .
y l ODCM Rev.-13' e"~' Page 47f ,
- l. -5/94 , .
a TABLE I3.4-1 (Continued) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM
~
NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES ~.AND. SAMPLING AND TYPEAND FREQUENCY AND/OR SAMPLE SAMPLE IDCATION(*) COLLECTION FREQ.- OF ANALYSIS
- 2. AIRBORNE Radioiodine and- Samples from 5' locations:- Continuous sampler Radiciodine' canisters:- -
Particulates_. :a.3 samples from close to.the operation lwith sample .I-131 analysis- j 3 SITE BOUNDARY locations-(in ' collection weekly,'or. weekly.- - R different sectors) of the. more frequently if
-highest calculated annual. required by dust- -Particulate Samoler:-
average ground level x/Q. loading *.. Gross beta radio activity analysis; b.1' sample from the vicinity :following filter;- community having one of the highest calculated annual' change:d ) ground level x/Q. . Gamma isotopic i 1 sample from a control loca- analysis' of l tion, as for example 15-30 km composite'(by
' distant and'in the least pre- -location) at least
-valent wind direction. quarterly-l l
~
.1
_ - - - - - . . . . . __ l _
Myt;
~ ,, ,
-4. . ._ < ;-
~
.3 .i
, :=
p
.I
' ODCM Rev. 13" @
.Page.48 ',
t , 5/94- - N TABLE'I3.4-1 (Continued) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM
~
NUMBER OF REPRESENTATIVE
- EXPOSURE PATHNAY SAMPLES AND SAMPLING AND TYPE.AND-FREQUENCY
~AND/OR SAMPLE SAMPLE LOCATION (*) COLLECTION FREQ. OF ANALYSIS-
- 3. WATERBORNE
- a. Surface f i sample upstream- Composite sample Gamma isotopic analysis'-
1 sample downstream- over 1-month monthly. Compositelfor-periods. tritium analysis quarterly.
- b. Ground Samples from 1 or.2= sources Quarterly.
4 only if'likely to be affectedh
- c. Drinking 1 sample of each.on 1 to-3 of Monthly. I-131 analysis on'each' of the: nearest water supplies (Composite) ~
composite when'.the dose-that could be affacted by its calculated for the-con-- discharge. sumption of the water is-greater thanil aren per 1 sample from a: control year.1 Composite for' gross location beta and gamma isotopic-analysis monthly.- Comp- > osite~.for tritium' analysis quarterly.- -
- d. Sediment from 1 sample.from downstream. area. Semiannually. Gamma isotopic analysis' shoreline with existing or. potential- semiannually.
a 4 1-- *m-- JN9 ,g.a=pW *u 5ypw p , - g --r '.at- g r y- g 7-v"-a y-we- W - r F -"t"?*4 I t'4 e e+ 1 2 -M E-
. . ^ -@ ,ng- _
.e l - ~
j ODCM R.vk 13- ~ ~ - Page 49 ,
;E -
-- l 5/94 , .
y: 4 TABLE I3.4-1 (Continued) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM y-
. y NUMBER OF REPRESENTATIVE 7
- EXPOSURE-PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY a AND/OR SAMPLE SAMPLE IDCATION('I ' COLLECTION FREQ. OF ANALYSIS I
- 4. INGESTION
- a. Milk Samples from milking animals- Maimonthly when Gamma - isotopic' . and I-131 in 3 locations within 5-km animals are on- analysis' semimonthly when distance having the highest pasture, monthly. animals are on pasture' dose potential. If there are at other times. (April 1 -..0ct. 1):
l none,:then 1' sample from monthly at-other times. l milking animals in each of' - L
' areas between 5 to- 8 km distance-where dose are cal-culated to be greater than 1 mrem per year.'
1 sample from milking animals
- at a. control. location (15-
- 30 km distance) and in'the least wind direction.-
- b. Fish and . 1 sample of two recreationally . Sample in season, Gamma isotopic' ?
u Invertebrates. important species in vicinity or semiannually -analysisfon edible - 1 of. plant discharge-area. 1 _if they are not portions. sanple of same species-in area seasonal. i not influenced by. plant discharge. b
, t j
l m_ _ _ _ _ _ _ _ _ . - _ m_ _ _. __ __ __._______d _.m______ _____ _ _ _ _ _. _ _ _ _ _ _ _ _
- j
, - e j ODCM Rev. 13 Page 50 l 5/94; TABLE I3'.4-1 (Continued)
RADIOIDGICAL ENVIRONME!"rAL MONITORING PROGRAM , NUMBER OF REPRESENTATIVE
~*
EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE IDCATION(*) COLLECTION FREQ. OF ANALYSIS. ..
- 4. INGESTION (Continued) 1
- c. Food Products Samples of 3 different kinds.of -Monthly when avail- Gamma . isotopic * ;and '-
broad leaf vegetation' grown able, if milk sampling I-131 analysis ~ ~ nearest each of.2.different- is not preformed. offsite locations of highest predicted annual average. ground level D/Q if milk sampling is not: preformed. . 1 sample of-each of.the similar Monthly when avail- - Gamma isotopic' ' and . broad. leaf vegetation grown able, if air; sampling I-131 analysis'. 15-30 km distance in the-least -is not per' Armed. prevalent wind direction if milk sampling is:not performed. l l t y pr9-e r 9 y g. "- w-g*ai iyV-
=
=P 4 '=r .- -M' Y' 7w 't M.. '* W % e *-ee __r9m ..--..___-a.a--
l ODCM Rev. 13 Pcg3 51 l 5/94
@ DIOLOGICAL ENVIRONMENTAL MONITORING TABLE I3.4-1 (Continued)
TABLE NOTATIONS
- c. Specific parameters of distance and direction sector form the centerline of the two reactors and additional description where pertinent, shall be provided for ecch and every sample location in Table .3.4-1 in a table and figure (s) in the ODCM. Deviations are peraitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling period. All deviations from the sampling schedule shall be documented in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5. It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media
~
and locatiore may be chosen for the particular pathway in question c , appropriate substitutions made within 30 days in the radiological environmental monitoring program. Pursuant to Technical Specification 6.14, submit as a part of or concurrent with the next Semiannual Radioactive Effluent Release Report a complete legible copy of the ODCM including a revised figure (s) and table for the ODCM reflecting the new location (s).
- b. One or more instruments, such as a pressurized ion chamber, for measuring and recoding dose rate continuously may be used in place of, or in addition to, integrating dosimeters. For the purpose of this table, a thermoluminescent dosimeter (TLD) is considered to be one phosphor; two or more phosphors in a packet are considered as two or more dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation.
- c. Methodology for recovery of radiciodine shall be described in the ODCM.
- d. Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours or more after sampling to allow for radon and thoron daughter decay. If gross beta activity is air particulate samples is greater that 10 times the yearly mean of control samples, gamma isotopic analysis shEl) be performed on the individual samples, g o. Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides tLat may be attributable to the effluents from the facility.
E:L :~ x 25 4'. ODCM-R3v. 13l Paga 52: 5/94-
=-
j f.; xThe;" upstream' sample"'shall.be-taken at=a' distance beyond .
- significant influence of the discharge. -The " downstream sample"- '
shall be taken in an area beyond but near the mixing zone..
- g. A-composite sample is.one in which the_ quantity ~(aliquot)_of.
liquid' sampled is proportional to the quantity.of flowing liquid and in which the method.of sampling: employed results in a specimen lthat is representative of the liquid flow. ,In this program. composite sample aliquots-shall be collected at time intervals that are very.short-(e.g.,-hourly) relative to the-compositing period:(e.g., monthly) in order to assure obtaining'a representative sample.
- h. . Groundwater samples shall kne taken when.this source is tapped for drinking or irrigation purposes in areas where the: hydraulic gradient or recharge properties are. suitable for contamination. ;
i.: The dose shall be calculated:for-the maximum. organ and-age group, using ST-0-104-878-0. I 1 i h f r i
-w m - - , - .- . . , - - . . . -,- - - - . w- m.~ w- -+
m 3 (l ODCM R$v. 13 Paga 53 p 3l; : 5/94 '- .
}
TABLE 13 .' 4 - 2 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES ReDortina Levels-AIRBORNE FOOD WATER PARTICULATE or FISH MILK PRODUCTS ANALYSIS (pCi/L) GASES , (pCi/m3 ) (pCi/kg,' wet) (pCi/L) (pci/kg, wet). H-3 20,000* Mn-54 1,000 30,000
-Fo-59 400 10,000 Co-58 1,000 30,000 '
Co-60 300 10,000 Zn-65 300 20,000 Zr-Nb-95 400** I-131 2 0.9 3 100 Cs-134 30 10 1,000 60 1,000 ' Cs-137 50 20 2,000, 70 2,000 Ba-La-140 200** 300
- For drinking water samples. This is 40 CFR Part 141 value. If no drinking pathway exists, a value of 30,000 pci/L may be used.
** Total for parent and daughter.
1
.lL ODCM R:v. 13-P go 54-ll 5/94 4
TABLE I3.4-], DEE:CTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS (*) Lower limit of Detection (T.T.n)(b)(c)
-AIRBORNE FOOD WATER PARTICULATE or FISH MILK PRODUCTS SEDIMENTS.
ANALYSIS - (pCi/L) GASES (pci/m3 ) (pCi/kg,_ (pci/L) (pCi/kg, (pCi/kg,
. wet) wet) dry)
Gross Beta 4 0.01 H-3 2,000
--Mn-54 15 130 Fa-59 30 260 Co-58,60 15 130 Zn-65 30 260 Zr-95 30 Nb-95 15 I-131 lid) 0.07 1 60 Cc-134 15 0.05 130 15 60 150-C3-137 18 0.06 150 18 80 180 Bn-140 60 60 La-140 15 15
.L w = .__
l ODCM Rev. 13 Pagn 55 l 5/94 TABLE I3.4-3 (Continued) TABLE NOTATIONS (a) This list dose not mean that only these nuclides are to considered. Other peaks that are identifiable at 95% confidence , level, together with those of the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating report pursuant to ODCM Control 3.5. , (b) Required detection capabilities for thermoluminescent dosimeters used for environmental measurements are given in Regulatory Guide 4.13. (c) The LLD is defined, for purposes of these controls, as the smallest concentration of radioactive material in a sample that will yield a net count (above system background) that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system (which may include radiochemical separation): 4.66s, LLD-E V
- 2.22
- Y ' exp (-AAt) ,
Whsre: LLD is the a oriori lower limit of detection as defined above (as picocuries per unit mass or volume), s, is the standard deviation of the background counting rate or of the counting rate of blank sample as appropriate (as counts per minute), E is the counting efficiency (as counts per disintegration), l V is the sample size (in units of mass or volume), 2.22 is the number of disintegrations per minute per picocurie, Y is the fractional radiochemical yield (when applicable), A is the radioactive decay constant for the particular radionuclide, and i at for the environmental samples is the elapsed time between sample collection (or end of the sample collection period) and time of counting. I Typical values of E, V, Y, and At should be used in calculation. 1 1 I 1 I l
, g; ._ . -. . _ ._ _ , .
'j! ODCM Rcv. 13
'Paga 56
.l: 5/94 )
I TABLE I3.4-3 (Continued) TABLE NOTATIONS It should be recognized that the.LLD is defined as an a Driori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. Analyses shall be' performed'in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such cases, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5. (d) LLD for. drinking water samples. I k l'
ODCM RLv. 13
.l Pago 57 l 5/94 RADIOLOGICAL ENVIRONMENTAL MONITORING LAND USE CENSUS CONTROL 3.4.2 A land use census shall be conducted and shall identify within a distance of 8 km (5 miles) the location (in each of the 16 meteorological sectors) of the nearest garden
- of greater than 50 m2 (500 ft8) producing broad leaf or vegetables.
APPLICABILITY: At all times. ApTION:
- a. With a land use census identify,ing a location (s) which yields a calculation dose or dose commitment greater than the values currently being calculated in ODCM Control 3.3.4.1, identify the new location (s) in the next Semiannual Radioactive Effluent Release Report, pursuant to ODCM Control 3.6.
- b. With a land use census identifying a location (s) that yields a calculated dose or dose commitment (via the same exposure pathway) 20% greater than at a location from which samples are currently being obtained in accordance with ODCM Control 3.4.1, add the new location (s) to the radiological environmental monitoring program within 30 days. The sampling location (s), excluding the control station location, having the lowest calculated dose or dose commitment (s) (via the same exposure pathway) may be deleted from this monitoring program after october 31 of the year in which this land use census was conducted. Pursuant to Technical Specification 6.14, submit as a part of or concurrent within the next Semiannual Radioactive Effluent Release Report a complete, legible copy of the entire ODCM including a revised figure (s) and table (s) for the ODCM reflecting the new J location (s). l SURVEILLANCE REOUIREMENTS l 3.4.2-1 The land use census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to- ,
door survey, aerial survey, or by consulting local l agriculture authorities. The results of the land use census are documented in ST-0-107-991-0 and are included in the Annual Radiological Environmental Operating Report ' pursuant to ODCM Control 3.5.
- Broad leaf vegetation sampling of at least 3 different kinds of vegetation may be performed at the SITE BOUNDARY in each of 2 different direction sectors with the highest predicted D/Qs in lieu of the garden census. ODCM Controls for broad leaf vegetation sampling in Table I3.4-1 item 4.c. shall be followed, including analysis of control samples.
L"
>l ODCM'Rav. 13 Pago 58
~l. 5/94 RADIOLOGICAL ENVIRONMENTAL MONITORING INTERLi\BORATORY COMPARISON PROGRAM CONTROL 3.4.3 In accordance with LGS Technical Specification 3.12.3,. analyses shall be performed on radioactive materials supplied as_part of an Interlaboratory-Comparison Program which has been approved by the Commission..
APPLICABILITY: At all times. ACTION: With analyses not being performed as required above, report the corrective actions taken to prevent a recurrence to the Commission in the Annual Padiological Environmental Operating-Report pursuant to ODCM Control 3.5. SURVEILLANCE REOUIREMENTS 3.4.3-1 The Interlaboratory Comparison Program shall be documented in ST-0-104-990-0 and described in the ODCM part II, section 4.2. A summary of the results shall be included in the-Annual Radiological Environmental. Operating Report pursusnt to ODCM Control 3.5.
l ODCM Rov. 13 i Page 59 l 5/94 ANNUAL RADIOlf;GICAL ENVIRONMENTAL OPERATING REPORT
- 3.5 Routine Annual Radiological Environmental Operating Report covering the operation of Unit 1 and Unit 2 during the previous calendar year shall be submitted prior to May 1 for each year. The initial report was submitted prior to May 1 of the year following initial criticality (1984). A single report is submitted for a multiple unit station. The Annual Radiological Environmental Operating Report shall include summaries, interpretations, and an analysis of trends of the results report period, including a comparison (as appropriate), with preoperational studies, operational controls and previous environmental surveillance reports and an assessment of the observed impacts of the plant operation on the environment. The reports shall alse include the results of land use census required by ODCM Control 3.4.2. The Annual Radiological Environmental Operating Report shall include the results of all radiological environmental samples and of all environmental radiation measurements taken during the report period pursuant to the locations specified in the tables and figures in the OFFSITE DOSE CALCULATION MANUAL, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Branch Technical Position, Revision 1, November 1979.
In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results. The missing data shall be submitted as soon as possible in a supplementary report. The report shall alto include the following: a summary description of the radiological environmental monitoring program and at least two legible maps. One map shall cover stations near the SITE BOUNDARY; a second shall include the more detailed distant stations. Covering all sampling locations keyed to a table giving distances and directions from the centerline of the reactor plant; the results of licensee participation in the Interlaboratory Comparison Program, required by ODCM Control I3.4.3 discussion of all deviations from the Sampling Schedule of Table I3.4-1; and discussion of all analyses in which the LLD required by Table I3.4-3 was not achievable.
j ODCM Rsv. 13 Page 60 l 5/94 ADMINISTRATIVE CONTROLS 3.6 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REFORT A Routine Semiannual Radioactive Effluent Release Reports covering the operation of Unit 1 and Unit 2 during the previous 6 months of operation shall be submitted within 60 days after January 1 and July 1 of each year. The period of the first report shall begin with the date of initial criticality. ST 107-992-0 shall be used to generate the report. A single unit submittal is made for the 2 unit station. The submittal combines those sections that are common to all units at the station. The Semiannual Radioactive Effluent Release Report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the facility as outlined in Regulatory Guide 1.21, " Measuring, Evaluation, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-cooled Nuclear Power Plants," Revision 1, June 1974, with data summarized on a quarterly basis following the format of' Appendix B thereof. The Semiannual Radioactive Effluents Release Report to be submitted 60 days after January 1 of each year shall include an annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction and atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, atmospheric stability. In lieu of submission with the first half year Semiannual Radioactive Effluent Release Report, the licensee has the option of retaining this summary of required meteorological data on site in a file that shall be provided to the NRC upon request. This same report shall include an assessment of the radiation doses due to the radiocctive liquid and gaseous effluents released from both units during the previous calendar year. This same report shall also include an assessment of the radiation doses from radioactive i liquid and gaseous effluents to MEMBER OF THE PUBLIC due to their activities inside the SITE BOUNDARY (Figures I2.2-la and I2.2-1b) during the report period. All assumptions used in making these assessments shall be included in these reports. The assessment of radiation doses shall be performed in accordance with the methodology and parameters of the OFFSITE DOSE CALCULATION MANUAL (ODCM).
l ODCM Rcv. 13 Page 61 l 5/94 The Semiannual Radioactive Effluent Release Report to be submitted i 60 days after January 1 of each year shall also include an assessment of radiation doses to the hypothetically highest exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and direct radiation) for the previous calendar year to show conformance with 40 CFR Part 160, Environmental Radiation Protection Standards for Nuclear Power Operation. Dose contribution from liquid and gaseous effluents is calculated based on Regulatory Guide 1.109, Rev 1, October 1977. The Semiannual Radioactive Effluent Release Reports includes the following information for each type of solid waste (as defined in 10 CFR Part 61) shipped offsite during the report period:
- a. Container volume,
- b. Total curie quantity (specify whether determined by measurement or estimate),
- c. Principle radionuclides (specify whether determined by measurement or estimate),
- d. Source of waste and processing employed (e.g., dewatered spent resin, compacted dry waste, evaporated bottoms),
- e. Type of container (e.g., LSA, Type A, Type B, Highway Route controlled), and
- f. SOLIDIFICATION agent or absorbent (e.g., cement; urea formaldehyde).
The Semiannual Radioactive Effluent Release Report includes a list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive material in gaseous and liquid effluents made during the reporting period. The Semiannual Radioactive Effluent Release Reports includes any changes made during the reporting period to procedure RW-C-100 (formerly the PROCESS CONTROL PROGRAM) and to the ODCM, as well as a listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to ODCM Control 3.4.2. The Semiannual Radioactive Effluent Release Reports includes an explanation as to why the inoperability of liquid or gaseous effluent monitoring instrumentation was not corrected within the time specified in ODCM Controls 3.2.1 or 3.3.1, respectively; and description of the events leading to liquid holdup tanks or gas storage tanks exceeding the Control limits. I
ODCM R:v. 13' l Pagn 62 l 5/94 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS Licensee-initiated major changes to the radioactive waste systems (liquid, gaseous, and solid):
- a. Shall be reported to the Commission in the Semiannual Radioactive Effluent Release Report for the period in which the change was made effective. The discussion of each change shall ccntain:
- 1. A summary of the evaluation that led to the determination that the change'could be made in accordance with 10 CFR 50.59;
- 2. Sufficient detailed information to totally support the reason for the change without. benefit of additional or supplemental information;
- 3. A detailed description of the equipment, components, and processes involved and the intsrface with other plant systems;
- 4. An evaluation of the change which shows the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste that differ from those previously predicted in the license application and amendments thereto;
- 5. An evaluation of the change which shows the expected maximum exposures to individual in the UNRESTRICTED AREA and.to the general population that differ from those previously estimated in the license application and. amendments thereto;
- 6. A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents and in solid waste, to the actual releases for the period prior to when the changes are to be made;
- 7. An estimate of the exposure to plant operating personnel as a result of the change; and i
- 8. Documentation of the fact that the change was reviewed and found acceptable by the PORC.
- b. Shall be reviewed and accepted by the PORC prior to implementation.
- c. Shall be documented by ST-0-RRR-990-0.
I
PART II CALCULATION METHODOLOGIES
a , m ..,, .. . .+ . . . . . . . . . . . . ., ~ -- ,. bs. n .
'ODCMsRsv.;13/
@ %m.1-N
; F' .
Paga ? 63 ; kv , o' '
. 5/ 94'
- h. ;p ,
s r l lO : LIQUID EFFLUENTS n
', lilt RADIATION MONITORING INSTRUMENTATION AND CONTROLS TThe-liquid' effluent monitoring instrumentation;and1 '
~
, controls-at Limerick for. controlling and monitoring normal , -
sradioactive material releases in accordance:with the Limerick Technical Specifications'are summarized as 1follows: Liquid Radwaste System: .The liquid.radwaste~dischargeL"'
=1)-
-monitor-(RISH63-OK604)'provides'an alarm and automatic"
,, -termination of radioactive material releases from that 4 liquid radwaste system'as-required by Technical Specification ~6.8.4.d.1.= Additional design-' features : of the. liquid radwaste-system which prevent:
-inadvertent, releases.tosthe environment include'1).
redundant discharge valven,c2) single discharge line . with loopLsealland siphon breaker to eliminate-probability of inadvertent discharges,- 3); Low Cooling Tower Blowdown flow interlock which isolates the radwaste discharge line. 2)' service Water System: The Service Water / discharge i monitor- (RISH10-1K605 AND ' RISH10-2K605) provides, an L alarm upon' indication of activity,in the serviceiwater
~
system as required by Technical Specification: 6.8.4.d.1.; While'the service water system is not'a' normal-release pathway, the monitor provides an indication of potential problems due to excessive-leakage of the heat'exchangers. In addition, the service waterL side of the fuel- pool heat exchangers11s
.kept at a higher pressurec.than the shell side to.
prevent-potential radioactive contamination of'the service water.- 1
- 3) RHR-.. Service Water System: The RHR Service Water Radiation-(RHRSW). Monitors (RISH12-0K619A,.RISH12-OK619B, RISH12-1K619C..RISH12-1K619D, RISH12-2K619C AND RISH12-2K619D) provide alarm and automatic termination of radioactive material ~ release from the RHRSW system, as required by Technical. Specification 6.8.4.d.1. While the RHRSW system is not a normal release pathway, the monitors provide indication of potential problems due to excessive leakage of the j heat exchangers.
,. y*' ,
2ODCM'Rav. '13, i 1Paga-64l
@ 5/94" 7
11.'21 LIOUID EFFLUENT MONITOR SETPOINT DETERMINATION-Per1thelrequirements of' Technical Specificationi6.8;4.'d;1, M alarm setpoints ushall be established for.the: liquid offluent' monitoring instrumentation to:ensureithat'the release concentration limits of' Specification 6.8.4.d.2 l m' and 6.8.4.d.3.are: met-(i.e., the. concentration of-
~, .
-radioactive material 1 released in: liquid effluents to
' UNRESTRICTED AREAS shall be limited to,the concentrations specified in 10 CFR 20, Appendix B, Table II, Column 2,
.for: radionuclides.and.2.0E-04.#Ci/mlifor dissolved orJ '
entrained noble gases). 1.2.1: Radwaste Discharae Monitor-and Discharoe' Flow Rate
- RISH63-OK604 r . .
~
^ The'setpoint for-the liquid radwaste discharge monitor and flow rate element are' determined by the following-equations. The radwaste discharge monitor high-high' alarm / isolation setpoint is calculated at least monthly based.on isotopes detected in the: liquid radwaste sample tanks released.during the previous month or on any:
. specific sample' tank being' released-(IC% ),'
the; [. Required minimum. cooling tower blowdownEflowLat l- ' time of discharge (CTBD),' and average l liquid radwaste discharge flow-(RR). The; flow rate H determination is calculated for each release and- , the MPC fraction calculated includes, in the 1 3 concentration'aix, the_most recent results from q i 1)-the quarterly; composite:for SR-89,DSR-90 and' j
'Fe-55, and 2)-the monthly 5 composita for.H-3, and '1
- 3) the sample (s)--for dissolved and entrained noble; j gases.
If the' calculated setpoint.is less than-the i existing setpoint, the setpoint will be reduced to-L the next value.' Ifithe calculated setpoint'is 'l '~ greater than the.existingisetpoint,fthe setpoint JI may remain at the lower value or increased'to the i calculated value.
~!
i: If there-vere no sample tanks released or no. l activity detected during the previous month,-then. i the calculation is performed using release. data? from the.most recent month during which isotopes were detected. In addition, if.there_were'no sample tanks released during the previous month, ' chemistry supervision may substitute more l.- restrictive values-(e.g., tritium)' based'onIthe ' plant sampling data. v - Ya , -
9 .Y
'ODCM R%v.713:
tOU fN Paga 65.
,7 5/94 B.
1.2.1-1 .Setooint Determination - RISH63-OK604 The setpoint for the. liquid radwaste 1
-dischargeLmonitor is determined by the.
following equation: CAMg ,m s (S) (RR) (E (Cjwe,) /NPCjue ) ] ' (ECj, ) (RR+CTBD) (1,1)
+BKg*.*
(RR+CTBD) (S) (E) (RR) (E3 C ,_/MPC 3 ,)
-)I where:
CPM g ,g = Calculated liquid radwaste discharge monitor (RISH63-OK604) count-rate-attributable to the gamma emitting radionuclide, cpm IC g ,
= the sum of the concentration of1the identified gamma emitting nuclides
.(#Ci/ml),
CTBD = the required minimum cooling towert blowdown rate at time of discharge 4 (gpm), I RR = average liquid radwaste discharge flow (gpm), BKG g,g = background _ count rate of liquid radwaste discharge monitor (CPM), E = the gross detection efficiency of the liquid radwaste discharge monitor (pci/ml/ cpm), and i S = 5, margin of safety factor to assure that the release is terminated prior to l 10 CFR 20 limits lbeing exceeded. Included in this factor are errors associated with monitor uncertainty, sampling uncertainty, flow rate uncertainty, and the contribution of other release paths'(Service Water and
; RHRSW) which are not normally contaminated.
= the effective gamma MPC ratio for the E(C Q MPC%) mixture of radionuclides in the liquid
-radwaste discharge line (unitless).
p r
>+~
- ' .ODCM RLv. Pags 66-: H
;p 4 ,
5/94' l x; s where:: the: concentration of.each identified C,""" =
. gamma ^ emitting.radionuclide'_i in'ths. .
liquid affluent (undiluted) (#Ci/ml)
'MPC ,,,g
= the MPC value correspondingfto radionuclide'i from'10'CFR-20 Appendix B,. Table II, Column 2-(dissolved and
~
entrained noble gases MF0 = 2.0E'
'pci/ml) (pCi/ml) . -
E(Citbete/MPChu) = the effective nongamma-MPC ratio for the mixture of radionuclides in the' liquid radwaste discharge line (unitless) where: C,wu = the concentration of each identified nongamma radionuclide:i in the liquid affluent (undiluted) (pci/ml)
- 4 MPC,wu = The MPC value. corresponding to radionuclide'l form 10 CFR 20, Appendix.
B, Table II, Column 2 (dissolved and entrained noble . gases MPC = 2E*' yCi/ml) (pci/ml)
~
- NOTE: The concentration mix must include the most recent sample-
, data for H-3, Sr-89, Sr-90, Fe-55 and. gross alpha.- t 1.2.1-2 Flow Rate Determination
- NOTE: If the effective MPC ratio for.the'aixture of radionuclides' [E(C,/MPC Y)] is $1.0,.
g 4 THEN'a flow-rate setpoint determination is.not required,fARQ s there is no limit on discharge flow rate. IE a flow rate determination is required, THEN the setpoint for the liquid radwaste flowErate is determined for each release by.the following equation:
~(1-2)
FLOW "3 $ ' (SF) [E (C3 /MPC3 )-1] where: FLOW gg3 = flow limit for radwaste discharge line (gpm). CTBD = required minimum-cooling tower blowdown; flow?for time'of-release (gpm). SF = 5; margin'of safety factor to assure that the' release does not= exceed 10 CFR 20 limits. .
# ODCM Riv. 13 Paga 65 ^F ' ' 5/94-1.2.1-1 'Setooint Determination - RISH63-OK604 lThe setpoint for the liquid radwaste discharge monitor is determined by the following equation:
CPMgum s (S) (RR) (E (Cjwe,) /MPCjue ) ) '(E Cj,_) (RR+CTBD)
+gKg("# (1,1)
(RR+CTBD) (S) (E) (RR) [E3 C ,_/MPC 3 ,_) where: CPMg ,g = Calculated liquid radwaste discharge monitor (RISH63-OK604) count rate attributable to the gamma emitting radionuclide, cpm E C , '"" = the sum of the concentration of the ' identified gamma emitting nuclides (pci/ml), CTBD = the required minimum cooling _ tower, blowdown rate ~at time of discharge' (gPm), RR = average-liquid radwaste discharge flow (gpm), , BKG ggg = background count rate of liquid radwaste
' discharge monitor (CPM),
E = the gross detection. efficiency'of the liquid radwaste discharge monitor-(pci/ml/ cpm), and S = 5; margin of safety factor to assure-that the release is terminated' prior to 10 CFR 20 limits being exceeded. Included in this factor are errors < associated with monitor uncertainty, sampling uncertainty, flow rate uncertainty, and the contribution of-other release paths (Service Water and RHRSW) which are not normally contaminated. Z(Ci g MPC, ,) = the effective gamma MPC ratio for the mixture of radionuclides in the' liquid radwaste' discharge line-(unitless). d
! ,-- , ,-m, - -
4.".. +
% ODCM R$v. 13 i!
- Pagsf66
, m 5/94. 4 6 7 where:
' Cg ,,, = the' concentration ~of.each' identified gamma: emitting radionuclide 1-in the liquid effluent . (undiluted)1(yci/ml)'
MPC g ,,, = ' the MPC value corresponding ~to . - radionuclide i from 10LCFR:20 Appendix-
, B,. Table'II,. Column-2s(dissolved-and-
' entrained' noble gases MPC = 2.0E'
'pci/ml) (pCi/ml).- p ;
i; E(Clya/MPC%3) = the effective nongamma MPC ratio'for the-mixture of radionuclides-in'the liquid
.radwaste discharge.line (unitiess).
where: C n,a = the-concentration of.each. identified-nongamma radionuclide i in.the liquid g effluent 1(undiluted) (gci/ml)* ; MPCg ,a = 1The MPC value corresponding to radionuclide i form 101CFR 20, . Appendix-B, Table II, Column 2 (dissolved and
- entrained noble ~ gases MPC = : 2E* yci/ml)
(#Ci/ml)-
- NOTE: The concentration mix must include,the most:recent~ sample: , <
data for H-3, Sr-89,.Sr-90,f Fe-55 and. gross alpha. 1.2.1-2 Flow Rate Determination a
- NOTE:'If the effective'MPC ratio.for theimixture
- of radionuclides.[E(C THEN Y)] is $1.~0, a flow rate setpo,/MPC, determination is ;not l required, &HD'
- int '
there is no limit c'... discharge flow rate.. If a-flow rate determination is. required,: THEN the setpoint for the liquid'radwaste flow 1 rate is-determined for each release by the following equation: FLOW " s (SF) [E (Cj/#PC3) -1) . (1-2) , -where: FLOW g ,q. = flow limit for radwaste discharge line (gpm). CTBD. = - required minimum cooling ~ tower blowdown flow.for time'of release (gpm).
- SF =- 5;Laargin-of safety factor to: assure.that-the.
, release does not exceed 10 CFR 20 limits. s a h n'. pi
-------la- r- , ,--a , , , - - ,,,- , , , , - - , -r,y4., a
% 4
^ E, ODCM'R:v.i13' Pngs-67 m
~ 5/947
- k [. 4 E(C g/MPCg ) -= the-affective--MPC ratio for the mixture of radionuclides ~in;the. liquid radwaste discharge
' lina (unitiess)
E where:
. i the concentration of each identified radionuclide C, J=
i in the111guid. effluent (undiluted) (pci/ml)*' MPC g =~ the MPC value corresponding ;to 'radionuclide 'l from ['
~10:CFR 20-Appendix B, Table II, Column 2, (dissolved and entrained noble gases MPC.= 2E*
pCi/ml) (pci/ml) . . g
- NOTE: The concentration mix-must include the most recent sample data.
for H-3, Sr-89, Sr-90, Fe-55 and dissolved and entrained noble j gases. 1.2.2 Service Water Radiation Monitor - RISH10-1K605. - 2K605 The Service Water Radiation Monitor high-high setpoint is determined by the following equation.
-The monitor high-high alarm setpoint-is. calculated monthly based on the background. count rate. If the calculated setpoint is'less than the existing monitor setpoint, the'setpoint will be reduced to the new value. If the calculated.setpoint is greater than the existing setpoint, the setpoint' may remain'at the existing setpoint or. increased- '
to the new value. To assure that a high .. background count ~ rate does not prevent. adequate ' monitor sensitivity-to meet the requirements.of-Technical Specifications 6.8.4.d'.2 and 6.7.4.d.3, a maximum background: count rate of 300 CPM shall be used for the alarm setpoint determination. 1.2.2-1 Satpoint Determination The setpoint'for the Service Water Radiation Monitor is determined by the-following equation: CPN,,s 2,,(CRB ,) (1-3) where: CPM ,= Calculated Service Water Radiation Monitor..(RISH12-1K605, -2K605) count rate,' CPM.
ODCM Rtv.: 13 Paga 68-5/94 Z,. = 3, multiplier to establish-monitor setpoint count ~ rate above background count-rate (unitless) CRB ,= Service Water monitor:(RISH12-- 1K605, -2K605): count- rate attributable to background radiation, CPM 1.2.3 RHR Service Water Monitor -RISH12-OK619A. -OK619B,
-1K619C. -1K619D, -2K619C. -2K619D The RHR Service Water Radiation Monitor high-high setpoint is determined by the following equation.
The monitor high-high alarm / isolation setpoint is calculated monthly based on the background count rate. If the calculated'setpoint is less than the existing monitor setpoint, the setpoint will be. reduced to the new value. If the calculated setpoint is greater than the existing setpoint, the setpoint may remain at the existing setpoint or increased to the new value. To assure-that a high background count rate does not prevent adequate monitor sensitivity to meet the requirements of' Technical Specifications 4.8.4.d.2 and 6.7.4.d.3, a maximum background count rate of. 300 CPM shall be used for the alarm setpoint determination. 1.2.3-1 Setpoint Determination The setpoint.for the RHR Service Water Radiation Monitor is determined by the following equation: CPNw sEm(CRB-) (1-4) where: CPM u ,, = Calculated RHR Service Water Radiation Monitor (RISH12-OK619A, -0K619B, -1K619C, - 1K619D, -2K619C, -2K619D) count rate, CPM. Z uaw = 3, multiplier to establish monitor setpoint count rate above background count-rate (unitless). 9
' ~~ ^ ^ ~~ ' ' '
gi s 43 ' '
' " 4 ODCM Rsv. 13 g(d
~Paga 69 c5/94 n
,r i CRB,,, .= RHR Service Water Radiation ~
Monitor (RISH12-0K619A, - $ OK619B, -1K619C, -1K619D,: - 77 , 2K619C, -2K619D) count rate 1
~4~ '
attributable'to background. o radiation, CPM.
; 1.3 :Licuid EffluentJDose Calculation -'10 CFR 50
, -1.3.1 Mambers of the Public Dose lODCM I3.2.3 limits the dose or dose commitment to MEMBERS OF THE PUBLIC from, radioactive materials in liquid affluents-from-Limerick Generating Station to:
- during any calendar quarter, n 5 3 mrem to total body
$10 mrem to any organ
- during any calendar year.
5 6 mrem to total body
$20' mrem to total organ.
Per ODCM'I3.2.3.1-the cumulative-dose contribution from liquid effluents for the current calendar quarter year shall-be determined at least once per
. i- 31 days in accordance with the following, H calculation methods. These equations are for the-three aquatic environment exposure pathways , [].
(potable water, fish, shoreline exposure) in the j, ' Limerick' aquatic' environment. Only.real pathways are addressed for each receptor. The receptors- ! and associated pathways are listed below. Doses !
- xll from each real pathway are summed'to give dose at f the receptor. The monthly results.are accumulated 1
J i: to give the quarterly doses and the quarterly results are accumulated to give the annual' doses. q l l
"> R ceptor Dist. Pathways Location (mi) Potable Water Fish Shoreline IGS Outfall o X X Citizen's Utility 2.5 X X X
-Phoenixville Water 9.0 X X X Phil.'Sub. Water 13.6 X X Crew Course 37.8 X 2
1 l
Q:,6 m , ODCM RLv.: 13
~
f' -
, P;g3 70 NE
- e;; -
5/94 ! s 'li3.1-1 ' Potable Water Pathway c,. l R,,j = 110 0 *# EOjD,j,j exp (-Aj n21) (1-6) M,F 1 1.3.1-2 Fish-(Aquatic Food). Pathway R,,j = 110 0 g *# E OjB jpD ,j ,j exp (-Aj (24)) (1-6) i 1.3.1-3 Shoreline Deposition Pathway. U R,,3 = 110,000 M F. A A *APA '# ~ '# p where: B,p = equilibrium bioaccumulation factor for nuclide i in pathway p, expressed as the ratio of.the concentration'in. biota, in pCi/kg, to the radionuclide concentration in water, in pci/ liter (liters /kg)
i:- OD'"A R v.l13 3; ,
" Psgai71 5/94 BIOACCUMULATION FACTORS ' (pCi/kg/pCi/1 iter)
' FRESHWATER-SALTWATER ELEMENT FISH . FISH. .
H. 9.0E-1 .9.0E-1 C 4.6E 3 1.8E 3 Na 1.0E 2 6.7E-2 P. 3.0E 3. 2.9E 4 ' Cr 2.0E 2 4.0E 2 Mn 4.0E 2- 5.5E 2 . Fe 1.0E 2 3.0E 3 I Co 5. OE '.1- 1.0E 2 ; Ni 1.0E 2 1.0E 2 Cu 5.0E 1 6.7E 2 , Zn 2.0E 3 2.0E 3 ; Br 4.2E 2 1.5E-2 , Rb '2.0E 3' 8.3E O Sr 3.0E 3 2.0E O Y 2.5E 1 2.5E 1 Zr 3.3E O 2.0E 2 Nb 3.0E 4 3.0E 4 Mo 1.0E 1 1.0E 1 Tc 1.5E 1 1.0E 1 Ru 1.0E 1 3.0E O Rh 1.0E 1 1.0E 1 Te 4.0E 2 1. 0E ' 1 I 1.5E 1 1.0E 1 Cs 2.0E 3 4.0E 1 Ba 4.0E O 1.0E 1 , LA 2.5E 1 2.5E 1 .! Ce 1.0E O 1.0E 1 Pr 2.5E 1 2.5E 1 ; Nd 2.5E 1 2.5E 1 W 1.2E 3 3.0E 1 Np 1.0E 1 1.0E 1 ' Rsf: ~ 1) U.S.N.R.C Reg. Guide.l.109, Rev. l', Table A-1
- 2) Letter LTR 881209L001, from R.J. Clark, U.S.N.R.C., to '
G.A. Hunger, Philadelphia Electric Co., December 9, 1988, transmitting evaluation of Limerick ODCM.
.?
l .p
R-U 4 s
'ODCM.R3v. 13 Pags172 5/94
>. i I D,,g = dose factor specific to.a~given age group a, radionuclide i,' pathway p, and' organ j which can be used to calculate
~
radiation dose (1) from an intake of-a radionuclide, in
- mrem /pci, or.(2) from exposure to a given concentration of a radionuclide in sediment, in mrem /hr.per pci/m8 Values are listed by age group in Table ~1-1.
F = ' waste dilution ~ flow rate of: liquid. effluent dilution flow / number of batches (f t 3/sec) .
= dilution' factor at point of exposure or at point of- J M,
withdrawal of drinking water (dimensionless). Values are graphically listed by receptor location in Figures 1.R3.1-: 1 to 1.3.1-5. Value will be based on average monthly , river flow. Q, = total release of nuclide 'i'-for time period (Ci). R,g = total dose for calculation time period to organ j of _ f individuals of age group a from all nuclides i in pathway , b (mrem) . T, = radioactive half-life of nuclide 1 (days). U ,, = usage factor specifying exposure time or intake rate for an individual of age group a associated with pathway p (hr/yr, liters /yr, or kg/yr). Pathway Infant Child Teen Adult Fish -- 6.9 8 16 8 21 8 Potable Water (1/yr) 330' 510' 510' 730' Shoreline R; creation . (hr/yr) -- 14' 67 8 12 8 Shoreline R2 creation (hr/yr) -- 90 b 600 b 600 b , i Ref: " Regulatory Guide 1.109, Rev 1, Table E-5 b EROL Table 5.2.A-3 w = shoreline width factor , (dimensionless) = 0.2. Ref: Regulatory Guide 1.109, Rev. 1. 1.752E+5 = time period during which sediment
- is exposed to contaminated water (hrs) (midpoint of plant life = 20 yrs)'
':cn - ,,
ODCM R;v. 13'
~
U" > P ga-73 5/94 1, - = radioactive decay-constant of, nuclidei' .(hr*) 12 =.. delay: time for-potable' water-pathway in hours-to-allow for nuclide' decay: during transport through the water purification-
. plant and the water distribution system,- Ref:. Regulatory Guide 1.109, Rev. 1, App. A.
24 = delay time for potable fish pathway in hours to. allow for. nuclide decay during. transport through the food chain,'as well;as-- during food preparation. Ref: Regulatory Guide 1.109, Rev. 1, App. A. 1100 = factor to convert from Ci/yr.perL , ft3 /sec to pCi/ liter. 110,000 = factor to~ convert.fromLCi/yr per ft3 /sec to pCi/ liter and to. account for proportionately constant (100).used in sediment radioactivity model.
,i i
i l i l I i
--m ._
- g. ; , 7 g .. -
m g l '
'ODCMLR5v.E13-
;;.) "' +
-
- Paga - 74 '
5/94
+ # ;
t . Llauld Efflu'ent Dose ~ Pro'iections E y 1. 4"
, , e- ,
'ODCM I3'.2.4 requires that the liquid radwaste treatment' system:
'shall be operable and appropriate portionslof.the_ systems _used: -
e 1
'to; reduce the radioactive'materialsiin. liquid l waste prioritoi ,
. their discharge swhen the" projected doses.due'to the. liquid - ;
effluent to UNRESTRICTED AREAS would~ exceed:
- . , - 0.06 arem/31, days-to the-total' body ~ ;
' or i
0.2 arem/31 days to;any organ. l - 1 The applicable liquidiradwaste treatment processing equipment *'
.for maintaining radioactive materials releases ALARA are delineated in; Figure;1.4-6.
Dose projections are made at least-once per 31-days by the following equations: , D,a - =' -(D g /d)
- 31 days ,1-8);
f D,,, =
' (D ,/d)
- 31 days ,(1-9) ,
where:
- D,g = the total body-dosefprojection for~the current-31-day period ~(mram). .l Da = .the total. body dose projection for the-current calendar quarter as: determined by>equationJ1-5,-
~
]
[ 1-6, and 1-7-(area). r D ,y, = the maximum organ dose projection 1for ;
.the currentL31-day period (arem). .
D, = the maximum organ dose to date for.the1 current. ., calendar quarter as determined by equations 1--' 5,:1-6, and 1-7J(arem). d = the actual number of' days in the current calendar quarter at the end of'the release . '7 b (days). The minimum ~ time elapsed is'seven (7) t
- days.
- L M 31 days = the number of days of concern l r i
i 1' , l , Y I
rw , .m < N [ ' ODCM Rav; 133 [cW iN R W'* t Pago;75) R
, (5/94. U e:
1 4 j
,E m ,, '
;-22 0 ; GASEOUS EFFLUENTS ,
l2.1 ' Radiation monitorina instrumentation and' Controls' g The gaseous. effluent monitoring; instrumentation'and controls at Limerick!for1 controlling monitoring radioactive material' releases in accordance with the ODCM Part:1 are:summarizedias- ! follows.. 1).~ North Vent (Common): The plant gaseous discharges.via this c
-vent are monitored by.two Particulate, Iodine and Gas'(PIG)
. monitors ' (RY26-075A and RY26-075B) in parallel and byc the, Wide Range' Accident MonitorJ(WRAM) ~ ;(RIX26-076) . -The PIGS ~
have separate Particulate, Iodine, and1 Gas sampling and' _< monitoring channels but the Station ODCM' Controls 3 require-only particulate and iodine sampling and noble gas ; monitoring. The WRAM has extended range (via three'. ! channels) noble gas' monitoring and~ particulate and iodine . sampling capability. In addition, the WRAM provides~an a isolation (Group A) of the large Drywell Purge and Vent- , valves.
- 2) South Vent fone ner' unit): The plant gaseous discharges.via each South Vent are monitored by-two redundant PIG monitors-(RY26-285A,B). As.is the case of the North Vent, each PIG.
has separate particulate, iodine, and gas' sampling and- 1 monitoring channels but the. Station-ODCM Part'I; requires 1; only particulate and iodine sampling with. gas monitoring.- 3
-r
- 3) Hot Maintenance Shoo (Common): Due-to the composition'ofJ the-radioactive materials in the affluentrateam (i.e., very- ,
low potential for: noble gas),'this release point is sampled; for particulate and' iodine.(P&I)' monitors 1(RY26-025). The P&I monitor has a separate particulate and iodine sampling- . and monitoring channels but. Station ODCM Part.I requires-only particulate and iodine sampling. .
.2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION ODCM I3.3.7.3 requires that an alarm setpoint be. established '
for the noble gas effluent monitoring channels-(RY26-075A,B,; RY26-185A,B,; RY26-285A,B,; and RIX26-076)?to ensure that the. release rate of' radioactive. materials does'not exceed the. i limits of ODCM'13.3.2.a, which corresponds to:a dose rate at the SITE BOUNDARY of 500 mrem /yr to the total body or.3000 mrem /yr to the skin. This specification also states that the dose rates from I-131, I-133, Tritium, and allLradionuclides.in particulate form with half-lives greater-than eight days, shall: be limited to a maximum of 1500 mrem /yr to any organ : (inhalation pathway only). [ ODCM Part I limits are expressed in terms of dose rate, while the instruments which monitor effluents produce data in units l of concentration or release rate. It is therefore necessary to identify the isotopes and calculate the corresponding release : rate which will result in the dose rate limit being reached at i
pp' m
;:: y -a <
~ _
- ' ~ "~
' ;~ ,
' ~ ' - ~ -- ~ -
, m .
Ek
- dDCM'R;v.!13.
]y L Ar
, .Paga;76 1 l ' -5/94. ,
4 Mi the site; boundary.- This' calculation lis made moreLcomplex by l the use of multiplefrelease points at_ LGS. j i 1 Calculation Bases' m -
.The alarm setpoint calculation-is performed; monthly and is l basedLon analytical'results of grab samples from the appropriate release point. The concentration of_each- -
Y' identified radionuclide in the grab samples is determined, and- l
- 7 the data'are-used to perform a setpoint_ calculation for.that-
' ~ nuclide mix:and release point.
$" The highest-calculated annualfavorage concentration (X/Q)-for 3 ;
an area at or beyond the site _ boundary (1.lE-05sec/M ,; NE sector) is used'in the setpoint calculation Maximum flow 1 rates.through the North'and South vents are used
~
in alarm setpoint calculations.. This is necessary since flow can vary. By using maximum values, any flow less than the ;
. maximum will assure that the monitor will alarm-before release rate limits are exceeded.. 1 For each release point the. noble gas release which would'cause, a SITE BOUNDARY total body dose rate of 500 mrom/yr and afskin, q dose of 3000'mram/yr is determined.
The fractional. contribution of noble gas is calculated for each-release point. The fractional contribution.torthe whole body' -t and' skin-dose rates due to nobleigases-is calculated'by.taking. the product of this. fraction-and the limiting release rate. . A comparison of this release rate for whole; body and skin dose rates due to noble gas release is made to determine ~if the . whole body or. skin dose limit will be most1 restrictive. EIt is expected that the whole-body limit will always be most' - , restrictive, but.the comparison is'necessary to assure compliance with ODCM I. -The anna of the contributions from each l release point, independently calculated for' iodines and noble - gases, will equal the maximum instantaneous' release rate allowed from'the site. 5 The purpose of calculating the release rate which corresponds - to the site boundary dose limit is Det to~ determine an- . acceptable release rate, but to determine,the maximum release 1 ' rate.which may be: exceeded. It is nnt-intended that releases ' will.be maintained at or near this limit, and in fact, requirements to. maintain offsite doses As Low'As Reasonably. Achievable (ALARA) are specified in ODCM I3.3.3 and ODCM L I3.3.4. 7 d w --e = % v .
.g_ -- . - - - ~ . ~ .
a* 3: m -
- ODCM Rsv'. 13
~
I'f 4 s lPaga 77 ,
.5/94~
~ L 2 '.' 2 .11 /Northi Vent' Noble Gas Effluent' Monitors ~RY26-075A-3,
"' RY26-075B-3, AND RIX26-076-2 s .
[ m + 4
?The North Vent Noble Gas' Effluent monitorfhigh-high'.. - ; setpoint is.calculatedimonthly based onLthe grab sample- ^
- results .' performed - in ' accordance Iwith10DCM . I3. 3--3. Due to the incorporation of.the'AIARA philosophy.in the~ q design.and operationiof the Limerick. affluent' systems, -! release point grab samples'may not, identify any~
-radionuclides. In this situation,-chemistry may use
- , the results of the'last grab sample which: identified. ,
.. radionuclides or use the default setpoint?which-is based on expected concentration ratios as reported.'in-
~ ' the UFSAR.- If any calculated alarm setpoint is less
-than the existing monitor setpoint,.the setpoint~will be reduced to the new value. If the, calculated.
setpoint value'is greater than-the existing value,.'the setpoint may-remain'at the= lower value or increasedLto the new value. 3 2.2.1-1. Setnoint Determination The setpoint for the North Vent-Noble gas Effluent Monitor is set.at'or below-the ; lesser of the ' NVSP , a: OR NVSP,c,g value ~. , j The Alert setpoint is not to exceed 1.1.E-04 pCi/cc, per' LGS'UFSAR Table 11.5-2,-using .4 the two unit maximum North Vent. flow rate. :; [VF,,) [500] [E C ,1 =
,,""", 3
( -1) L [3. 447 5E9] E [ (C 3 ,) (Kj) ] . j R [ VF,,l . [3000] [E C3 ,] . .
]
gp#8" ' i' [3. 447 5E9] E [ (Cj,) (Lj +1.11Mj) ] where: E NVSPm = North Vent Setpoint - -Noble Gas Whole Body (yCi/cc) NVSP,c,g = North Vent Setpoint - Noble Gas Skin (pCi/cc) VFmo = Fractional contribution to site boundary noble gas dose rate from the North Vent as-calculated in
- 4. equation 2-7. (unitiess).
500 = Total body dose rate limit (mrem /yr) + 1 3000 = Skin Dose rate limit (arem/yr) l i
.s
, e r. - , -
k%a ' ; &:M ,
+
k,/
~
^
ODCM! rov.[13f j P g3'78 a
'N .5/94-
., H REC,,y . = - Total- noble . gas; activity from North . Vent , grab : sample l (pCi/cc)
'3.4475E9' = ' Conversion-factor
~
(pCl) (cc)
'm3 ) {pCl): ,
=(1".1E-5 sec/m3 ) (1E6 pCl/pCl) (664,000 cfm) (1/60 min /sec) (2.832Ed cc/fc3)- }
.(2-3) where: ,
1.1E-5 sec/m3 = highest annual average X/Q (NE Sector)" 1E6 pCi/pci = units conversion 664,000 cfm = maximum North Vent. flow rate for two unit
- operation
, 1/60 min /sec = units conversion 2.832E4 cc/ft 3 = units conversion C,,y = concentration of noble gas nuclide.1,as l determined by radioanalysis offNorth Venti grab sample -(pci/cc) K, = Total body dose conversion factor'for noble ~ 3 gas nuclide 1 (arem/yr per pCi/m , from ; Table 2-1). L, = Beta skin dose ~ conversion factor noble gas ' nuclide i (arem/yr per .pcim 3,1per Table 2-1) . M, = Gamma air dose conversion' factor for noble o gas nuclide 1 (arad/yr per. pci/m 3 , per 1 Table 2-1). ..? r i
. i
- -- -_e - -
9
n, - g ,.
)d
'" ~
;ODCM R v.J13 ^
, 1 ;-
.Paga 79?
Ry ,
. ~3 5/94 *
@W h ,: c , 2 ~lly _ _~
^
4
. - 242.2- ' South' Vent' Noble Gas Effluent' Monitors'-RY26-185A-3',
tK " RY26185B-3, RY26-285A-3. AND RY26-285B-3
.Each unit's South Vent'NobleEGas Effluent monitor high-high- '
setpoint~is calculated monthly.basedron:the grab: sample; ,
;resultsLperformedsin accordance with ODCM I3.3-3. .DueLto theLincorporation of the ALARA philosophy in the design and-
-operation of the Limerick affluent systems, release point; grab; samples may not identify ~any radionuclides.- Withithis
. situation,.chemistryLuay use:the results of the. grab ^ sample:
which identified radionuclide or use the default setpoint "which-is' based on expected-concentration ratios.as reported'.
.inLthe UFSAR.- If'any calculated alarm setpoint.isEless .
than the existing. monitor:setpoint,.the setpoint will be : reduced.to:the new'value. If the calculation setpoint ' value is greater'than'the existing.value, the setpoint may.
-remain at the lowerLvalue, or increased to the:new value.
-r 2.2.2 Setpoint determination-The setpoint for the South Vent Noble Gas Effluent- i and Monitor is set at the lesser of the SVSP "
SVSP value. SVSP Land SVSP are:caTUulated! for' Ech unit's SoutY Vent. ThEAlert;setpoint is,, ; not to exceed 3.4 E-6 pCi/cc, per LES UFSAR Table 11.5-2, for each^ unit's South VentiNoble Gas channel, using'each unit's maximum South Vent; flow. rate. When a' containment purge occurs through'one inch /two inch vent valves to the South' Vent,-an 4 grab sample will be' analyzed for. noble. gas activity, and the setpoint for the containmenti purge will be calculated'per this=ri.: tion.- This l setpoint will be compared to the x sting monitor l setpoint. IE the calculated containment. purge setpoint is ; i less than the~ existing setpoint, THEN the setpoint will be reduced to.the new - value. ; IE the~ calculated containment purge se.tpoint.is. greater than the existing setpoint,. . . THEN the existing setpoint will be maintained. At - , the completion of the' containment purge,;the ! setpoint will be . restored tx) .the monitor.setpoint' ,3 that existed immediately prior to the containment purge. SVSPmra s; (2-4)
. [1.2149E9] E [ (Cj,y) (Kj) ] 3
- - . , .. . . ~ ,u ODCM R;vri13n 30 , , Pigs 80: 1 5/94; j 1
gygp" , W m ) M W W evY i _ g g _5 y [1. 2149E9] E [ (Cj,y) (Lj+1.11Mj) ] i
- where : .
South: Vent Setpoint - Noble Gas:Wh' ole Body. SVS P,au, = (yci/cc) SVSPgg = SoutA VentLSetpoint - Noble Gas' Skin (yCi/cc)~ ' 1 VF,,a = Fractional contribution to; site
-4 boundary noble gas dose rate from the Unit's South Vent as calculated in equation.2-8 or 2-8a (unitless) >:
'500 = Total body dose rate limit'(arem/yr) 3000 = Skin dose rate limit (arem/yr)
EC gy = Total noble gas activity from each unit south , Vent grab sample (yci/cc). i 1.2149E9 =- Conversion factor (pci) (cc) ' l (m )(pcj), a
= (1.1E-5 sec/m3 ) (1E6pCi/pCl) (234,000 cfm) (1/60 min /sec) (2. 83E+4 ' cc/ft 3 )'- (2-6)-
where: i 1.1E-5 sec/m3 = highest annual average X/Q' (NE Sector) 1E6 pCi/yCi = units conversion 234,000 cfm '= maximum South-Vent flow rate 1/60 min /sec = units conversion 2.832E4 cc/ft3 = units conversion C, g = concentration of noble gas nuclide i' determined by radioanalysis'of South Vent grab sample (yci/cc) , K, = Total body dose conversion factor for. noble gas nuclide 1 (mrem /yr per'pci/m 3, from Table 2-1). .'
- = , , m .-,1
y~ arns, m . -_
~ . ., ,,
"ll% , - eq ; ~ . 3ODCM'R"dvE13: f W. - ! Pngn ? 81' ~ f . 1 - 5/94; --
- m. ,
s , 1
\ t
~
k' L i' ,=" Beta skin dose: conversion factor? noble' igassnrclide:1'(arem/yr per pCi/m3,sper. l Tabit . 2-1)'. L 4
.M.g
!=: Gamma' air dose. conversion factor for
~
noble gas nuclide.,i'(mrad /yr per.pCi/m 3,. '
~
per Table:2-1). i 2; , 2.2.3 Noble Gas Effluent-Fractional Contribution-- The noble gas effluent-fractional contribution.'is' L
'w calculated monthly 1using.results'of.thel grab . ,
samples. performed 11n:accordance with:ODCM I3.3-3." ,
- The results of this calculation are used'in . ,
- equations 2-1, 2-2,: 2-4,:and 2-5. This_ methodology; assumes that the total body dose. is : limiting:.for . l noble gas' releases. If equations 2-1,-2-2, 2-4,- 'r and 2-5 show that the skin dose is'. limiting, fractional. skin dose should-be substituted for the. s whole body values used in equations 2-7, 2-8,: and ,
2-8a. 2.2.3-1 Calculation of VF,,,, . VF t,,,, and - VF hwo, 2 . VF" = E [ (Cjw) .(Ky) 3 +EE[ (C'#) (C32,y) (Kj) 3 +E [ (Cjssy) (Kj) )- (K') ] M E [Cj,,y) (Kj) ) VF18 " = E [ (Cj,) (Kj) ) +E [ (Cj,,y) (Kj) ] +E [ (C ,,y) (Kj) ] . ( 2 -7 ) i. 3 , I #'8 ' ' ( 2 -7 ) VFas m = 3 [ ( c) m ) ( g ,) ) g [ (1c ,",y) { g)) ) g [ ( c , , ,y)g ( g ) ) where: VF,,a = fractional' contribution to site' boundary noble gas total body dose rate from the North Vent e (unitless). VF ,,a3
= fractional contribution to site boundary noble gas total body dose rate'from the Unit 1 South Vent (unitless).
VF2suc = fractional contribution to site boundary. noble. gas total body dose rate from the Unit 2 South Vent (unitless). r
p-. g yu -- - - -- -
- - ~ . -
--e +- w .
f
- ODCM 1R">v. r131 -
,' r %"
3 m. 7 ~ 4 Pags 82
- 5/94' . Gj **
C,,y = concentration.of noble gas nuclideIi as.
~ determined by radioanalysis of! North Vent: grab-sample:(sci /cc)'
q , 4 4 K, = . total: body! dose conversion factor for.' noble gas! radionuclide 1 (arem/yr per, pci/m 3) C n,y . = , concentration.of noble 1 gas'-nuclideli as: ' d determined.by radioanalysis of. Unit.1: South- - Vent' grab sampleL(pci/cc). . C lasy = concentration of noble: gas nuclide'ifas . determined by radioanalysis of Unit 2 South-Vent grab sample--(pci/cc) 2.2.4 ~ Noble Gas Effluent-DefaM t Setnoint This methodology:may-be used when grab sample-results<from either.the North Vent or the South-Vent do not identify any radionuclides.g This methodology is based on expected release ~ concentration ratios as. outlined in section-11.3-of the Limerick.UFSAR. 2.2.4 North Vent' Noble Gas Monitors (RY26-075A-3 and-RY26-075B-3)'. .The default setpoint for the North Vent-noble; gas , effluent monitor is set'at'or.below the. NVSP,, value $3.45E-5: yCi/cc. ' l gp* g [8.90E-1] [500] [1.15E-6] (2 -9 E l [3.447 5E9] [500] [4. 30E-9] b where: NVSP,, = ' Default North Vent. Setpoint - Noble . Gas - (yCi/CC).. 4 - 8.90E-1 = Default fractional'~ contribution to site boundary- 1 noble gas total. body dose rate from the North l Vent '-(unitless) . )
, 4 . 3 0E (4 . 3 0E-9 ) + (5. 31E-10)
~ where: 4.30E-9 = Summation of the North Vent concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor. (pCl) (mrem) (m3) J (cc) (yr) (pCl) I
- w -e , , - ,- , , _ . , . , . - - , - - , , - . . .~.,ary+,,4e -e eW
^~~ " '
gpp $dP at- ' SW :p " '
- P. '
_ " ' ' ' ~^ q;pA o :s i:q
- ODCM ' R',v.113 :
; ,1 , <
-: Paga : 81 ' ',
4 ,q < 5/94 p;p
-m ? Lp' ,
'=- - Beta skin dose conversion: factor inoble < '
gas nuclide;11.(arem/yr per pCi/m 3 , per
.,@ : Table 2-1)~.
M, '=. Gamma" air dose conversion. factor for .
' noble' gas nuclide;1'.(arad/yr perfpci/m3 ,
~'
'per' Table,2-1)..
, N' 2.2'.3 . Noble Gas Effluent Fractional' Contribution: r . The noble gas'affluentifractional-contribution'is. . ,' ' calculated monthly.using results of.'the. grab
, samples. performed..in:accordance with;ODCM I3.3-3.,
The results of thisLcalculation are'used/in. . equations 2-1, 2-2,-2-4,_and 2-5. This, methodology-
' assumes that the. total body _ dose'isilimitingsfor; noble gas releases. If equations.4 2-1,.2-2,12-4',
andL2-5 show that the.skinLdose.is limiting, 1 fractional skin ~ dose should be substituted for the whole body values used in equations 2-7, 2-8,-and 2-Ba. ; 2.2.3 Calculation of VF,,g, qVFggy,c,.and VF25nci Z (C'"") (K') ]
.VF " = E [ (Cjyy) (Kj) ) +E [ (Cj2 ,y) (Kj) ] +E [ (Cj,,y) (Kj) ] - ' M '-
~
?
x 2 h E [C32 ,y) (Kj)] j y,1" , E [ (Cjuy) (Kg) ] +E [ (C j2 ,y) (K j) ) +E [ (Cjasy) (Kj) ) VF8 " = Z [ (Cjyy) (Kg) 3 +E [ (C ,y) (Kg) 3 +E [ (Cas,y) .(Kj) l ( 2 -7 )' ' 32 _ f where: VF,,o = fractional contribution to site boundary noble _ gas total body dose rate from the North Vent (unitless). s VF uvua = fractional contribution to site boundary! noble gas total body dose rate from the Unit 1 South Vent'(unitless). VF 2swo = fractional contribution to site' boundary noble. gas total body dose rate from the Unit 2~ South 2' Vent (unitless). 4
(.; ,- _, .7
--e- - ->
; - - - - - - - - - - - ~
* , M - s .i f'y ,
E - ODCM R3v. 13. ' gytn ; am -Pagaf82" 5/94; y -
- g. ' t >
' Cy =1 . concentration of' noble. gas;nuclide11._asf determined by.radioanalysis of North 1Ventigrab. ~
sample (pCi/cc).
" - -- ' total: body-dose-conversion, factor-for noble gas L Ki' radionuclide'i (arem/yr per pci/m 3)
- Cg,y =- concentration of noble' gas nuclide 1-as determined.by radioanalysis;of. Unit;l SouthL Vent' grab' sample-(pCi/cc) l C usy = concentration of: noble ~ gas nuclide -i as - ,
determined by;radioanalysis of; Unit.2 South e Vent. grab samplex(#Ci/cc)- ! 2.2.4 -Noble' Gas Effluent Default Setnoint. This. methodology may.be~used when grab sample. results from either the NorthLVent or the South: , 1 Vent do not identify any radionuclides. This: methodology is based on expected. release. concentration. ratios as outlined'in section 11.3 of'the Limerick UFSAR. i North Vent Noble Gas' Monitors (RY26
~
2.2.4 . 075A-3 and RY26-075B-3). .The default 3 setpoint for the North. Vent noble gas affluent' monitor is set at or below the NVSP,, value 33.45E-5. gCi/cc. , [8.90E-O [500] [1.15E-6] (2 -9 ) NVSP**s [3. 447 5E9] [500] [4. 3 0E-9] i
+
where: NVSPun = Default North Vent Setpoint - Noble Gas (yCi/CC) , 8.90E-1 = Default' fractional contribution'to site-boundary noble gas total' body dose rate from.the-North-Vent (unitiess) !
, 4 . 3 0E-9 (4 . 3 0E-9 ) + ( 5 . 31E-10 ) -
p where: 4.30E-9 = Summation of the North Vent concentration ~of . noble gas nuclide i multiplied by the corresponding whole body dose factor. (pCl) (mrem) (m3) (cc) (yr) (pCl) i IL 'l
4-Y <
,; -p
, _ g59. '
7.ODCM R N..J13' ei M - (, -_ -Pagn'83 ,j
-5/94.
ml. , ]
. a
'N, , l Summation.of the South. Vent (Unit l^&L2).
4 5.31E = i n concentration'of noble gas nuclide i multiplied
' ~
- n. , , by the corresponding whole' body dose factor.- I y '
j
," s
-(pCl) (mrem) (m3)
(cc) (yr) (pCl). ,
., :l 7 Ref: ' a) . Based'on expected annual..releaseffrom 4 UFSAR Table.11.3-1.
b) Based on maximum North Vent flow of-; -(-
'664,000 cfm.and-South Vent flow of .,
234,000 cfm for Unit-1?and
. Unit 2 vents.
c)' ODCM II Table 2-1.-. , 500 = Total body. dose ~ rate limit (mrem /yr)' [ 1.15E-6 = Total noble gas concentration from North ; Vent (pCi/cc)' .; Ref: a) Based UFSAR Table 11.3-1. b) Based on: maximum North. Vent-flow of' , 664,000 cfm 3.4475E9 = Conversion factor.
~
(pCi)'(cc) (m3 ) (pCl) , h t f 4.30E-9 =. Summation of the North Vent' concentration of noble gas nuclide~i multiplied byfthe ! corresponding whole body dose factor. ; p I' (pci) (mrem) (m 3) s - (cc) (yr) (pCl) ; Ref: a) Based UFSAR Table 11.3-1. 4 b) Based on maximum North Vent flow of 664,000 cfm. c) ODCM II Table 2-1. 1
'l b
r ue,-
- ~ - . .. . - . - ., . .. ,
g . rp d
,q -
ODCM Rhv.'13'
, 1 Paga 84;
, 5/94..
- j
-2.2.4-2 - South > Vent Noble Gas . Monitors : (RY2 6-185A-3, RY2 6-2 8 5A-3 ', ; RY2 6-18 5B-3, and RY26-285B-3)..
The' default.setpoint-for each Unit's South.
. M Vent noble" gas effluent monitor isl set at or. ;
below the.
~ SVSP, value\ (5 6. 09E-6 pCI/cc) . =
~
3ygp" , -(5.49E-2] [500] [7.14E-8]- I - (2 -10 ) - 4 [1. 214 9E9] [2. 6 5E-10) . -
. >where:- I
. SVSP , = Default South' Vent Setpoint - Noble ,
Gas (pCI/cc) , 5.49E-2 = - Default fractional contribution ~to site-boundary noble _ gas total body dose rate.from the South Vent-(unitiess)-
, 2.65E-10:
(4. 3 0E-9 ) + (5. 31E-10) where: 2.65E-10 -- - Summation:of the Unit's-South?Ven't concentration of noble _ gas nuclide-i multiplied by'the-corresponding.whole body ;
- dose' factor. ,
(pCl) (mrem) (m 3) (cc) (yr) (pCl) F r 4.30E-9' = Summation of the North Vant concentrr,n of!
- noble gas.nuclide i multiplied by'tte corresponding- whole body : dose; fact ,.:
(pCl) (mrem) (m 3) (cc) (yr) (pcl) . a r E g. t t w e. -.__.__.--_.-.-.._N--.A--_-.
g 4 :c >~ "; .
-- * "- ; - v - -- * + 4 +
w " g ,- q; <
- i ,
. ' ~ - _ - L. i , ,
- ODCMJRiv. 136'
~
- -PLgs
- 851 wM4 -
. 5/04~
f,%,? w _ , - o i. i Summation' of' the South Vent J (Unit-r14 2); t
/ , 5.31E-10! =
;concentrationiof noble 2 gas;nuclide:i _ .'
s - multiplied'by-the; corresponding 1whole. body-dose factor ~ . s , (pCl) (mrem) (m3) l (cc) (yr)-(pCl) . i . Ref:..a) ' Based'on expected annual > release '
- ^ from UFSAR. Table 11.3-1.
.c b)' Based on maximum' North Ventiflow of' i 664,000 cfm and South' Vent. flow'of.'
234,000 cfm for Unit:1 and Unit: 2' vents.- c) ODCM II Table 2-1; _ l 500 = Total' body dose rate.. limit (mrem /yr) [ 7.14E-8 = Total noble gas concentration fromlNorthHVent a' (pci/cc) i Ref: a) Based UFSAR Table-11.3-1. { b) Based on: maximum North; Vent >flowfof' 664,000 cfm. ,
,1 2149E9 = ' -Conversion factor (pCl) (cc) ' 'I
, (m3 ) (pCl) . -
'i Ref:' a) ODCM II. equation 2-3L
. .. . I 2.65E-9 = Summation of the North Vent: concentration"ofL '
noble' gas nuclide'i' multiplied'by the' corresponding,whole, body.. dose factor. (PCl) (cc) (m3 ) (pCl) , Ref: a) Based UFSAR Table 11.3-1.. . Based on maximum ~ North Vent flow of. b) 664,000 cfm. c) ODCM II Table 2-1. 3 4 t 4 e e + - . - - - - w ew ..e < . - - w , r -
3 ,,
- id o '
- o -<
~l ~
< ODCM Rav.(13.:
>>+ .Psga 86i
;7
. < , .5/94
&x
, 2.2.55 Wide Ranae Accident' Monitor Noble ~ Gas Effluent ,
Monitor'(RIX-26-076-4) The'_ Wide Range Accident Monitor (WRAM)i nobleLgas i" l total effluent channe1Ldisplays the' North 1 Vent ,
. noble' gas release rate. DThis monitor has-Main ~
-Control Room Annunciation as wellfasla groupl6A isolation. function.on.the primary containment purge and vent valves. The isolationLsetpoint: ;
valve'of;$2.1 pCi/cc specified in; Technical.
. Specification ' 3.3.2-2 is based 'cn1 the accident t -dose limits for'containmentfpurge'during an- _ . h?'
accident-(Ref: . UFSAR'_ Section 11.13 ) .a . For.-routinej operations the total. effluent alert and'high. " < setpoints are based upon the methodology of Sections 2.2.5-1-and 2.2.5-2. The setpoint units. are-in~microcuries_per second using the two'_ unit t 4
- maximum North vent flow' rate ofE664,000 scfm. . The-
- Jtotal effluentfchannel'High setpointuis set at'a-
'value'less than-or equal to' ten times'the~ Alert setpointf(not to. exceed thef2.1 pCi/cc equivalent-using the two-unit ~ maximum North Vent'flowirate).
For containment _ purge. operations,;the high setpoint is based;on an isotopicJanalysis(of thet .
~ containment _ atmosphere using'CH-1009.(Ref: Section '
2.2.5-3).- These values are.always.:more'. conservative than the Technical Specification-
~
Table 3.3.2-2 requiredLyalue ofis.2.14Ci/cc. If the calculated setpoint-valueLis'less1than,the; existing monitor setpoint, the setpoint will be reduced to the.new value.. If:the calculated setpoint'is. greater 9than thelexisting.value, th'e" : setpoint may remainiat the' lower value,.'r o 1
-increased ~to the new value.-
I f f 1 d a
- - ~' -
<;g , - , .
J /^' w ODCM Rhv'.U13
- PHgW87:._
~
[ ;;;
-5/94'
'e, '
'212.5-1 -Routine Operations Alert Setooint?
Determination For routine' operations,cthe Alert-setpoint forlthe WRAM. Noble l Gas total'
~
r effluent channel is' set atLor below'the- t
. The lesser of . the NVSP,Ys. OR-not Alert,setpoint NVSP,ogg _.value.
to exceed. 1.1 E-04:pCi/cc equivalent,.~using.the
-two-unit maximum North Vent: flow rate,
.per LGS UFSAR Table 11.'5-2. o (VFyw] (500] [E Csa) ygp" g _ _
[3. 447 5E9] E [ (Cm) (Kj). ] . , ggp" g. IVFel [3000] [ECfw] _ [3. 447 5E9] E [ (C 3 ,) (Lj + 1.11Mj) ] , where: NVSP, .
= North Vent Setpoint - Noble Gas:Whole ,
Body.(pci/cc) , NVS P,c,g = North Vent Setpoint --Noble Gas Skin (pci/cc) . _ VF,y,a = Fractional contribution-to site boundary . j noble gas dose rate from the North Vent = f as calculated in equation 2-7.t (unitless). 500 = Total body dose rate. limit ~-(arem/yr)
-3000 =-. Skin Dose rate limit (arem/yr)
ECi ,y = Total noble gas activity from North Vent. grab sample.(pci/cc) 3.4475E9 = Conversion. factor) (pCl) (cc) ' I (m3 ) (pCl) .
=(1.1E-5 sec/m 3) (1E6pCl/pCl) (664,000 cfm)'(1/60 min /sec) (2.832E4 cc/fc3) (2 -3 )
)
where: 3 1.1E-5 sec/m = highest annual average X/Q.(NE Sector)- 1E6 pCi/pci = units conversion
,_ . ~ .- .x .
=;
_..j'u' t
~
'+
e gb , . W '
"ODCM Rivhl3;
<Paga'88; f' Mf.., - m i
_ ~ 5/941 "
+t gy;u ,
J l.664,000Lcfm7 J=4 -maximum; North Vent [ flow ratei for two- . b ^o - unit'operstion, ,J,
'z ." '
'1/60 min /sec =-. units. conversion
*t' "2.832E4 cc/ft 3 =' units' conversion.
C,,9 = : concentration of. noble gas nuclide 11as:
' determined byLradioanalysis'of' North,l :
Vent. grab sample (#Ci/cc). -
- Kg =- Total.b'ody doseLeonversion factorlfor': 3. !
, noble gas nuclide i c (mrem /yr per ~ pCi/m ' '
,1 -
from. Table 2-1).' L' = Beta skin dose conversion factor noble 3 gas nuclide 1 (arem/yr per pCi/m ,1 per-Table 2-1).- ,'
~ ~
M'
=- < Gamma ~ air dose' conversion ~factorJfor: 3 3'
noble. gas-nuclide i.(mrad /yr per pci/m ,.. [ ~ per Table:2-1). l , The setpoint values are converted from pCi/cc to pCi/sec using. i the maximum two-unit-North Vent flow rate: 1 ~ NVS P,gg, = WW,,y,) [3. m E8[ J 2 W )' : NVSP,,: 7 = . [NVSP,g)' [3.134E8 ) (2-15). , where: :
.i NVSPTEWB = WRAM total:sffluent' channel--North Vent? j
- Satpoint -! Noble' Gas. Whole Body. 1
(#Ci/sec).. .l NVSP ygg = WRAM tiotal effluent channelLNorth Vent' Setpoint -' Noble Gas Skin-(#Ci/,sec). , 3 NVSP,,y, = North Vent Setpoint - NobleLGas Whole
- Body l(#Ci/sec).;
b NVSPuou = North Vent Setpoint - Noble Gas Skin. l (gCi/sec). 3.134E8 =
=
Conversion'factori(cc/sec). . ' (664,000 scfm)fi/60 min /sec)- (2.'832E4. cc/ft )- (2-16)i ' w b
, - ,-a - - - - - - . - . . , . . _ _ , _ . _ ..- ._L.___ _ __ _ _ . _ - _ _ .~ _ =
ca C& 1 iQ ~ ;j' M t N, , *; ;( : " ODCM-Rtv.*13lS
^ '
kd n
~
,c, Paga $j9j
-s 2.215-2 ' Routine ~Onerations'Hiah Setnoint- '
Determination .
. For: routine -operations, 'the highisetpoint for'-
the WRAM Noble Gas total: ef fluent- channel:~is -
~ '
~ set at or'below ten times ~the lesser.of'the.
routine operations'NVSP,y, or,NVSP ,,g 1 7 value..
;NVHP,,y, = W@,,,,) ; [ M ] ' :(bH) .
NVHPitst = [ NVS P,,,g ) - [ 10 ] - (2-18)- a ' where:' NVHP3 ,y, = WRAM total affluent' channel North Vent High Satpoint Noble Gas Whole. Body-
~
(pci/sec) '. -- NVHPTESC = WRAM total' effluent channellNorth Vent High Setpoint Noble Gas Skin (pCi/sec).. NVSP,ay, = WRAM total effluent channel North. Vent. Satpoint'- Noble Gas Whole Bodyi (pci/sec).
' NVSP,,,g .
= WRAM total effluent channelLN orth Vent Setpoint - Noble Gas Skin ](pCi/isec) .
10 = multiplication factor to calculate High value (unitless) 2.2.5-3 Hiah Setnoint Determination - Containment Purce ODerations. During routine purge operations 1via North Stack,- the setpoint .will be : determined prior to initiation of the; purge. based on'the containment noble gas grab sample. required'by ODCM 13.3-3A.- The WRAM high setpoint-is set at-or.below the-lesser of the WRSP,apy,OR WRSP value. At no time 4willlthe setpoint behherthen-'6.58E+8pCi/sec'(Ref: ~ Specification Table 3.3.2-2' limit of~$ 2.1 pCi/cc converted'to_pCi/sec-(2.1 pCi/cc-is based on maximum 2 unit North Vent flow rate). R WRSP" " s [1.10E+1] E [ (C ,) (Kj) (2-19) 3 [VFal [3000] [ECj,] WRSP " #s [1.10El) E [ (C ,) (Lj+1.1Mj) ) (2-20) 3
* ' ^
c - $ ODCM R;v. 13 P293'90
- G 5/94-where:
WRSP,,,- = WRAM Purge Setpoint - Noble Gas'Whole b Body (pCi/sec.) WRSP,,g = WRAM Purge Setpoint - Noble Gas Skin (yci/sec.) VF,ma = Fractional contribution to site boundary noble gas dose rate.from North Vent as
' calculated in equation 2-7-(unitless).
500 = Total body dose rate _ limit (arem/yr). 3000 = Skin dose rate limit (mrem /yr). IC g = _ Total noble gas activity from. containment grab sample (pci/cc). 1.1El = Conversion factor
' (pCl) (sec)
(pCi) (m3) (1.1B-5 sec/m 3) (1E6pCi/pCl) (1/60 min /sec) (2.832E4 cc/ft 3) (2 -21) min-cc 472 sec-ft3 where: 1.1E-5 = highest annual average - X/Q :(sec/m 3 ) (NE sector). 1E6 = units conversion (pCi/pci) 1/60 =- . units . conversion (min /sec)- 2.832E4 = units conversion- (cc/ft 3) ' 472 = units conversion min-ce
,sec/ft 3 Cg = concentration of noble gas nuclide i as determined by radioanalysis of containment grab sample (pci/cc).
K, = Total body dose conversion factor for noble 3 gas nuclide i (mrem /yr per pCi/m from Table 2-1).
4 . y- . .
~ '
_ff ~ k
^ :; -
"' ?
'ODCM)NsvF13i
< l60 '[ '
- PLgs 91b '
+ ,5/94 y ,
J[ "" ,Il{
.,. Beta: skin) dose conversion factor for~ noble:
; gas nuclide i- (mrem /yr per. pci/m3 from : +
1 Table;2-1). M , '-~
= GanmaLairJdose conversion: factor ~for noble .,~
Lgas-nuclide'it (arad per pCi/m '3 from LTable 2-
'1).
' 2.3 Gaseous-Effluent Dose-Evaluation The Annual: gaseous effluent dose evaluations are performed using the computer based RM-21A; report processor. . ,.
Instantaneous offsite: Dose Calculations areLperformed with; the-MesoRem Jr Common' Dose Model' computer. program. The: , following sections describe the computational models, e assumptions and: bases. Emergency dose calculations are performed using the MesoRem Jr Common Dose Model computeri program. Monthly dose calculations are performed based on-limiting sector average annual meteorological dispersion parameters.. For the noble gas monthly dose calculati'on, effluent release-data are based on the latest grab sample-analysis for radionuclide composition and the' hourly 7 average effluent-monitor response for. total release.' . activity. For'the iodine and particulate; monthly dose' - i calculations,-the effluent' release radionuclide composition and release activity are based onithe . . continuous composite samples for the time period of the dose calculation. . The quarterly dose-calculations.are afsummation of the-applicable monthly dose results.. The. annual. dose calculations'are based onLthe actual 3 meteorological conditions concurrent'with the: effluent M
-releases. Wind direction,Jtemperature-lapseJrate, ambient temperature, ground level windspeed,;and. release elevation windspeed-are provided for each hour of the year..'The meteorological dispersion ~valuesL(X/Q,.' depleted X/Q, and D/Q) are. calculated for each-hour and linked with the corresponding release data. The effluent release r
radionuclide composition ~and activity:araibased on the ; same parameters as the monthly dose analyses. , f
- 9
7> 19g
*;&N a .
ElTE '
- ODCM RiveJ13t gy " '
Pcgr 92f K ]f
; g~q . -
5/94; 2.3.1 Site' Boundary Dome-Rate'- Noble' Gases- ,
- . .. . . . l ODCM I3.3.2.a' limits?the: dose. rate (at.therSITE4 1 m, BOUNDARY-due to noble gas releases tol'$500 mrem /yr
. total. body and $3000.mren/yr= skin. . Radiation d ;
monitor alarm setpoints are. established:to ensure- 1 that these' release limits are not exceeded. "In Lj a"s the event any gaseous releasesefrom thelstationL
~
results:in an. alarm setpoint;being exceeded, an evaluation of the SITE BOUNDARY doseirate~ resulting from the release.would be performed 1 ,
~
using'MesoRem Jr. common Dose Model' Computer-Program. Simultaneous releases from.the North'and South Vents are considered in evaluating compliance ~with the release rate limits of ODCM I3.3.2.a following: any-releases exceeding the: alarm setpoints.. Monitor indications (readings).are: averaged over time periods not.to exceed 15 minutes when determining noble gas release rate based on correlation of the monitor' reading and monitor sensitivity. .The 15-min averaging: allows for reasonable monitor: response to potentia 11yl L changing radioactive material concentrations and to exclude potential electronic spikes in monitor) readings that may>be unrelated 1to radioactive. material releases. When identified, electronic. soiking monitor responses,are:being. excluded from-the dose calculation.
^
l NOTE: For, administrative purposes,'more . ' conservative alarm.setpoints than those .. , required to meet 10-CFR 20.-Dose Rate limits are imposed. However,. conditions exceeding: ~ these.more limiting alarm setpoints do-not m
.necessarily indicate radioactive materia 1J
- release rates! exceeding the doseJ11mits of ODCM I3.3.2.a. 'Provided actualireleases do not resultin' radiation monitor indications, I exceeding values based on-the dose rate' limits of ODCM I3.3.2.a, no further; analysis are required for' demonstrating- ,
- compliance with the limits?of ODCM I3.3.2.a.
l-i s I
m ' V -ODCM R:;v.i13 Pag 3 93:
' 5/94 The site-boundary dose rate:from noble' gas..
- effluent releases in the. event of.ainoble gas effluent setpoint-exceeding the value specified in ODCM II sections 2.2.1 (or 2.2.4-1), 2.2.2 (or, c 2.2.4-2), and 2.2.10 is calculated using the methodologyLstated below. .This. methodology is based on actual meteorological dispersi'on. Dem= (53. 882) (X/0) (( (F,) (0 ,)3 + (F ,y)2 (Ojg,y) + (F SV) 2 (O ssy) i ) Kj]' (2-22
'11
#E 3 [ [(F,) (O ,)2 + (F SV)t (Oj2,y) + (F 2SV) (Olssv)]IJ) +
Dp,g= (53. 882) (X/0) 11
'(SF) E [ (F yy) (Ojyy) + (F3 SV) (Oj2,y) + (F2 ,y) (Oj,3y) ] Nj (1.11) d=3
. ( 2-2 3 ) -
where: , D,pg = Total. Body Plume Dose Rate (rem /hr) DPsK = Skin Plume Dose Rate (rem /hr)- 53.882 = Units conversion factor rem-m 3 -pCl-yr-min-cc
,pCi-br-mrem-m 3 -sec-ft 3 X/Q = 1.1E-05 highest annual average relative concentration (NE Sector) (sec/m 3)
F,y = North Vent Flow Rate (cfm) Qi ,y = concentration of: noble gas nuclide i during period of release from North Vent (gCi/cc)
)
i F 1sv = Unit 1 South Vent Flow Rate (cfm) Qitsy = Concentration of noble gas nuclide i during period of release from Unit 1 South Vent (4Ci/cc). F 2sv = Unit 2 South Vent Flow Rate (cfm) Q tzsv
= Concentration of noble gas nuclide i during i period of release from Unit 2 South Vent (gCi/cc).
> '2 i: A YM ' g&, -- @
, . .o ,.
p-Y JW ' " M, EODCMcR,vb 13
-m' ' ' .' _ #
PagaD94
' i. ~ -
~
[7 g -
'5/943
- h. ~ , ' ' ' .
-Total-body! dose factor 0for~ noble: gas-nuclide
~
='
; K(
X > i . :: J Values are lisited-in Table'2-1. arem-m 3 2:h ,
;pgj-yy ,
,+
^
'4, L, =- ' Skin dose factorEfor the b' eta' contribution for noble gas nuclide 1. Values are liste'd . in Table 2-1. gygg.g 3 1i pCi-yr . i 1.11 = the average ratio'.of tissue to: air energy absorption coefficients (arem/ mrad) (Ref: Regulatory Guide 1.109 Section:2.2) ^ SF = 0.7 is the attenuation. factor that' accounts R for the dose-reduction due to shielding. provided by residential structure. l (dimensionless) . (Ref: Regulatory Guide.1'.109 Table E-15).
~
Mi = Gamma air dose-factor =for. noble gas'nuclide: ,
- i. Values are-listed in Table 2-1.
mrad-m3
, pCi-yr ,
2.3.2 Site Boundary Dose Rate Radiciodine~and Particulate,g, t ODCM I3.3.2.d. limits-the dose rate to $1500 arem/yr to any organ . (inhalation - pathways . only) for 'I- 131, . 'I-133, Tritium, and all' radionuclides in particulate: form with. half-lives' greater than'8; days in~ gaseous effluents.. Compliance with ODCM I3.'3.2.d is determined. monthly by. , ~ performance of ODCM II Section 2.3.4. Simultaneous releases-from the North and South Vents are considered in evaluating' compliance with the . . release rate ~1imits of ODCM I3.3.2.b. Release activity is based upon the results of'the continuous composite sampler analysis performed in accordance.with~oDCM- ' Table.I3.3-3. F r wI- + . -, ,- ,- - - -
,-e -
m -- m w q
. w . - .-
4 " , ODCM Ray; 13.
- .Pagn:95 m
7 x 5/94: Thisimethodology is:basedlon the worst sector-(NE)
- annual average meteorological dispersion but, if further> refinement is required to' meet the' limits.cf-t i' ODCM I3.3.2.b, actual'aeteorological: data from the-. time-
'" period.of concern may be~used~to calculate actual i meteorological dispersion.
2.3.3 ' Noble ~ Gas Air Doses ODCM:I3.3.3 limits'the air-dose due to noble' gases'
' released:in gaseous effluents (from both reactor' units)- " ~
to ' areas at. or- beyond the.: SI" BOUNDARY to:
's 10 mrad gamma for-any'guarter-
's 20 mrad beta-for any quarter.. .
$ 20 mrad gamma-during any calendar year 5 40 mrad-beta during any calendar year As required by ODCM 13.3.3.1 Surveillance Requiresent, these doses are calculated at least once per 31 days using the results.of the most recent grab ~ samples for isotopic composition performadLin accordance with ODCM Table 13.3-3 when release point grab-sampler do .
not identify any radionuclides.. Total release activity l is based upon the hourly average effluent monitor
-response. As -identified, ' electronic spiking monitor.
responses are excluded from'the release activity l analyses. The monthly dose calculation is' performed using the.most-limiting ~ average' annual-meteorological
-dispersion values.. The quarterly doses ~are based on' the summation of the applicable monthly.results. The.
annual dose calculations are based upon' actual release-meteorological conditions as' described in Section . 2.3.5. The monthly dose calculations are performed in-accordance with the methodology below. D, AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (C 1 ,) (C32y)+(F2n)(Ci sa)]Nj (2-24) 3 ,) + (F i D, AIR = (0.114 ) (1.11E-5) (472) E [ (F,) (C 2 ,) (C32y)+(Fan) (Ci sn)] Nj (2-25)~ 3 ,) + (F where: Du,, = Gamma air dose from' noble gas releases (rad /hr) D ui, = Beta air dose from noble gas release (rad /hr) 0.114 = Units conversion rad-pcl-yr
,pci-br-mrad 1.1E-5 = Highest average annual relative concentration (NE Sector) (sec/m3) 4
ODCM R v. 13 P ga 96 5/94 472 = Units conversion
' min /sec
.sec-ft) ,
F,y = Average North Vent Flow rate for period of release (cfm) Cg,y = Concentration of noble gas nuclide i from North Vent effluent (pCi/cc) F isy = Average Unit l' South Vent flow rate for-period of release (cfm) C itsy = Concentration of noble gas nuclide i from Unit 1 South Vent effluent (pC1/cc) F2sv = Average Unit 2 South Vent flow rate for period of release (cfm) C l2sv = Concentration of noble gas nuclide i from Unit 2 South Vent effluent (pci/cc) M, = Gamma air dose factor for noble gas nuclide 1. Values are listed in Table 2-1. mrad-m3 pCi-yr . N, = Beta air dose factor for noble gas nuclide i. values are listed in Table 2-1. mrad-m PCi-yr . 2.3.4 Basioiodine and Particulate Dose Calculations ODCM I3.3.4 limits the dose (from both reactor units) to a MEMBER OF THE PUBLIC from I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released to areas at or beyond I the SITE BOUNDARY to:
$ 15 mrem to any organ during any calendar quarter s 30 mrem to any organ during any calendar year As required by ODCM I3.3.4.1 Surveillance Requirement, these doses are calculated at least j i once per 31 days using the results of the I
- - - - ~- -
lh' i N
'ODCM RIv.o13' Paga.97 '!
5/94 l q continuous composite samplejanalysis performed,in , M accordance with;ODCM. Table I3.3-3. Due to the-incorporation of the AIARA philosophy;in the_. ; design and. operation of the Limerick effluent: . .; systems,'these composite-samples may not identify-
,.,: any' radionuclides. Total release activity.is
. based upon detectable concentration of the .
- 3
' continuous composite samples-and average . . .
appropriate vent flow during the' sampling ~ period.
. The' monthly.Ldose calculation 11s' performed usingL '
the most limiting average annual meteorological-Ldispersion values.. The quarterly doses ~are_ based on the summation _of the' applicable monthly. results.- The annual dose calculations are based. upon actual release' meteorology as described:in '
- Sectionl 2. 3'. 5. The monthly dose calculations are-performed in accordance with.the methodology-below. Total organLdose is_obtained.by the.
summation of.the organ dose from each pathway-for-each. receptor. 2.3.4-1 Ground Pathway > Daru = (3.6E-6 ) (472) (1. 82E-9 ) E e 35 ' E : [ (F,y) (Ojyy) + (F 2,y) (Oj2,y) + (Fasv) (Oissv) + (Fm) (0 3m) ] DFr ,r,t,x (T e) ' _ _(2-26)l
,1-is 2.3.4-2 Veaetation. Meat. Cow Milk. and' Goat Milk Pathway Dy ,u = (3.6E-6) (472) E '
c
'2
[(Fyy) (Oj,y) '+ (F1 ,y) (Oj3,y) + (F2 ,y) (Oj,,y) + (Fy). (Oj ) ) (l'.1E-5) DFr,r,t,u + _ (Te ) 3, E (F av) (Djuy) + (F1 ,y) (Of2sv) + (Fasv) (04 say) + (Fm) (03 m) ] (1. 82E-9 ) DFI ,r.c x . (2-27) W 4 ( i
0 ODCM'RGv. 13
< Prg3 98
. 5/9 4 -
2.3.4-3 Inhalation Pathway
\
Dim = (3 '.6E-6 ) (472) E
'2
( (F,y) (Ojyy) + (F1 ,y) (On,y) '+ (F 3 ,y) (Oj,,y) + (Fw) (04 ) ] (1.1E-5) DF,,t,, + 'l ( T,) -
. 33
[ (F,y) (Ojyy) + (F1 ,y) (On,y) + (Fasv)(04ssv)+(Fm) (O lm) ] (1. OE-5) DFr.t.u . (2-28) where: D,, = dose from ground pathway due to' release of particulates and iodines (rem). D yp,, = dose from vegetation, meat, cow milk, and goat milk, pathways due to releases of particulates, - iodines, and tritium (rem) D,ip
= dost from inhalation-pathway due to release of particulates, iodines, and tritium-(rem)~
3.6E-6 = units conversion factor rem-Cl-sec hr-mrem-pC1 t 472 = units conversion factor
' min-cc BaC-ft,
^
1.82E-9 = highest average' annual deposition (ESE Sector) 1 ma E = summation for each release time. period t (unitless). . F,y = average North Vent flow rate during release (cfm). ; i Q ,,y = concentration of nuclide I from North Vent effluent (pci/cc).
h
~
ODCM Rsv. 13
- ' Pagi 99,
, . ~'.
5/94 average Unit'1: South.VentJflow rate during1
' F3 ,y = .
- release"(cfa). -
concentration ~of nuclideDi from' Unit'1 South
=
. Q n,y Vent offluent?(pci/cc).
F 2sv = ' average Unit'2 South Vent flow rate during. t release - (cfm) '. : ;
. Qi2sv~
= ' concentration of nuclide i from Unit 2 South
' Vent effluent.(pci/cc).
F ,, = average Hot Maintenance Shop. flow rate duringE q release 1(Ofa).- Q,i
= concentration of nuclide i from Hot = Maintenance. '
effluent (pCi/cc). DF,,g,t,, = dose factor for organ type k, age group'1,- pathway number n; dose factors.are based.on'ai computer program'which is similar..to the NRC program GASPAR results from this Drogram: . o-provide input data in.the' form'of a lookup- . l table - values of DFggn ' are provided in Table 2-1 j 2.
-1 i = isotope number (1 through 35) (3 through 17 :are1 noble gases).
K = ' organ type (1 through 8, where totalLbody'= 1, GI-tract =J2, bone = 3, liver =.'4, kidney , =: 5, . thyroid = 6, lung = 7, skin =.8). L = age group (1'through 4, where adult 1= 1,
- teen = 2, child = 3, infant =;4).
N = pathway number (1 through 7).-
~
T, = time duration of' release (hrs). i highest average annual X/Q (NE Sector) (sec/m )3 . 1.1E-5 = l 1.0E-5 = 4 highest averag)e annual depleted X/Q :(NE-Sector) (sec/m . I 2.3.5 Annual Dose Evaluation ODCM I3.6 requires an Annual Dose evaluation be: performed and reported'in accordance with Regulatory Guide 1.21 in the Semiannual-Radioactive Effluent Release Report' submitted.60 days after the first of each year. This dose evaluation is processed by the RM-21A. In the' event that this computer model is unavailable, this analysis can be performed using the same . , methodology. The liquid portion of this annual j i
- .~__ _ _ - _ _ _ . . _ __ ._. _ ___
< ODCM RIV.;13- ; Paga 100: .
5/94~ l dose' calculation is described in Section_1.3 of
'ODCMlII. The annual gaseous' dose calculation uses-.
"o' the same methodology described in Section.2.3.1, 2.3.3, and 2.3.41with the. exception of meteorology; which.is based upon actualisector:
average atmospheric dispersion values'using the guidance of Regulatory Guide '1.111 (Section C. lc) .- Finalized hourly. values of wind direction, ground level and release elevation wind speed,.ambientt temperature, and temperature lapse rate.(for P-G stability class) are provided annually using the
' instrumentation specified in ODCM'I3.1-1. These
. values.ure calculated'for each hour.and. linked to the corresponding hourly averaged effluent.releasej rate. Doses-are then calculated for each hour at the various receptors of interest'(depending upon release direction). Radioactive material release-.
rate is calculated as described in Sections 2.3.3 and 2.3.4. . Dose at each receptor is accumulated for the year and the maximum dose for plume, inhalation, and ingestion pathways are reported.. The gaseous effluent dose receptors are.~ listed'.in-Table-2-4 and the dose is calculated using-the methodology below. 2.3.5-1 Plume-Pathway-11 D,m= (3. 6 E-6 ) (47 2 ) E (X/0) E ' [ (F,) (03 ,) + (F 2,y) (On,y) + (Fasv)-(Onsv) l C2=3 [e (~M (*U"t)(DFja) T e) . (2-29) 2.3.5-2 Ground' Pathway
## d2#"
Dopm= (3. 6E-6 ) (472) E (X/0) - E # 1 (DFja) (T e) e
*2-3. (Fas v) (Onsv) + (Fm) (Oim) - (2-29) 2.3.5-3 Veaetation. Meat, cow Milk, Goat Milk'.
-Pathway Dvem = (3.6E-6) (472) EC 3
E [ (F yy) (Ojyy) + (F 2,y) (On,y) + (Fasv) (Onsv) + (Fm )-(Olm )3 I(X/ De)3 (D F1 ,r.z.x)
+ -
(Te) 35 E. [ (Fyv) (Ojui.) + (F2s v) (Onsv) (Fasy) (On,y) + (Fm) (Om) ] [D/O] e (DF 1 ,r,t,x) ,
.(2-31)
,1-18
ODCM Rav'. 13 Prgs 101 5/94 2.3.5-4 Vecetation. Meat. Cow Milk. Goat Milk Pathway Dy ,m = (3.6E-6) (472) E e '2 2s v) ( 012sv) + (Fm) (0 3m)] [ (X/0,)] (DFj,y,g,y) E [ (F,y) (Ojyy) + (F2 ,y) ( Of ,,y) + (F + 1-1 - (Te)
- 35 '
E [(Fyy) (Ojyy) + (F 1,y) (Oj2,y) + (F2sv) (O J sv) + (Fm) (Ojm)] [D/O ep2] d (DFj,g,c,y) ,1.ie i (2-32). where: O,p
= annual dose from plume pathway (rem) .
DopnA = annual dose from ground pathway (rem) D yp,,, = annual dose from vegetation, meat,--cow milk, and goat milk pathways (rem) D,,,,, = annual dose from inhalation pathway (rem) 3.6E-6 = units conversion factor rem-Cl-sec hr-mrem-pC1, 472 = units conversion factor
' min-cc
.sec-ft, E = summation for each release time period t (unitless).
(X/Q), = relative concentration for time period "t" (sec/m3) . F yy = average North Vent flow rate during release (cfm). Qay = concentration of nuclide i from North Vent effluent (pci/cc). F3 ,y = average Unit 1 South Vent flow rate during release (cfm). Q i g,y = concentration of nuclide i from Unit 1 South Vent effluent (pCi/cc). F 2sv = average Unit 2 South Vent flow rate during release (cfm).
(('k ; ' ' *
' ODCM R;v. ?13:
,1; - P2gn 102
~5/94 4
Q12sv ,= concentration of nuclide i from Unit 2' South
-Vent effluent (gCi/cc).
Eii = decay constant of nuclide 1 (secd).
-dr = distance to receptor "r". ,
u, = average windspeed for. time period "t" (m/sec). , DF,,g,g, = . dose factor for organ' type k, age group ~1, pathway number n; dose factors are based'on results-of.a computer. program that'is. based' on'and is similar to the NRC. program'GASPAR; results~from this program.provideLinput datat in the form of a' lookup table:- values of , DFgt , are provided in Table 2-2. i = isotope number (1 through 35) (3 through 17 - Lare noble gases). K = organ type (1 through 8,.where; total' ' body =11,JCI tract = 2,' bone = 3, liver ~= 4, kidney = 5,' thyroid = 6, lung.= 7, skin'= 8). L = age group (1 through 4, wh'ere' adult = 1,. 4 teen = 2, child = 3,' infant = 4). N = pathway number.(1 through-7). T, = time duration of. release.(hrs). F ms = average Hot. Maintenance Shop' flow rate-during release-(cfm). ;
- Q ,, = concentration of nuclide i from Hot
. Maintenance Shop effluent (pci/cc)..
p (D/Q)t " deposition concentration for time period "t" 2 (1/m), (X/Q g) = relative depleted concentration for time period "t" (sec/m3) .
. 2.4 Gaseous Effluent Dose Proiection ODCM I3.3.5 requires the VENTILATION EXHAUST TREATMENT SYSTEM be used to reduce radioactive material levels prior-to discharge when' projected doses from both units'to areas- '
at and beyond the SITE BOUNDARY would exceed 0.6 mrom to any organ in a 31' day period. , p. v.--.e , . . _.. ,_ , , -
, ..-s .- g , w F
^s ~ ,
.. ODCM R2v. 13
, .Pcgn s103.
A 5/94-The applicable' gaseous processing systems.for maintaining a radioactive material' releases.ALARA are the,. Gaseous l , Radwaste Treatment System and LExhaust' Treatment: System in
' Figures 2-1 and 2-2. j A dose projection is performed.at least once per 31-days by the following equation:
= (Dmax/d) =131d (2-33)'
Dmaxp where: Dmaxp = maximum organ dose projection _for. current:31-day.
-period (arem)
Dmax- = maximum organ dose to date.for current calendar. quarter as determined by equation. (2-26) (2-27). or (2-28) -(area) . d = number.of days remaining in current' calendar quarter. The minimum time elapsed is seven'(7) days. > 31d = the-number of. days of concern. 3.0 Soecial Dose Analysis 3 1 Total Dose to MEMBERS OF THE PUBLIC ODCM I3.3.7 requires that the annual dose or dose , commitment to any MEMBER OF THE PUBLIC, due to releases'of radioactivity and radiation, from the uranium fuel cycle , shall be limited to:
$ 25 mrem whole body or any organ except thyroid 5 75 mrem. thyroid l
ODCM I3.3.7.2 Surveillance Requirement requires that cumulative dose contributions from direct radiation ~from , operations be evaluated when the calculated dose from.the j release of radioactive materials in ligmid or gaseous q effluents exceed twice the limits of OIX3( I 3 .' 2 . 3 . a , l 3.2.3.b, 3.3.3.a, 3.3.3.b, 3.3.4.a,.or'3~.3.4.b. The 1 direct radiation contribution'shall be determined by-the methodology described below.1 This methodology calculates j the direct radiation contribution which then must be added I to the dose or dose commitment-determined in-accordance with sections.ODCM II1.3.1, 2.3.3, and'2.'3.4 to determine total dose from all pathways. This evaluation of direct-radiation contribution is in accordance with-ANSI /ANS 6.6.1-1979 Section 7. -Thelerror using this method is estimated to be approximately 8%. The following evaluation is performed for aach receptor of concern. D,,, = DTTLot - Dx gg - D ig ,,t (3-1)
-l
}lr Y
< OD'CM Rtv./13:
10 Pzga-104 5/94 where: Dyg = cumulative dose contribution from direct
-radiation'at receptor l'(mrem).
NOTE: Due to the statistics of; radiation measurements and to. , the' conservation of effluent calculations it is
~
may yield a negative value. . In:this plausible the situation the va D ,lue 3 for Dgg-shall be reported as zero(0). D ng = total dose at receptor of interest (as ' o evaluated by TLD measurement) (nrem) .- , NOTE: If there is not a TLD location at theiactual' receptor, , . location, a'more conservative location will be used-to evaluate Total Dose. Dgg = mean of the background dose as evaluated by. TLDs at background sites (mrem). -
~
Durn = effluent contribution to dose (as evaluated in' sections 2.3.3 and 2.3.4.1)'. 3.2 Doses Due to Activities Inside the SITE BOUNDARY. y In accordance with ODCM I3.6, the Semiannual. . Radioactive effluent Release Report submitted within 60 days after January:1 of-each: year shall include an assessment of radiation dose from radioactive. liquid. and gaseous effluents to MEMBERS'OF.THE PUBLIC:due to their activities inside the SITE. BOUNDARY. There are three locations within the SITE BOUNDARY that are accessible to MEMBERS OF THE PUBLIC for.
~
~
i activities unrelated to the operation of Limerick' station. Theta locations are: 1) the railroad; tracks which run along the river within the SITE BOUNDARY; .
- 2) the Limerick Atomic Information Center,'on~Longview1 Road next-to the 500kv substation; and 3);Fricks Lock'-
environmental laboratory, operated by RMC Environmental Services,-Inc. Of these three locations,.the railroad tracks are the closest to the plant confines. The highest annualLdose for the three ' - locations should be determined byfcalculating dose.at. the railroad track location. t E i
- e. - w
- ODCM Rsv.L13
' ~Paga-105
'5/94 1
The-following methodologyiis'use1 to evaluate dose =at the railroad tracks, Information Center,-and'Fricks!
, Lock locations.. This dose assessment-is= based on the results of the annual: dose evaluation': outlined in ODCM -
Section 2.3.5. The maximum dose calculated will be reported. Dr su " Usu
- X/Osu = 0.25 (3 -2 )
g; where: Dps,x = Dose to MEMBERS ~OF THE PUBLIC within theiSITE BOUNDARY.in Sector"X".(arem). D,,x = Dose at SITE BOUNDARY in Sector "X"-(mrem). Relative average annual atmospheric dispersion
~
=
X/Qux for year of' interest at' SITE BOUNDARY'in-Sector "X" (sec/m3 ) . X/Q,g = Relative-average: annual atmospheric dispersion for year of interestLat railroad, Information-Center-or Fricks Lock for 3distances listed' - below in Sector "X" (sec/m ) Sector Distance to Location (m) Railroad Tracks: S 300 SSW 225 SW .225 WSW 225 W '225-WNW 345 NW 450 Information Center: ESE 884 Fricks Lock: WSW 450-0.25 = maximum occupancy. factor for railroad tracks,iLimerick Atomic Information Center or Fricks Lock Environmental-Laboratory (unitless).
-ODCM Riv. 13 4 : Pag 3 106' 5/94;
,4 4.0 .Radioloaical Environmental Monitorina Procram-4.1 samolina Procram The ' operational' phase : of the ' Radiological _ , ,
. Environmental: Monitoring. Program (EEMP) is conducted- !
I in accordance'with:the requirements of ODCM I3.4-3., The' objectives of the program are:
- To provide data on measurable. levels of radiation.
i i*. and radioactive materials.in the site environs.- .
- To-evaluate.the relationship!between quantities of.
- radioactive materials: released from LGS and:
resultant-radiation doses to. individuals from
- principal pathways of exposure.
-The sampling requirements'(type of; samples,; collection frequency, and analysis) and sample locations are presented in Appendix E.
I 4 . :2 Interlaboratory Connarison Procram ,
' Technical' Specification 6.8.4.e.3 requires analyses:be.
performed on radioactive material l supplied.as part of-an-
.Interlaboratory Comparison.
Participation in an approved-Interlaboratory Comparison' > Program provides a check >on-the preciseness of. _ . measurements of radioactive materialJin environmental
~
samples. A summary of the.Interlaboratory Comparison Program results is-provided'in the Annual. Radiological Environmental Operating Report. pursuant to ODCM I3.5. 4 9 4 e h i
. t, i.. l e4 - ,.m ., - .-.. .S.. _ . - - - - -_
-m. --
\
l l (. l TABLES 4 l I 1 I l 1 l I 4 i 1 1 4 I h i I i l i
----_-- _ __ _________ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ J
, _ _ _ ,. , __ = _ . . _ _
li: a -- ' '
- p,
'ODCM Rr.v.113:
Pr.g3c107
.-i-
-5/94-
, r;1.
TABLE 1-l' . INGESTION INDIVIDUAL DOSE FACTORS . (D,ipj) For liquid effluents Units For All Ingestion Pathways are:- mrem /pci-t l l
,I' I
I o
ODCM R;v. 13 l Pcga 108 l 5/94 Table 1-1 Liauid Dose Factors From Table E-11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E-07 ~C14 2.840E-06 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 N224 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 P32 1.930E-04 1.200E-05 7.460E-06 0.000E+00 0.000E+00 0.000E+00 2.170E-05 Cr51 0.000E+00 0.000E+00 2.660E-09 1.590E-09 5.860E-10 3.530E-09 6.690E-07 -Mn54 0.000E+00 4.570E-06 8.720E-07 0.000E+00 1.360E-06 0.000E+00 1.400E-05 Mn56 0.000E+00 1.150E-07 2.040E-08 0.000E+00 1.460E-07 0.000E+00 3.670E-06 Fs55 2,750E-06 1.900E-06 4.430E-07 0.000E+00 0.000E+00 1.060E-06 1.090E-06 F 59 4.340E-06 1.020E-05 3.910E-06 0.000E+00 0.000E+00 2.850E-06 3.400E-05 CoS8 0.000E+00 7.450E-07 1.670E-06 0.000E+00 0.000E+00 0.000E+00 1.510E-05 Co60 0.000E+00 2.140E-06 4.720E-06 0.000E+00 0.000E+00 0.000E+00 4.020E-05 Ni63 1.300E-04 9.010E-06 4.360E-06 0.000E+00 0.000E+00 0.000E+00 1.880E-06 Ni65 5.280E-07 6.860E-08 3.130E-08 0.000E+00 0.000E+00 0.000E+00 1.740E-06 Cu64 0.000E+00 8.330E-08 3.910E-08 0.000E+00 2.100E-07 0.000E+00 7.100E-06 Zn65 4.840E-06 1.540E-05 6.960E-06 0.000E+00 1.030E-05 0.000E+00 9.700E-06 Zn69 1.030E-08 1.970E-08 1.370E-09 0.000E+00 1.280E-08 0.000E+00 2.960E-09 Br83 0.000E+00 0.000E+00 4.020E-08 0.000E+00 0.000E+00 0.000E+00 5.790E-08 Br84 0.000E+00 0.000E+00 5.210E-08 0.000E+00 0.000E+00 0.000E+00 4.090E-13 Br85 0.000E+00 0.000E+00 2.140E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.110E-05 9.830E-06 0.000E+00 0.000E+00 0.000E+00 4.160E-06 Rb88 0.000E+00 6.050E-08 3.210E-08 0.000E+00 0.000E+00 0.000E+00 8.360E-19 Rb89 0.000E+00 4.010E-08 2.820E-08 0.000E+00 0.000E+00 0.000E+00 2.330E-21 Sr89 3.080E-04 0.000E+00 8.840E-06 0.000E+00 0.000E+00 0.000E+00 4.940E-05 Sr90 7.580E-03 0.000E+00 1.860E-03 0.000E+00 0.000E+00 0.000E+00 2.190E-04 Sr91 5.670E-06 0.000E+00 2.290E-07 0.000E+00 0.000E+00 0.000E+00 2.700E-05 Sr92 2.150E-06 0.000E+00 9.300E-08 0.000E+00 0.000E+00 0.000E+00 4.260E-05 Y90 9.620E-09 0.000E+00 2.580E-10 0.000E+00 0.000E+00 0.000E+00 1.020E-04 Y91m 9.090E-11 0.000E+00 3.520E-12 0.000E+00 0.000E+00 0.000E+00 2.670E-10 Y91 1.410E-07 0.000E+00 3.770E-09 0.000E+00 0.000E+00 0.000E+00 7.670E-05 Y92 8.450E-10 0.000E+00 2.470E-11 0.000E+00 0.000E+00 0.000E+00 1.480E-05 Y93 2.680E-09 0.000E+00 7.400E-11 0.000E+00 0.000E+00 0.000E+00 8.500E-05 Zr95 3.040E-08 9.750E-09 6.600E-09 0.000E+00 1.530E-08 0.000E+00 3.090E-05 Zr97 1.680E-09 3.390E-10 1.550E-10 0.000E+00 5.120E-10 0.000E+00 1.050E-04 Nb95 6.220E-09 3.460E-09 1.860E-09 0.000E+00 3.420E-09 0.000E+00 2.100E-05 Mo99 0.000E-00 4.310E-06 8.200E-07 0.000E+00 9.760E-06 0.000E+00 9.990E-06 Tc99m 2.470E-10 6.980E-10 8.890E-09 0.000E+00 1.060E-08 3.420E-10 4.130E-07 Tc101 2.540E-10 3.660E-10 3.590E-09 0.000E+00 6.590E-06 1.870E-10 1.100E-21 Rul03 1.850E-07 0.000E+00 7.970E-08 0.000E+00 7.060E-07 0.000E+00 2.160E-05 Rul05 1.540E-08 0.000E+00 6.080E-09 0.000E+00 1.990E-07 0.000E+00 9.420E-06 Rul06 2.750E-06 0.000E+00 3.480E-07 0.000E+00 5.310E-06 0.000E+00 1.780E-04 Ag110m 1.600E-07 1.480E-07 8.790E-08 0.000E+00 2.910E-07 0.000E+00 6.040E-05 To125m 2.a60E-06 9.170E-07 3.590E-07 8.060E-07 1.090E-05 0.000E+00 1.070E-05 Te127m 6.770E-06 2.420E-06 8.250E-07 1.730E-06 2.750E-05 0.000E+00 2.270E-05 Tc127 1.100E-07 3.950E-08 2.380E-08 8.150E-08 4.480E-07 0.000E+00 8.680E-06 Tol29m 1.150E-05 4.290E-06 1.820E-06 3.950E-06 4.800E-05 0.000E+00 5.790E-05 Tol29 3.140E-08 1.180E-08 7.650E-09 2.410E-08 1.320E-07 0.000E+00 2.370E-08
ODCM Rsv. 13
.l: Page 109 i
;[ 5/94 Table 1-1 (Continued)
Liauid Dose Factors ' From Table E-11 or Reg.. Guide 1.109
'Ingsstion Dose Factors For Adult:
BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Te131m, 1.730E-06 8.460E-07 7.050E-07 1.340E-06 8.570E-06 0.000E+00 8.400E-05 Ta131 1.970E-08 8.230E-09 6.220E-09 1.620E-08 8.630E-08.0.000E+00 2.790E-09 Ta132 2.520E-06 1.630E-06:1.530E-06 1.800E-06 1.570E-05 0.000E+00 7.710E ;I130 7.560E-07 2.230E-06 8.800E-07 1.890E-04 3.480E-06 0.000E+00 1.920E-06 I131 4.160E-06 5.950E-06 3.410E-06'1.950E-03 1.020E-05 0.000E+00 1.570E-06' , I132- 2.030E-07 5.430E-07 1.900E-07 1.900E-05 8.650E-07 0.000E+00.1.020E-07 ~I133 1.420E-06 2.470E-06 7.530E-07 3.630E-04 4.310E-06 0.000E+00 2.220E-06 I134 1.060E-07 2.880E-07 1.030E-07 4.990E-06 4.580E-07-0.000E+00 2.510E-10 I135 . 4.430E-07 1.160E-06 4.280E-07 7.650E-05 1.860E-06-0.000E+00-1.310E-06 Ca134' 6. 220E- 05 1.4 8 0E-04 1.210E-04 0.000E+00 4.790E-05 1.590E-05 2.590E-06 Ca136 6.510E-06 2.570E-05 1.850E-05 0.000E+00 1.430E-05 1.960E-06 2.920E-06 Cs137 7.970E-05 1.090E-04 7.140E-05 0.000E+00 3.700E-05 1.230E-05 2.110E-06 Cs138 -5.520E-08 1.090E-07 5.400E-08 0.000E+00 8.010E-08 7.910E-08 4.650E-13 Ba139 9.700E-08 6.910E-11 2.840E-09 0.000E+00 6.460E-11 3.920E-11-1.720E-07 Ba140 2.030E-05 2.550E-08 1.330E-06 0.000E+00 8.670E-09 1.460E-08 4.180E-05
-Ba141 4.710E-08 3.560E-11 1.590E-09 0.000E+00 3.310E-11 2.020E-11.2.220E-17 Ba142 2.130E-08 2.190E-11 1.340E-09 0.000E+00 1.850E-11 1.240E-11 3.000E-26 La140 2.500E-09 1.260E-09 3.330E-10 0.000E+00 0.000E+00 0.000E+00 9.250E-05 ;
La142 1.280E-10 5.820E-11 1.450E-11 0.000E+00:0.000E+00 0.000E+00 4.250E-07 Co141 9.360E-09 6.330E-09 7.180E-10 0.000E+00 2.940E-09.O.000E+00 2.420E-05 Ce143 1.650E-09 1.220E-06 1.350E-10 0.000E+00 5.370E-10 0.000E+00 4.560E-05 1 C0144 4.880E-07 2.040E-07 2.620E-08 0.000E+00 1.210E-07 0.000E+00 1.650E-04 Pr143 9.200E-09 3.690E-09 4.560E-10 0.000E+00 2.130E-09 0.000E+00 4.030E-05 Pr144 3.010E-11 1.250E-11 1.530E-12 0.000E+00 7.050E-12 0.000E+00 4.330E-18 Nd147 6.290E-09 7.270E-09 4.350E-10 0.000E+00 4.250E-09 0.000E+00 3.490E W187 1.030E-07 8.610E-08 3.010E-08 0.000E+00 0.000E+00 0.000E+00 2.820E-05 Np239 1.190E-09 1.170E-10 6.450E-11 0.000E+00 3.650E-10 0.000E+00 2.400E-05 l i
,--w -m +-a
l ODCM Rsv.L13 Page 110
.l 5/94 Table-1-1 (Continued)
Llauld Dose Factors
.From Table E-12 or Reg. Guide 1.109
-Ingestion Dose Factors For Teen:
BONE LIVER ~ T. BODY THYROID KIDNEY LUNG GI-LLI
- H3 0.000E+00 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E C14- 4.060E-06 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 N324 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06'2.300E-06 P32 2.760E-04 1.710E-05 1.070E-05 0.000E+00 0.000E+00 0.000E+00 2.320E-05~
-Cr51 0.000E+00 0.000E+00 3.600E-09 2.000E-09 7.890E-10 5.140E-09 6.050E-07 'Mn54 0.000E+00 5.900E-06 1.170E-06 0.000E+00 1.760E-06 0.000E+00 1.210E-05 Mn56 0.000E+00 1.580E-07-2.810E-08 0.000E+00 2.000E-07 0.000E+00 1.040E-05 F355 3.780E-06 2.680E-06 6.250E-07 0.000E+00 0.000E+00 1.700E-06 1.160E-06
_Fs59- 5.870E-06 1.370E-05 5.290E-06 0.000E+00 0.000E+00'4.320E-06 3.240E-05 CoS8 0.000E+00 9.720E-07 2.240E-06 0.000E+00 0.000E+00 0.000E+00 1.340E-05 Co60- 0.000E+00 2.810E-06 6.330E-06 0.000E+00 0.000E+00 0.000E+00 3.660E-05 ;
.Ni63 1.770E-04 1.250E-05 6.000E-06 0.000E+00 0.000E+00 0.000E+00 1.990E-06 Ni65 7.490E-07 9.570E-08 4.360E-08 0.000E+00 0.000E+00 0.000E+00~5.190E-06 JCu64 0.000E+00 1.150E-07 5.410E-08 0.000E+00 2.910E-07 0.000E+00 8.920E-06 Zn65 5.760E-06 2.000E-05 9.330E-06 0.000E+00 1.280E-05 0.000E+00 8.470E-06 i Zn69 1.470E-08 2.800E-08 1.960E-09 0.000E+00 1.830E-08 0;000E+00 5.160E-08 Br83 0.000E+00 0.000E+00 5.740E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84- 0.000E+00 0.000E+00 7.220E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 '
Br85 0.000E+00 0.000E+00 3.050E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.980E-05 1.400E-05 0.000E+00 0.000E+00 0.000E+00 4.410E-06 Rb88 0.000E+00 8.520E-08 4.540E-08 0.000E+00 0.000E+00 0.000E+00 7.300E-15 Rb89 0.000E+00 5.500E-08 3.890E-08 0.000E+00 0.000E+00 0.000E+00 8.430E-17 Sr89 4.400E-04 0.000E+00 1.260E-05 0.000E+00 0.000E+00 0.000E+00 5.240E-05 Sr90 8.300E-03 0.000E+00 2.050E-03 0.000E+00 0.000E+00 0.000E+00 2.330E-04 Sr91 8.070E-06 0.000E+00 3.210E-07 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Sr92 3.050E-06 0.000E+00 1.300E-07 0.000E+00 0.000E+00 0.000E+00 7.770E-05 Y90 1.370E-08 0.000E+00 3.690E-10 0.000E+00 0.000E+00 0.000E+00 1.130E-04 Y91m 1.290E-10 0.000E+00 4.930E-12 0.000E+00 0.000E+00 0.000E+00 6.090E-09 . 'Y91 2.010E-07 0.000E+00 5.390E-09 0.000E+00 0.000E+00 0.000E+00 8.240E-05 Y92 1.210E-09 0.000E+00 3.500E-11 0.000E+00 0.000E+00 0.000E+00 3.320E-05 i- Y93- 3.830E-09 0.000E+00 1.050E-10 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Zr95 4.120E-08 1.300E-08 8.940E-09 0.000E+00 1.910E-08 0.000E+00 3.000E-05
-Zr97 2.370E-09 4.690E-10 2.160E-10 0.000E+00 7.110E-10 0.000E+00 1.270E-04 Nb95 8.220E-09 4.560E-09 2.510E-09 0.000E+00 4.420E-09 0.000E+00 1.950E-05 Mo99 0.000E+00 6.030E-06 1.150E-06 0.000E+00 1.380E-05 0.000E+00 1.080E-05 Tc99m 3.320E-10 9.260E-10 1.200E-08 0.000E+00 1.380E-08 5.140E-10 6.080E-07 '
Tc101 3.600E-10 5.120E-10 5.030E-09 0.000E+00 9.260E-09 3.120E-10 8.750E-17 Rul03 2.550E-07 0.000E+00 1.090E-07 0.000E+00 8.990E-07 0.000E+00 2.130E-05 , Rul05 2.180E-08 0.000E+00 8.460E-09 0.000E+00 2.750E-07 0.000E+00 1.760E-05
'Rul06 3.920E-06 0.000E+00 4.940E-07 0.000E+00 7.560E-06 0.000E+00 1.880E-04 Ag110m 2.050E-07 1.940E-07 1.180E-07 0.000E+00 3.700E-07 0.000E+00 5.450E-05 Ta125m 3.830E-06 1.380E-06 5.120E-07 1.070E-06 0.000E+00 0.000E+00 1.130E-05
, _Te127m 9.670E-06 3.430E-06 1.150E-06 2.300E-06 3.920E-05 0.000E+00 2.410E-05 . Te127 1.580E-07 5.600E-08 3.400E-08 1.090E-07 6.400E-07 0.000E+00 1.220E-05 4 Tol29m 1.630E-05 6.050E-06 2.580E-06 5.260E-06 6.820E-05 0.000E+00 6.120E-05 ' Te129 4.480E-08 1.670E-08 1.090E-08 3.200E-08 1.880E-07 0.000E+00 2.450E-07 Te131m 2.440E-06 1.170E-06 9.760E-07 1.760E-06 1.220E-05 0.000E+00 9.390E-05 Te131 2.790E-08 1.150E-08 8.720E-09 2.150E-08 1.220E-07 0.000E+00 2.290E-09 ' l Te132 3.490E-06 2.210E-06 2.080E-06 2.330E-06 2.120E-05 0.000E+00 7.000E-05
l- ODCM Rav. 13 Paga 111
'l 5/94 Table 1-1 (Continued)
! Licuid' Dose Factors l From Table E-12'or Reg. Guide 1.109 ( Ingsstion Dose Factors For Teen: l BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ( LI130. 1.030E-06 2.980E-06=1.190E-06 2.430E-04 4.590E-06 0.000E+00 2.290E-06 I131 5.850E-06 8.190E-06 4.400E-06 2.390E-03'1.410E-05 0.000E+00 1.620E-06. I132 2.790E-07 7.300E-07 2.620E-07 2.460E-05 1.150E-06 0.000E+00 3.180E-07
'I133 2.010E-06 3.410E-06 1.040E-06 4.760E-04 5.980E-06 0.000E+00 2.580E-06 -I134 1.460E-07 3.870E-07 1.390E-07 6.450E-06 6.100E-07 0.000E+00 5.100E-09 I135 6.100E-07 1.570E-06 5.820E-07 1.010E-04 2.480E-06 0.000E+00 1.740E-06 Cs134 8.370E-05 1.970E-04 9.140E-05 0.000E+00 6.260E-05 2.390E-05 2.450E-06 C2136 8.590E-06 3.380E-05 2.270E-05 0.000E+00 1.840E-05 2.900E-06 2.720E-06 Cs137 1.120E-04 1.490E-04 5.190E-05 0.000E+00 5.070E-05 1.970E-05 2.120E-06 ~Cs138 7.760E-08 1.490E-07 7.450E-08 0.000E+00 1.100E-07 1.280E-08 6.760E-11 Ba139 1.390E-07 9.780E-11 4.050E-09 0.000E+00 9.220E-11 6.740E-11 1.240E-06 -B2140 2.840E-05 3.480E-08 1.830E-06 0.000E+00 1.180E-08 2.340E-08 4.380E-05 B2141 6.710E-08 5.010E-11 2.240E-09 0.000E+00-4.650E-11 3.430E-11 1.430E-13 Ba142 2.990E-08 2.990E-11 1.840E-09 0.000E+00 2.530E-11 1.990E-11 9.180E-20 La140 3.480E-09 1.710E-09 4.550E-10 0.000E+00 0.000E+00 0.000E+00 9.820E-05 La142 1.790E-10 7.950E-11 1.980E-11 0.000E+00 0.000E+00 0.000E+00-2.420E-06 C3141 1.330E-08 8.880E-09 1.020E-09 0.000E+00 4.180E-09 0.000E+00-2.540E Cc143 2.350E-09 1.710E-06 1.910E-10 0.000E+00 7.670E-10 0.000E+00 5.140E-05 Ca144 6.960E-07 2.880E-07 3.740E-08 0.000E+00 1.720E-07 0.000E+00 1.750E-04 Pr143 1.310E-08 5.230E-09 6.520E-10 0.000E+00 3.040E-09 0.000E+00 4.310E-05 Pr144 4.300E-11 1.760E-11 2.180E-12 0.000E+00 1.010E-11 0.000E+00 4.740E-14 Nd147 9.380E-09 1.020E-08 6.110E-10 0.000E+00 5.990E-09 0.000E+00 3.680E-05 W187 1.460E-07 1.190E-07 4.170E-08 0.000E+00 0.000E+00 0.000E+00 3.220E-05 Np239 1.760E-09 1.660E-10 9.220E-11 0.000E+00 5.210E-10 0.000E+00 2.670E-05 l
l
,4 > - - _ _ -._ - .. _ . ___-- , . - . _ . __ . _ _ _ 'e l-ODCM Rsv. 13 Pagn:112 I _5/94
. Table 1-1 (Continued) ,
- Licuid Dose Factors From. Table E-13 or Reg. Guide 1.109
< Ingestion Dose Factors For Child:
BONE LIVER T. BODY THYROID KIDNEY. LUNG GI-LLI' 7
' H3- 0.000E+00 2.030E-07 2.030E-07 2.030E-07 2.030E-07,2.030E-07 2.030E-07 C14 1.210E-05 2.420E-06 2.420E-06 2.420E-06-2.420E-06 2.420E-06 2.420E-06 Nn24 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 P32 8.250E-04 3.860E-05 3.180E-05 0.000E+00 0.000E+00 0.000E+00 2.280E-05 '
Cr51 0.000E+00 0.000E+00 8.900E-09 4.940E-09-1.350E-09 9.020E-09 4.720E-07 JMn54 0.000E+00 1.070E-05 2.850E-06 0.000E+00 3.000E-06 0.000E+00 8.980E-06 Mn56 0.000E+00 3.34CE-07 7.540E-08 0.000E+00 4.040E-07.0.000E+00-4.840E-05 1.150E-05 6.100E-06 1.890E-06 0.000E+00'O.000E+00 3.450E-06.1.130E-06 Fa55 ,
~Fa59 1.650E-05 2.670E-05 1.330E-05 0.000E+00 0.000E+00 7.740E-06.2.780E-05 ,
CoS8 0.000E+00 1.800E-06 5.510E-06 0.000E+00 0.000E+00 0.000E+00 1.050E-05
- 'Co60 0.000E+00 5.290E-06 1.560E-05'O.000E+00 0.000E+00 0.000E+00 2.930E-05z N163 5.380E-04 2.880E-05 1.830E-05 0.000E+00 0.000E+00 0.000E+00 1.940E-06
Ni65 2.220E-06 2.090E-07 1.220E-07 0.000E+00 0.000E+00 0.000E+00.2.560E-05 i Cu64 0.000E+00 2.450E-07 1.480E-07 0.000E+00 5.920E-07 0.000E+00 1.150E-05 ! 1.370E05 3.650E-05 2.270E-05.0.000E+00 2.300E-05 0.000E+00 6.410E-06 Zn65' Zn69 4.380E-08 6.330E-08 5.850E-09 0.000E+00 3.840E-08 0.000E+00 3.990E-06 Br83 0.000E+00 0.000E+00 1.710E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 '
- Br84 0.000E+00 0.000E+00 1.980E-07 0.000E+00.0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 9.120E-09.0.000E+00 0.000E+00 0.000E+00 0.000E+00 g RbB6 0.000E+00 6.700E-05 4.120E-05 0.000E+00 0.000E+00 0.000E+00 4.310E-06 I Rb88 0.000E+00 1.900E-07 1.320E-07 0.000E+00 0.000E+00 0.000E+00 9.320E-09 I Rb89 0.000E+00 1.170E-07 1.040E-07 0.000E+00 0.000E+00 0.000E+00 1.020E-09~ l Sr89 1.320E-03 0.000E+00 3.770E-05 0.000E+00 0.000E+00 0.000E+00 5.110E-05 Sr90 1.700E-02 0.000E+00 4.310E-03 0.000E+00 0.000E+00 0.000E+00 2.290E-04 Sr91 2.400E-05 0.000E+00 9.060E-07 0.000E+00 0.000E+00 0.000E+00 5.300E-05 Sr92 9.030E-06 0.000E+00 3.620E-07 0.000E+00 0.000E+00 0.000E+00 1.710E-04 Y90 4.110E-08 0.000E+00 1.100E-09 0.000E+00 0.000E+00 0.000E+00 1.170E-04
- Y91m 3.820E-10 0.000E+00 1.390E-11 0.000E+00 0.000E+00 0.000E+00 7.480E-07 Y91 6.020E-07 0.000E+00 1.610E-08 0.000E+00 0.000E+00 0.000E+00 8.020E-05 Y92 3.600E-09 0.000E+00 1.030E-10 0.000E+00.0.000E+00 0.000E+00 1.040E-04
, Y93 1.140E-08 0.000E+00 3.130E-10 0.000E+00 0.000E+00 0.000E+00 1.700E-04 Zr95 1.160E-07 2.550E-08 2.270E-08 0.000E+00 3.650E-08'O.000E+00 2.660E-05 l Zr97 6.990E-09 1.010E-09 5.960E-10 0.000E+00 1.450E-09 0.000E+00_1.530E-04 Nb95 2.250E-08 8.760E-09 6.260E-09 0.000E+00 8.230E-09 0.000E+00 1.620E-05 f Mo99 0.000E+00 1.330E-05 3.290E-06 0.000E+00 2.840E-05 0.000E+00 1.100E-05 q Tc99m 9.230E-10 1.810E-09 3.000E-08 0.000E+00 2.630E-08 9.190E-10 1.030E-06 1 Tc101 1.070E-09 1.120E-09 1.420E-08 0.000E+00 1.910E-08 5.920E-10 3.560E-09 Rul03. 7.310E-07 0.000E+00 2.810E-07 0.000E+00 1.840E-06 0.000E+00 1.890E-05. IRul05. 6.450E-08 0.000E+00 2.340E-08 0.000E+00 5.670E-07 0.000E+00 4.210E-05 Rul06- 1.170E-05 0.000E+00 1.460E-06 0.000E+00 1.580E-05 0.000E+00 1.820E-04 Ag110m 5.390E-07 3.640E-07 2.910E-07 0.000E+00 6.780E-07 0.000E+00 4.330E-05 , Te125m 1.140E-05 3.090E-06 1.520E-06 3.200E-06 0.000E+00 0.000E+00 1.100E-05 Te127m 2.890E-05 7.780E-06 3.430E-06 6.910E-06 8.240E-05 0.000E+00 2.340E-05 Te127 4.710E-07 1.270E-07 1.010E-07 3.260E-07 1.340E-06 0.000E+00 1.840E-05 ! Te129m 4.870E-05 1.360E-05 7.560E-06 1.570E-05 1.430E-04 0.000E+00 5.940E-05 i Tc129 1.340E-07 3.740E-08 3.180E-08 9.560E-08 3.920E-07 0.000E+00 8.340E-06 Ta131m 7.200E-06 2.490E-06 2.650E-06 5.120E-06 2.410E-05 0.000E+00 1.010E-04 Te131 8.300E-08 2.530E-08 2.470E-08 6.350E-08 2.510E-07 0.000E+00 4.360E-07 i Te132 1.010E-05 4.470E-06 5.400E-06 6.510E-06 4.150E-05 0.000E+00 4.500E-05
l
~j' ODCM Rnv. 13 Paga 113 l 5/94 Table 1-1 (Continued)
Liauid' Dose Factqu From Table E-13 or Reg. Guide 1.109 Ingsstion Dose Factors For Child: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 2.920E-06 5.900E-06 3.040E-06 6.500E-04 8.820E-06 0.000E+00 2.760E-06 I131 1.720E-05 1.730E-05 9.830E-06 5.720E-03 2.840E-05 0.000E+00-l'.540E-06 I132 8.000E-07 1.470E-06 6.760E-07 6.820E-05 2.250E-06 0.000E+00 1.730E-06
.I133 5.920E-06 7.320E-06 2.770E-06 1.360E-03 1.220E-05 0.000E+00 2.950E-06 1I134 4.190E-07 7.780E-07 3.580E-07 1.790E-05 1.190E-06 0.000E+00 5.160E-07 I135 1.750E-06 3.150E-06 1.490E-06 2.790E-04 4.830E-06 0.000E+00 2.400E-06 1 C3134 2.340E-04 3.840E-04 8.100E-05 0.000E+00 1.190E-04 4.270E-05 2.070E-06
!C3136 2.350E-05 6.460E-05 4.180E-05 0.000E+00 3.440E-05 5.130E-06 2.270E-06 C2137 3.270E-04 3.130E-04 4.620E-05 0.000E+00 1.020E-04 3.670E-05 1.960E-06
;C3138 2.280E-07 3.170E-07 2.010E-07 0.000E+00 2.230E-07 2.400E-08 1.460E-07 Ba139 4.140E-07 2.210E-10 1.200E-08 0.000E+00 1.930E-10 1.300E-10 2.390E-05 Ba140 8.310E-05 7.280E-08 4.850E-06 0.000E+00 2.370E-08 4.340E-08 4.210E-05 Ba141 2.000E-07 1.120E-10 6.510E-09 0.000E+00 9.690E-11 6.580E-10 1.140E-07
- B3142 8.740E-08 6.290E-11 4.880E-09 0.000E+00 5.090E-11 3.700E-11 1.140E-09 ,
lLa140 1.010E-08 3.530E-09 1.190E-09 0.000E+00 0.000E+00 0.000E+00 9.840E-05 La142 5.240E-10 1.670E-10 5.230E-11 0.000E+00 0.000E+00 0.000E+00 3.310E-05 Ca141 3.970E-08 1.980E-08 2.940E-09 0.000E+00 8.680E-09 0.000E+00 2.470E-05 CD143 6.990E-09 3.790E-06 5.490E-10 0.000E+00 1.590E-09 0.000E+00 5.550E-05 Ca144 2.080E-06 6.520E-07 1.110E-07 0.000E+00 3.610E-07 0.000E+00 1.700E-04 Pr143 3.930E-08 1.180E-08 1.950E-09 0.000E+00 6.390E-09 0.000E+00 4.240E-05 Pr144 1.290E-10 3.990E-11 6.490E-12 0.000E+00 2.110E-11 0.000E+00 8.590E-08 Nd147 2.790E-08.2.260E-08 1.750E-09 0.000E+00 1.240E-08 0.000E+00 3.580E-05 W187 4.290E-07 2.540E-07 1.140E-07 0.000E+00 0.000E+00 0.000E+00 3.570E-05 Np239 5.250E-09 3.770E-10 2.650E-10 0.000E+00 1.090E-09 0.000E+00 2.790E-05
,,p...- 4p . .I s - m -m - - - <w -+x. - s s, .* , s.-
['
?"
. 'j;' - ODCM Rav. 13 Pcg3 114
.[ 5/94 Table 1-1 (Continued)
.Liauid Dose Factors AFrom-Table E-14 or Reg. Guide 1.109 Ingestion. Dose Factors For Infant:
BONE- LIVER T. BODY THYROID KIDNEY. LUNG- .GI-LLI i H3 0.000E+00 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.080E-07 . - C14 2.370E-05 5.060E-06 5.060E-06'5.060E-06 5.060E-06 5.060E-06.5.060E-06 Nn24 1.010E-05'1.010E-05 1.010E-05 1.010E-05 1.010E-05_1.010E-05 1.010E-05 i P32- ' 1.700E-03 1.000E-04 6.590E-05 0.000E+00 0.000E+00 0.000E+00 2.300E-05 < Cr51 0.000E+00 0.000E+00 1.410E-08 9.200E-09 2.010E-09 1.790E-08 4.110E-07L
.Mn54 0.000E+00 1.990E-05 4.510E-06 0.000E+00 4.410E-06 0.000E+00 7;310E-06 Mn56 0.000E+00 8.180E-07 1.410E-07 0.000E+00 7.030E-07 0.000E+00 7.430E-05 ,
. Fa55 1.390E-05 8.980E-06 2.400E-06 0.000E+00 0.000E+00-4.390E-06 1.140E-06 Fa59 3.080E-05 5.380E-05 2.120E-05 0.000E+00 0.000E+00 1.590E-05 2.570E-05 CoS8 0.000E+00 3.600E-06 8.980E-06 0.000E+00 0.000E+00 0.000E+00 8.970E-06 Co60 0.000E+00 1.080E-05 2.550E-05 0.000E+00 0.000E+00 0.000E+00 2.570E-05 Ni63 6.340E-04 3.920E-05 2.200E-05 0.000E+00 0.000E+00 0.000E+00 1.950E-06 N165' 4.700E-06 5.320E-07 2.420E-07 0.000E+00 0.000E+00 0.000E+00.4.050E-05 Cu64 0.000E+00 6.090E-07 2.820E-07 0.000E+00 1.030E-06 0.000E+00 1.250E-05 Zn65~ 1.840E-05 6.310E-05 2.910E-05 0.000E+00 3.060E-05 0.000E+00 5.330E-05 '
Zn69 9.330E-08 1.680E-07 1.250E-08 0.000E+00 6.980E-08 0.000E+00 1.370E-05' l 2Br83 0.000E+00 0.000E+00 3.630E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 ; Br84 0.000E+00 0.000E+00 3.820E-07'O.000E+00 0.000E+00 0.000E+00 0.000E+00- * , ' Br85 0.000E+00 0.000E+00 1.940E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00. 4 Rb86 0.000E+00 1.700E-04 8.400E-05 0.000E+00 0.000E+00 0.000E+00 4.350E-06 . i ' Rb88 0.000E+00 4.980E-07 2.730E-07 0.000E+00 0.000E+00 0.000E+00-4.850E-07 Rb89 0.000E+00 2.860E-07 1.970E-07 0.000E+00 0.000E+00 0.000E+00 9.740E-08 Sr89 2.510E-03 0.000E+00 7.200E-05 0.000E+00 0.000E+00 0.000E+00 5.160E-05 Sr90 1.850E-02 0.000E+00 4.710E-03 0.000E+00 0.000E+00 0.000E+00 2.310E-04
- Sr91 5.000E-05 0.000E+00 1.810E-06 0.000E+00 0.000E+00 0.000E+00 5.920E-05 Sr92 1.920E-05 0.000E+00 7.130E-07 0.000E+00 0.000E+00 0.000E+00 2.070E-04
- .Y90 8.690E-08 0.000E+00 2.330E-09 0.000E+00 0.000E+00 0.000E+00 1.200E-04 I Y91m 8.100E-10'O.000E+00 2.760E-11 0.000E+00 0.000E+00:0.000E+00 2.700E-06 Y91 1.130E-06 0.000E+00 3.010E-08 0.000E+00 0.000E+00 0.000E+00 8.100E-05 Y92 7.650E-09 0.000E+00 2.150E-10 0.000E+00 0.000E+00 0.000E+00 1.460E-04 l Y93 2.430E-08 0.000E+00 6.620E-10 0.000E+00 0.000E+00 0.000E+00 1.920E-04 Zr95 2.060E-07 5.020E-08 3.560E-08 0.000E+00 5.410E-08 0.000E+00.2.500E-05 Zr97 1.480E-08 2.540E-09 1.160E-09 0.000E+GO 2.560E-09 0.000E+00 1.620E-04 Nb95 4.200E-08 1.730E-06 1.000E-08 0.000Ev00 1.240E-08 0.000E+00 1.460E-05
' Mo99 0.000E+00 3.400E-05 6.630E-06 0.000E+00 5.080E-05 0.000E+00 1.120E-05 :
- Tc99m 1.920E-09 3.960E-09 5.100E-08 0.000E+00 4.260E-08 2.070E-09 1.150E-06 ,
. Tc101 2.270E-09 2.860E-09 2.830E-08 0.000E+00 3.400E-08 1.560E-09 4.860E-07
- Rul03 1.480E-06 0.000E+00 4.950E-07 0.000E+00 3.080E-06 0.000E+00 1.800E-05 Rul05 1.360E-07 0.000E+00 4.580E-08 0.000E+00 1.000E-06 0.000E+00 5.410E-05 Rul06 2.410E-05 0.000E+00 3.010E-06 0.000E+00 2.850E-05 0.000E+00 1.830E-04 Ag110m 9.960E-07 7.270E-07 4.810E-07 0.000E+00 1.040E-06 0.000E+00 3.770E-05
iTa125m 2.330E-05 7.790E-06 3.150E-06 7.840E-06 0.000E+00 0.000E+00 1.110E-05 Te127m 5.850E-05 1.940E-05 7.080E-06 1.690E-05 1.440E-04 0.000E+00 2.360E-05 Te127 1.000E-06 3.350E-07 2.150E-07 8.140E-07 2.440E-06 0.000E+00 2.100E-05 Te129m 1.000E-04 3.430E-05 1.540E-05 3.840E-05 2.500E-04 0.000E+00 5.970E-05 Te129 2.840E-07 9.790E-Od 6.630E-08 2.380E-07 7.070E-07 0.000E+00 2.270E-05 Te131m 1.520E-05 6.120E-06 5.050E-06 1.240E-05 4.210E-05 0.000E+00 1.030E-04
- Te131 1.760E-07 6.500E-08 4.940E-08 1.570E-07 4.500E-07 0.000E+00 7.110E-06 i
To132 2.080E-05 1.030E-05 9.610E-06 1.520E-05 6.440E-05 0.000E+00 3.810E-05
.m. e - o ,, u -.y- ,- - - -. + - - .
1 l' ODCM Rsv. 13 l Pags 115 l 5/94 Table 1-1 (Continued) Liauid Dose Factors Fro 3' Table E-14 or Reg. Guide l'.109 Ingsstion Dose Factors For Infant: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 6.000E-06 1.320E-05 5.300E-06 1.480E-03 1.450E-05 0.000E+00 2.830E-06 I131 3.590E-05 4.230E-05 1.860E-05 1.390E-02 4.940E-05 0.000E+00 1.510E-06 I132 1.660E-06 3.370E-06 1.200E-06 1.580E-04 3.760E-06 0.000E+00 2.730E-06 1 I133 1.250E-05 1.820E-05 5.330E-06 3.310E-03 2.140E-05 0.000E+00 3.080E-06 l I134 8.690E-07 1.780E-06 6.330E-07 4.150E-05 1.990E-06 0.000E+00 1.840E-06 I135 3.640E-06 7.240E-06 2.640E-06 6.490E-04 8.070E-06 0.000E+00 2.620E-06 C3134 3.770E-04 7.030E-04 7.100E-05 0.000E+00 1.810E-04 7.420E-05 1.910E-06 Cs136 4.590E-05 1.350E-04 5.040E-05 0.000E+00 5.380E-05 1.100E-05 2.050E-06 C2137 5.220E-04 6.110E-04 4.330E-05 0.000E+00 1.640E-04 6.640E-05 1.910E-06 C3138 4.810E-07 7.820E-07 3.790E-07 0.000E+00~3.900E-07 6.090E-08 1.250E-06 B3139 8.810E-07 5.840E-10 2.550E-08 0.000E+00 3.510E-10 3.540E-10 5.580E-05 Bn140 1.710E-04 1.710E-07 8.810E-06 0.000E+00 4.060E-08 1.050E-07 4.200E-05 Bn141 4.250E-07 2.910E-10 1.340E-08 0.000E+00 1.750E-10-1.770E-10 5.190E-06 Ba142 1.840E-07 1.530E-10 9.060E-09 0.000E+00 8.810E-11 9.260E-11 7.590E-07 La140 2.110E-08 8.320E-09 2.140E-09 0.000E+00 0.000E+00 0.000E+00 9.770E-05 La142 1.100E-09 4.040E-10 9.670E-11.0.000E+00 0.000E+00 0.000E+00 6.860E-05 l Co141 7.870E-08 4.800E-08 5.650E-09 0.000E+00 1.480E-08 0.000E+00 2.480E-05 { Ca143 1.480E-08 9.820E-06 1.120E-09 0.000E+00 2.860E-09 0.000E+00 5.730E-05 1 Co144 2.980E-06 1.220E-06 1.670E-07 0.000E+00 4.930E-07 0.000E+00 1.710E-04 ! Pr143 8.130E-08 3.040E-08 4.030E-09 0.000E+00 1.130E-08 0.000E+00 4.290E-05 Pr144 2.740E-10 1.060E-10 1.380E-11 0.000E+00 3.840E-11 0.000E+00 4.930E-06 Nd147 5.530E-08 5.680E-08 3.480E-09 0.000E+00 2.190E-08 0.000E+00 3.600E-05 W187 9.030E-07 6.280E-07 2.170E-07 0.000E+00 0.000E+00 0.000E+00 3.690E-05 Np239 1.110E-08 9.930E-10 5.610E-10 0.000E+00 1.980E-09 0.000E+00 2.870E-05
}
I i 1 l
g,"
.- - - - - - ~ - - --- -
+"
, l[ ,
.ODCM R$v. 13'
- i. Pcg3 116-j~
.h .5/94-
- O ,
' Table 1-2 - Assumptions 1used in Limerick Liquid - ! Effluent Dose Evaluation ,
N ' IDdSX - . Descrintion . Value
- 1 Fraction of produce ~from local garden =7.600E ;2] Fraction'of leafy veg from local garden .1.000E+00 4 3l3011 density >in plow layer (kg/m**2) 2.400E+02 4EFractionlof' activity retained;on sprayed: vegetation: 2.500E-01' 5 Shielding fa'c tor for residential. structures 7.000E-01
'6 POriod.of buildup offactivity in' soil.(hr) -1~.752E+05 L 7 Pariod ofLpasture1 grass. exposure to activity (hr) 7.200E+02'
- T 18,Pariod of crop exposure to-activity (hr) 1.440E+03
!91 Holding time in animal; drinking water pond (hr) 0.000E+00
.10 Delay' time for ingestion of grass by+ animals l(hr) 0.000E+00
'11' Delay' time for ingestion ^of ' stored fee by animals (hr) ' 2.160E+03 L12 ~ Delay time for ingestion 'of leaf tveg by. nan (hr)= 2.400E+01
~13fDelay-time for= ingestion of other veg by man-(hr). 1.440E+03 14 LTransport ' time = ilk-man ~ (hr) 4.800E+01
;15; Time between slaughter and consumption of meat animalL (hr) . 4.800E+02.
7.000E - L161 Grass' yield, wet wt (kg/m**2) .
-17 Other= vegetation' yield, wet wt1(kg/m**2) .
. 2.uo0E+00 lL8 Waatb Eing. rate ~ constant for1 activity on_ vegetation (1/hr) 2.100E-03 .
19 Milk cow feed-consumption rate (kg/ day: wet) 5.000E+01- '[ 20 Goat-feed consumption rate (kg/ day wet) 6.000E+00. L21 Beef. Cattle feed consumption rate .(kg/ day ' wet) 5.000E+01-- < J221 Milk cow water consumption rate (1/ day) - 6.000E+01: - 231 Goat water; consumption. rate-(1/ day) 8.000E+00
'24LBsef1 cattle water consumption rate (1/ day) 5.000E+01 25-Enytl transit time for water ingestion (hr) _ 1.200E+01- "
26 Enytl transit time for fish-ingestion;(hr) . 2.400E+01. 27'Enytl transit time for invertebrate ingestion (hr) ' 2.400E+01 L28 Envtl transit time for shore exposure (hr) 0.000E+00 f 29 Water ingestion (1/yr) adult 7.300E+02 130; Water ingestion (1/yr) teen 5.100E+02-
"31= Water ingestion (1/yr) child 5.100E+02
, ,32. Water ingestion (1/yr) infant 3.300E+022
- 33 Shore exposure (hr/yr) adult 1.200E+01
.34 Shore exposure (hr/yr) teen 6.700E+01 ,
35 Shore' exposure (hr/yr) child 1.400E+01
'36< Shore' exposure (hr/yr) infant 0.000E+00 '
- 37. Fresh water sport fish ingestion (kg/yr) adult 2.100E+01
. _381 Fresh water sport fish ingestion (kg/yr) teen 1.600E+01
'39 Fresh. water sport fish ingestion (kg/yr) child 6.900E+00-
- N40 Fresh water sport fish ingestion (kg/yr) infant ' O.000E+00 441 Fresh water commercial fish' ingestion.(kg/yr) adult 2.100E+01 42, Fresh water commercial fish ingestion (kg/yr) teen 1.600E+01 143. Fresh water commercial fish ingestion (kg/yr) child 6.900E+00' 144 ' Fresh' water commercial fish ingestion (kg/yr) infant 0.000E+00 -
;452 Fresh water invertebrate ingestion (kg/yr) adult 5.000E+00
.46 Fresh water invertebrate ingestion (kg/yr) teen 3.800E+00 'i L47 Fresh water invertebrate ingestion (kg/yr) child 1.700E+00-48 Fresh water invertebrate ingestion (kg/yr) infant 0.000E+00 4 .
y g 4e ,m -
E@.. f , 'ODCM'R v.-13J Pags 117'
,- ;[ .5/94 ,
_ J Tableil-2 . . ,
- ' Assumptions used-in-Limerick. Liquid Effluent Dose Evaluation
,Index . .
~ . .
Descrintion Value i49 - Salt' Water Sport . Fish Ingestion. (kg/yr) . Adult 2.100E+01-l50 Salt WaterESport Fish ~ Ingestion 1(kg/yr); Teen- -1.600E+01 , 512 -Salt' Water ~ Sport Fish : Ingestion (kg/yr) Child' 6.900E+00 52: :Selt; Water' Sport Fish ~ Ingestion (kg/yr)' Infant- 0.000E+00 , 53 : : Salt Water-Commercial FishiIngestion (kg/yr) Adult 2.100E+01
;54. : Salt Water Commercial. Fish-Ingestion (kg/yr) Teen 1.600E+01; l55. Salt. Water Commercial. Fish Ingestion (kg/yr) Child L 6.900E+00 ;
56 Salt Water commercial Fich Ingestion (kg/yr) Infant 'O.000E+00 1 57, Salt Water Invertebrate Ingestion (kg/yr) Adult ~ ~ 5.000E+00 .: 581 Snit ' Water Invertebrate Ingestion (kg/yr) Teen ,
- 3.800E+00 d 59, - SDlt Water LInvertebrate ~ Ingestion (kg/yr) ' Child l'.700E+00 l l60: Salt Water Invertebrata-Ingestion (kg/yr) . Infant . ~0.000E+00 i L61J Irrigated Leafy Vegetable Ingestion (kg/yr): Adult 6.400E+01 i l 62; : Irrigated Leafy Vegetable Ingestion -(kg/yr) Teen 4.200E+01-
~
l63 Irrigated Leafy Vegetable' Ingestion (kg/yr) Child 2.600E+01 ; L64 ' Irrigated Leafy Vegetable Ingestion :(kg/yr) Infant.
- 0.000E+00 R L65 -Irrigated other Vegetable-Ingestion (kg/yr): Adult
- 5.200E+02- .
L 66_ Irrigated Other Vegetable Ingestion (kg/yr) Teen 6. 3 00E+ 02 : E67 Irrigated Other Vegetable Ingestion (kg/yr) Child 5.200E+02 68 ~ Irrigated Other' Vegetable Ingestion (kg/yr)-Infant 0.000E+00 69 . Irrigated Root Vegetable Ingestion (kg/yr)-Adult- 5.200E+02. E70 Irrigated Root Vegetable Ingestion' (kg/yr)- Teen '6.300E+02 71 Irrigated; Root Vegetable Ingestion -(kg/yr). Child 5.200E+02
- 72. =Ir'.1 gated Root Vegetable-Ingestion (kg/yr) Infant. 0.000E+00 o 73 Irrigated Cow Milk Ingestion 1(1/yr) Adult 3.100E+02 g 74_ : Irrigated Cow Milk Ingestion (1/yr) Teen 4.000E+02 ;
175 _ Irrigated Cow Milk Ingestion (1/yr). Child 3.300E+02 76 IrrigatedLCow Milk Ingestion (1/yr) Infant 3.300E+02 J
- 77 Irrigated. Goat Milk Ingestion'(1/yr) Adult 3.100E+02 l 78 Irrigated Goat Milk Ingestion (1/yr) Teen- 4.000E+02 !
79 . Irrigated Goat Milk Ingestion (1/yr)' Child 3.300E+02 l l 3 80. . Irrigated Goat Milk Ingestion (1/yr) Infant -3.300E+02-81 Irrigated Beef Ingestion (1/yr). Adult 1.100E+02 1
- .'82 Irrigated Beef Ingestion (1/yr) Teen 6.500E+01- U
.83 Irrigated Beef Ingestion 1(1/yr) Child 4.100E+01 )
84; Irrigated Beef Ingestion (1/yr) Infant 0.000E+00 z i L , _ 2
, , . . . . . . - - . _ - ~ . _ . __ - . - . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ .
[' , jli' .ODCM Rtv.:13! Paga:118-
.l .
5/94 Table'2-1;
' Dose-Factorr.for Noble Gas Total Body Beta Skin Gamma Air . Beta Air Dose Factor Dose Factor. Dose-Factor :: Dose Factor Ki (arem/yr Li (ares /yr 'Mi (arad.yr Ni (mrad /yr-
.per per per per
- Inddx' Radionuclide pCi/m 3) pCi/m 3) pCi/m 3) ' pCi/m)F 3 ,l
.I 3 Ar-41 8.84E-03 2.69E-03 9.30E-03 3.28E-03 'i
!4 'Kr-83m- 7.56E-08 ------- 1.93E-05' 2. 8 8E-04 -- 1 l
5 Kr-85m 1.17E-03 1.46E .1.23E-03 11.97E-03 H 6 Kr-85 1.61E 1.34E-03 1.72E-05 1.95E-03 l
'7- Kr-87 5.92E-03' 9.73E-03 6.17E-03 1.03E-02 8 Kr-88 1.47E-02 2.37E-03 1.52E-02 :2.93E-03' a 9 Kr-89 1.66E-02 1.01E-02 1.73E-02 1.06E .
10 Kr-90 1.56E 7.29E-03 1.63E-02. '7.83E-03
- 11. Xe-131m 9.15E-05 -4;76E-04 1.56E-04 1.11E-03 i 12 Xe-133m 2.51E-04 9.94E 3.27E-04~ 1.48E-03 13 Xe-133 2.94E-04 3.06E-04 3.53E-04 :1.05E-03 14 Xe-135m 3.12E-03 7.11E-04 '3.36E-03~ 7.39E-04 15 Xe-135 1.81E-03 1.86E-03 1.92E-03 2.46E-03 16 Xe-137 1.42E-03 1.22E-02 ~1.51E-03. 1.27E-02 17 Xe-138 8.83E-03 4.13E-03 9.21E-03 4.75E-03 J
li , ODCM-R2v.'13 Pnga 119
; Jl_ 5/94
-TABLE'2-2 INGESTION INDIVIDUAL DOSE FACTORS (DFg ,t,y)
For Gaseous Effluents i UNITS'FOR AIRBORNE PATHWAYS
.(Pathway Numbers 1 and 7) are:
3 mrem-m /Ci-sec UNITS FOR DEPOSITION PATHWAYS (Pathway Numbers 2-6) are: mrem-m2 /Ci Pathway No. Pathway 1 Plume 2 Ground 3 Vegetable 4- Meat 5 Cow Milk 6 Goat Milk 7 Inhalation 1 l
ODCM R v. 13 l Prga 120 l 5/94 Table 2-2 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: H3 F r Pathway: Plume T. BODY GI-TRACT BONE LIVFR KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcin 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfCnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tr nt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.53E+01 6.53E+01 0.00E+00 6.53E+01 6.53E+01 6.53E+01 6.53E+01 0.00E+00 T@rn 7.75E+01 7.75E+01 0.00E+00 7.75E+01 7.75E+01 7.75E+01 7.75E+01 0.00E+00 Child: 1.21E+02 1.21E+02 0.00E+00 1.21E+02 1.21E+02 1.21E+02 1.21E+02 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.98E+00 7.98E+00 0.00E+00 7.98E+00 7.98E+00 7.98E+00 7.98E+00 0.00E+00 Torn: 4.75E+00 4.76E+00 0.00E+00 4.76E+00 4.76E+00 4.76E+00 4.76E+00 0.00E+00 Child: 5.75E+00 5.75E+00 0.00E+00 5.75E+00 5.75E+00 5.75E+00 5.75E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.88E+01 1.88E+01 0.00E+00 1.88E+01 1.88E+01 1.88E+01 1.88E+01 0.00E+00 T::n: 2.45E+01 2.45E+01 0.00E+00 2.45E+01 2.45E+01 2.45E+01 2.45E+01 0.00E+00 child: 3.87E+01 3.87E+01 0.00E+00 3.87E+01 3.87E+01 3.87E+01 3.87E+01 0.00E+00 Infcnt: 5.87E+01 5.87E+01 0.00E+00 5.37E+01 5.87E+01 5.87E+01 5.87E+01 0.00E+00 For Pathway: Goat Milk T.DODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.83E+01 3.88E+01 0.00E+00 3.83E+01 3.83E+01 3.83E+01 3.83E+01 0.00E+00 Tssnt 4.99E+01 4.99E+01 0.00E+00 4.99E+01 4.99E+01 4.99E+01 4.99E+01 0.00E+00 Child: 7.89E+01 7.89E+01 0.00E+00 7.89E+01 7.89E+01 7.89E+01 7.89E+01 0.00E+00 Infcnt: 1.20E+02 1.20E+02 0.00E+00 1.20E+02 1.20E+02 1.20E+02 1.20R+02 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.01E+01 4.01E+01 0.00E+00 4.01E+01 4.01E+01 4.01E+01 4.01E+01 0.00E+00 T :n 4.03E+01 4.03E+01 0.00E+00 4.03E+01 4.03E+01 4.03E+01 4.03E+01 0.00E+00 Child: 3.57E+01 3.57E+01 0.00E+00 3.57E+01 3.57E+01 3.57E+01 3.57E+01 0.00E+00 Infant: 2.05E+01 2.05E+01 0.00E+00 2.05E+01 2.05E+01 2.05E+01 2.05E+01 0.00E+00
ODCM ROV. 13 l Pago 121 [ 5/94 l Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: C14 lFor Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' Adult 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T;cn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnts 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.22E+03 5.22E+03 2.61E+04 5.22E+03 5.22E+03 5.22E+03 5.22E+03 0.00E+00 Tstn: 8.79E+03 8.79E+03 4.39E+04 8.79E+03 8.79E+03 8.79E+03 8.79E+03 0.00E+00 Child: 2.14E+04 2.14E+04 1.07E+05 2.14E+04 2.14E+04 2.14E+04 2.14E+04 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.64E+03 1.64E+03 8.22E+03 1.64E+03 1.64E+03 1.64E+03 1.64E+03 0.00E+00 Tonn: 1.39E+03 1.39E+03 6.94E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 0.00E+00 Child: 2.61E+03 2.61E*03 1.31E+04 2.61E+03 2.61E+03 2.61E+03 2.61E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tann: 3.31E+03 3.31E-03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child: 8.13E+03 8.13E-03 4.07E+04 8.13E+03 3.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tscn: 3.31E+03 3.31E+03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child: 8.13E+05 8.13E+03 4.07E+04 8.13E+03 8.13E+03 8.13E+03 8.13E+03 0.00E+00 Infent: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 0.00E+00 tin: 1.54E+02 1.54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 0.00E+00 Child: 2.13E+02 2.13E+02 1.14E+03 2.13E+02 2.13E+02 2.13E+02 2.13E+02 0.00E+00 Infant: 1.68E+02 1.68E+02 8.39E+02 1.68E+02 1.68E+02 1.68E+02 1.68E+02 0.00E+00
.l' ODCM Rsv. 13 Pags 122 l 5/94 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ar41 For Pathway: Plume T. BODY GI-TRACT BONE- LIVER KIDNEY THYROID LUNG- SKIN Adult: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 TGen 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 Child: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 Infant: 1.96E+02 1.96E+02 1. 9 6E+02 1. 96E+02 1. 9 6E4 02 1.96E+02 1.96E+02 1.96E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER . KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tern: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00EF00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfGnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,
Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
l ODCM Rev. 13 Page 123 l 5/94 Table 2-2 (Continued) INDIVIDUAT1 DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cr51 . For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Tecn: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Child: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Infant: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.06E+03 2.66E+05 0.00E+00 0.00E+00 2.33E+02 6.31E+02 1.40E+03 0.00E+00 Teen: 1.55E+03 2.61E+05 0.00E+00 0.00E+00 3.40E+02 8.61E+02 2.21E+03 0.00E+00 Child: 3.05E+03 1.62E+05 0.00E+00 0.00E+00 4.63E+02 1.70E+03 3.10E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.29E+02 3.23E+04 0.00E+00 0.00E+00 2.83E+01 7.68E+01 1.71E+02 0.00E+00 Teen: 1.03E+02 1.73E+04 0.00E+00 0.00E+00 2.25E+01 5.71E+01 1.47E+02 0.00E+00 Child: 1.60E+02 8.50E+03 0.00E+00 0.00E+00 2.43E+01 8.90E+01 1.62E+02 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For $4thway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.20E+02 1.31E+05 0.00E+00 0.00E+00 1.15E+02 3.11E+02 6.91E+02 0.00E+00 Teen: 9.09E+02 1.53E+05 0.00E+00 0.00E+00 1.99E+02 5.05E+02 1.30E+03 0.00E+00 Child: 1.85E+03 9.83E+04 0.00E+00 0.00E+00 2.81E+02 1.03E+03 1.88E+03 0.00E+00 Infant: 2.94E+03 8.56E+04 0.00E+00 0.00E+00 4.19E+02 1.92E+03 3.73E+03 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.24E+01 1.57E+04 0.00E+00 0.00E+00 1.38E+01 3.73E+01 8.29E+01 0.00E+00 Teen: 1.09E+02 1.83E+04 0.00E+00 0.00E+00 2.39E+01 6.06E+01 1.56E+02 0.00E+00 lChild: 2.22E+02 1.18E+04 0.00E+00 0.00E+00 3.37E+01 1.23E+02 2.25E+02 0.00E+00 ' Infant: 3.52E+02 1.03E+04 0.00E+00 0.00E+00 5.02E+01 3.30E+02 4.47E+02 0.00E+00 l For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
, Adult: 3.17E+00 1.05E+02 0.00E+00 0.00E+00 7.23E-01 1.89E+00 4.56E+02 0.00E+00 Teen: 4.29E+00 9.51E+01 0.00E+00 0.00E+00 9.74E-01 2.38E+00 6.64E+02 0.00E+00 Child: 4.89E+00 3.44E+01 0.00E+00 0.00E+00 7.71E-01 2.71E+00 5.38E+02 0.00E+00 Infant: 2.84E+00 1.13E+01 0.00E+00 0.00E+00 4.19E-01 1.82E+00 4.07E+02 0.00E+00
- __ _ ___m__- - _ _ _ _ _ _ . _ _ _ _
. .. ~ , - .. .-- - -- . . .
- l 1
'ODCM Rav. 13 '
Paga'124
] '5/94 ,
T
. Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS'FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: 'Mn54
- For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG' -SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00,0.00E+00 0.00E+00 0.00E+00;I Tacn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.
1- ~ Child:' O.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG' SKIN Adult: 4.23E+07 4.23E+07 4.23E+07 4.23E+07'4.23E+07 4.23E+07 4.23E+07 4.96E+07: Taon: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 i Child: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07.' Infant: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4~.23E+07 4.23E+07:4.96E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4 Adult: 1.61E+06 2.58E+07 0.00E+00 8.43E+06 2.51E+06 0.00E+00 0.00E+00 0.00E+00 , Tosn: 2.53E+06 2.61E+07 0.00E+00 1.27E+07 3.80E+06 0.00E+00 0.00E+00 0.00E+00- i Child: 5.03E+06 1.59E+07 0.00E+00 1.89E+07 5.30E+06 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00.
' For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- SKIN-Adult: 3.21E+04 5.16E+05 0.00E+00 1.68E+05 5.01E+04 0.00E+00 0.00E+00.0.00E+00 Toen 2.55E+04 2.63E+0E 0.00E+00 1.28E+05 3'.83E+04 0.00E+00 0.00E+00 0.00E+00 l Child: 3.91E+04 1.23E+05 0.00E+00 1.47E+05 4.12E+04 0.00E+00 0.00E+00'O.00E+00, !
- Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' '
For Pathway: Cow Milk , T. BODY GI-TRACT BONE- LIVER KIDNEY THYROID LUNG SKIN- ' Adult: 2.94E+04 4.73E+05 0.00E+00 1.54E+05 4.59E+04 0.00E+00 0.00E+00 0.00E+00 Tcan: 5.10E+04 5.27E+05 0.00E+00 2.57E+05 7.67E+04 0.00E+00 0.00E+00 0.00E+00' Child: 1.02E+05 3.23E+05 0.00E+00 3.85E+05 1.08E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 1.62E+05 2.63E+05 0.00E+00 7.15E+05 1.59E+05 0.00E+00 0.00E+00 0.00E+00- t For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.53E+03 5.67E+04 0.00E+00 1.85E+04 5.51E+03 0.00E+00 0.00E+00 0.00E+00-Tson: 6.12E+03 6.33E+04 0.00E+00 3.09E+04 9.20E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.23E+04 3.87E+04 0.00E+00 4.62E+04 1.29E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 1.95E+04 3.15E+04 0.00E+00 8.58E+04 1.90E+04 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.00E+02 2.45E+03 0.00E+00 1.26E+03 3.12E+02 0.00E+00 4.44E+04 0.00E+00 Tesn: 2.66E+02 2.12E+03 0.00E+00 1.62E+03 4.03E+02 0.00E+00 6.29E+04 0.00E+00 Child: 3.01E+02 7.26E+02 0.00E+00 1.36E+03 3.18E+02 0.00E+00 5.00E+04 0.00E+00 i Infant: 1.58E+02 2.24E+02 0.00E+00 8.03E+02 1.58E+02 0.00E+00 3.17E+04 0.00E+00 I I L J n ' n m- ---
l ODCM Rnv. 13 l Paga 125 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: CoS8 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ) Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
.To:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Fcr Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1. '.6E+07 1.16E+07 1.16E+07 l Tacn: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 l Child: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 Infant: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.76E+06 1.59E+07 0.00E+00 7.85E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Totn: 2.72E+06 1.63E+07 0.00E+00 1.18E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 5.43E+06 1.04E+07 0.00E+00 1.77E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 7.30E+05 6.60E+06 0.00E+00 3.26E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tcan: 5.79E+05 3.46E+06 0.00E+00 2.51E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 8.98E+05 1.71E+06 0.00E+00 2.93E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.89E+05 1.71E+06 0.00E+00 8.42E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn: 3.27E+05 1.95E+06 0.00E+00 1.42E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 6.63E+05 1.26E+06 0.00E+00 2.17E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 1.08E+05 1.08E+06 0.00E+00 4.33E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.26E+04 2.05E+05 0.00E+00 1.01E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00
,Tecn: 3.92E+04 2.35E+05 0.00E+00 1.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 7.96E+04 1.52E+05 0.00E+00 2.60E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Infant: 1.30E+05 1.30E+05 0.00E+00 5.20E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,For Pcthway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN (Adult: 6.57E+01 3.37E+03 0.00E+00 5.02E+01 0.00E+00 0.00E+00 2.94E+04 0.00E+00 Tssn: 8.80E+01 3.02E+03 0.00E+00 6.57E+01 0.00E+00 0.00E+00 4.26E+04 0.00E+00 Child: 1.00E+02 1.09E+03 0.00E+00 5.62E+01 0.00E+00 0.00E+00 3.51E+04 0.00E+00 Infant: 5.77E+01 3.53E+02 0.00E+00 3.87E+01 0.00E+00 0.00E+00 2.46E+04 0.00E+00
-l ODCM R v. 13 Pagn 126 l 5/94 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Fe59 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Tecn: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Child: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Infcnt: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+0E 8.34E+06 8.34E+06 9.80E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.80E+06 2.43E+07 3.11E+06 7.30E+06 0.00E+00 0.00E+00 2.04E+06 0.00E+00 To n: 4.28E+06 2.62E+07 4.75E+06 1.11E+07 0.00E+00 0.00E+00 3.50E+06 0.00E+00 Child: 8.69E+06 1.32E+07 1.08E+07 1.75E+07 0.00E+00 0.00E+00 5.06E+06 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.29E+06 3.73E+07 4.76E+06 1.12E+07 0.00E+00 0.00E+00 3.12E+06 0.00E+00 Tscn: 3.43E+06 2.10E+07 8.87E+06 8.87E+06 0.00E+00 0.00E+00 2.80E+06 0.00E+00 Child: 5.43E+06 1.14E+07 6.74E+06 1.09E+07 0.00E+00 0.00E+00 3.16E+06 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.79E+05 4.17E+06 5.32E+05 1.25E+06 0.00E+00 0.00E+00 3.49E+05 0.00E+00 T:;ns 8.37E+05 5.12E+06 9.28E+05 2.17E+06 0.00E+00 0.00E+00 6.83E+05 0.00E+00 Child: 1.74E+06 3.63E+06 2.15E+06 3.48E+06 0.00E+00 0.00E+00 1.01E+06 0.00E+00 Infcnt: 2.77E+06 3.35E+06 4.02E+06 7.02E+06 0.00E+00 0.00E+00 2.07E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.23E+03 5.42E+04 6.91E+03 1.63E+04 0.00E+00 0.00E+00 4.54E+03 0.00E+00 Tsan: 1.09E+04 6.66E+04 1.21E+04 2.82E+04 0.00E+00 0.00E+00 8.88E+03 0.00E+00 Child: 2.26E+04 4.71E+04 2.80E+04 4.53E+04 0.00E+00 0.00E+00 1.31E474 0.00E+00 Infcnt: 3.60E+04 4.36E+04 5.22E+04 9.12E+04 0.00E+00 0.00E+00 2.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.35E+02 5.96E+03 3.73E+02 8.80E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 Tccn: 4.54E+02 5.66E+03 5.05E+02 1.17E+03 0.00E+00 0.00E+00 4.84E+04 0.00E+00 Child: 5.29E+02 2.24E+03 6.56E+02 1.06E+03 0.00E+00 0.00E+00 4.02E+04 0.00E+00 Infcnt: 3.00E+02 7.86E+02 4.30E+02 7.46E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00
l ODCM Rnv. 13 Paga 127 j 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Co60 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Tecn 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Child: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Infcnt: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 For Pcthway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.02E+07 8.68E+07 0.00E+00 4.62E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 1.61E+07 9.29E+07 0.00E+00 7.13E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Childs 3.24E+07 6.08E+07 0.00E+00 1.10E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.11E+06 2.65E+07 0.00E+00 1.41E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tenn: 2.46E+06 1.42E+07 0.00E+00 1.09E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 3.83E+06 7.19E+06 0.00E+00 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.78E+05 5.77E+06 0.00E+00 3.07E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 1.17E+06 6.78E+06 0.00E+00 5.21E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.38E+06 4.48E+06 0.00E+00 8.09E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 3.90E+06 3.93E+06 0.00E+00 1.65E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.13E+04 6.93E+05 0.00E+00 3.69E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 1.41E+05 8.14E+05 0.00E+00 6.25E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.86E+05 5.37E+05 0.00E+00 9.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 4.68E+05 4.71E+05 0.00E+00 1.98E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONF LIVER KIDNEY THYROID LUNG SKIN Adult: 4.69E+02 9.03E+03 0.00E+00 3.65E+02 0.00E+00 0.00E+00 1.89E+05 0.00E+00 Tecn: 6.29E+02 8.22E+03 0.00E+00 4.79E+02 0.00E+00 0.00E+00 2.76E+05 0.00E+00 Child: 7.18E+02 3.05E+03 0.00E+00 4.16E+02 0.00E+00 0.00E+00 2.24E+05 0.00E+00 Infant: 3.73E+02 1.01E+03 0.00E+00 2.54E+02 0.00E+00 0.00E+00 1.43E+05 0.00E+00
l m n. ; j ODCM-Rsv. 13 , Page 128 i j 5/94 l a-Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zn65 For Pathway: Plume T. BODY GI-TRACT. BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
. Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 Infant: -0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Tsant 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Child:
Infant: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07-For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' Adult: 1.58E+07 2.20E+07 1.10E+07 3.50E+07 2.34E+07 0.00E+00 0.00E+00 0.00E+00 Tsan: 2.43E+07 2.25E+07 1.53E+07 5.32E+07 3.40E+07 0.00E+00 0.00E+00 0.00E+00 . Child: 4.93E+07 1.39E+07 2.98E+07 7.93E+07 5.00E+07 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+07 1.50E+07 7.50E+06 2.39E+07 1.60E+07 0.00E+00 0.00E+00 0.00E+00 Tasna 8.54E+06 7.75E+06 5.27E+06 1.33E+07 1.17E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.31E+07 3.70E+06 7.91E+06 2.11E+07 1.33E+07 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 : For Pathway: Cow Milk , T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.15E+07 5.79E+07 2.89E+07 9.20E+07 6.15E+07 0.00E+00 0.00E+00 0.00E+00 Toon: 7.19E+07 6.63E+07 4.44E+07 1.54E+08 9.86E+07 0.00E+00 0.00E+00 0.00E+00 . Child: 1.44E+08 4.07E+07 8.71E+07 2.32E+08 1.46E+08 L.00E+00 0.00E+00 0.00E+00 I Infant: 1.85E+08 3.39E+08 1.17E+08 4.01E+08 1.95E+08 0.00E+00 0.00E+00 0.00E+00 l l For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
- Adult: 4.99E+06 6.95E+06 3.47E+06 1.10E+07 7.38E+06 0.00E+00 0.00E+00 0.00E+00 Tasnt 8.63E+06 7.83E+06 5.33E+06 1.85E+07 1.18E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.73E+07 4.89E+06 1.05E+07 2.78E+07 1.75E+07 0.00E+00 0.00E+00 0.00E+00 Infcnt: 2.22E+07 4.07E+07 1.40E+07 4.81E+07 2.33E+07 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation ;
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4 Adult: 1.43E+08 1.69E+03 1.03E+03 3.27E+03 2.19E+03 0.00E+00 0.00E+00 0.00E+00 Toon: 1.93E+08 1.48E+03 1.22E+03 4.24E+03 2.74E+03 0.00E+00 0.00E+00 0.00E+00 Child: 2.23E+03 5.17E+02 1.35E+03 3.59E+03 2.26E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 9.85E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 0.00E+00 0.00E+00 0.00E+00
1 l ODCM Rev. 13 Pago 129 l l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr83m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 TG:n: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 ; Child: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 j Infant: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 For Pathway: Ground I T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TsOns 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ) Tctn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 f Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j l For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , InfGnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For P0thway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 l Infont: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i j l For Pathway: Goat Milk i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfCnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation < T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1 iAdult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Tenn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I i
] ODCM Rav. 13 Pcgs 130
] 5/94 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr85 Fcr Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 i TsOne 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 l Child: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 l ' Infant: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 For Pathway: Ground l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacna 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . ' Infant: 0.00E+00 0.00E+00 0.00E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tssnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00
- Child
- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Infant
- 0.00E+00 0.00E+00 0.00E+00 0.00E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 f For Pathway: Goat Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
l ODCM Rev. 13 Pago 131 , l 5/94 Table 2-2 (Continued) 1 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLEENTS -- FOR ISOTOPE: Kr85m .For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 TIOns 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 I Child 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Infants 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T3 n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For P:thway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
. = . - - -, - . . . . - _ . - . - --
( l' ODCM Rsv. 13 Paga 132 7l 5/94 Table 2-2 (Continued) , 4 Kr87 [ INDIVIDUAL' DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: lFor Pathway: Plume . T. BODY' GI-TRACT BONE LIVER KIDNEY' THYROID LUNG SKIN . i
' ' Adult:- 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 T&Ons 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02-Child: 1.31E+02 1.31E+02'1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Infant:' 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 1
'For' Pathway: Ground . 1 T. BODY GI-TRACT ' BONE LIVER KIDNEY THYROID LUNG _ SKIN
~'
Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00'E+00 0.00E+00 J Tasnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00', Infant: 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 ' : l For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY ' THYROID LUNG SKIN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ~ Adult: Tacn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0 i .Taan 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 f Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00~0.00E+00 0.00E+00 '
- Infant
- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i
, LAdult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' T33ns 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' c' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 ' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
; For Pathway: Goat Milk T.30DY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN- ,
Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ! Tosnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 - i
- .-Infant
- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation ,
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 ' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i i P
.. . . - , , - - , , , , , ,,,,-3 --
, . - , - _ , . v-
j ODCM Rsv. 13 l Page 133 l 5/94 i Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr88
!For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 'TOOn: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 Child 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 Infcnt: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00Z+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tenn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
a
- l. 'ODCM Rsv. 13 Page 134
;l 5/94 Table 2-2 (Continued)
- INDIVIDUAL DOSE FACTORS FOR GASEOUS' EFFLUENTS -- FOR ISOTOPE: Kr89. j For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN L Adult:. 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02.3.72E+02 7.46E+02 Toon: '3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 l
- Child: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+G2 3.68E+02 3.72E+02 7.46E+02 l Infant: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 i For Pathway: Ground i T. BODY GI-TRACT. BONE LIVER KIDNEY THYROID LUNG SKIN. .
~ Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' ! ' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 L< Infant: 0.00E+00 0.00E+00.0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 For' Pathway: Vegetable
- T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
, Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00
- Tacn
- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:' O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 6
l
- For Pathway
- Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN t Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00'O.00E+00
, : Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+001 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ; Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 - Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT SONE LIVER KIDNEY. THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 < Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tean: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . P
, ~ - - -
w - _ - _ _ . _ . . - , _ -
. -.. . - = . - - . - - . . - . - ~ - ..-. - - -- . -. . . - - . - .. ~.
- j. ODCM Rsv. 13 Paga 135 1 5/94 1
Table 2-2 (Continued) l L . l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr89 ] LFor' Pathway: Plume T. BODY GI-TRACT BONE- LIVER KIDNEY THYROID LUNG SKIN
- iAdult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- T@sn: 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 iInfcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lFor Pathway: Ground 1
- T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
- Adult
- 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02'
- TcSnt - 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Child
- 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 ,
Infant: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 l t 'For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.42E+06 4.14E+07 2.58E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lTesn: 1.20E+07 5.00E+07 4.20E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.91E+07 3.95E+07 1.02E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' For ' Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.68E+05 9.41E+05 5.86E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 } Tenn: 1.42E+05 5.90E+05 4.95E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00- , Child: 2.68E+05 3.63E+05 9.37E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t 4 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk. i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.09E+05 4.52E+06 2.82E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+001 Toan: 1.49E+06 6.19E+06 5.20E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.67E+06 4.98E+06 1.29E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Infant: 7.02E+06 5.03E+06 2.45E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 :
For Pathway: Goat Milk ! T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 7 Adult: 1.70E+06 9.50E+06 5.92E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Teen: 3.13E+06 1.30E+07 1.09E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' child: 7.72E+06 1.05E+07 2.70E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 1.47E+07 1.06E+07 5.14E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.76E+02 1.11E+04 9.64E+03 0.00E+00 0.00E+00 0.00E+00 4.44E+04 0.00E+00 Tosn 3.96E+02 1.18E+04 1.38E+04 0.00E+00 0.00E+00 0.00E+00 7.66E+04 0.00E+00 Child: 5.47E+02 5.30E+03 1.90E+04 0.00E+00 0.00E+00 0.00E+00 6.84E+04 0.00E+00 i Infant: 3.62E+02 2.03E+03 1.26E+04 0.00E+00 0.00E+00 0.00E+00 6.44E+04 0.00E+00 '
. -. . -- . . . ~ ~ _ . . . . . , -. ...
l' ODCM Rav.E13 ,
.Pagn'136
-j 5/94
~
Table 2-2'(Continued) ..
- INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:' -Kr90 5' ' For Pathway: Plume .)
T. BODY GI-TRACT. BONE' LIVER KIDNEY THYROID LUNG SKIN ! Adult:: '3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02'I TOOn t . 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+0216.33E+02-Child: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02'6.33E+02 . Infant: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02.! ForLPathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY . THYROID LUNG . -SKIN , Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00. TGOng 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00: Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 3
'For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 3 'Taan 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00
, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00J For Pathway: Meat i T. BODY GI-TRACT BONE LIVER KIDNEY' THYROID LUNG SKIN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' Adult:
Taen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'.i Infant: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 - For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 Taant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.'00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , .Tasna 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+001 ; Child: 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation , T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacna 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: .0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 f e
- - - - - . . . , . -% < - - . . -., .w- y - ,
l ODCM Rsv. 13 Page 137 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr90 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TG;n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.38E+10 1.63E+09 5.64E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOsn: 1.79E+10 2.04E+09 7.27E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.09E+10 1.54E+09 1.22E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Meat ' T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.45E+08 5.24E+07 1.81E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 2.90E+08 3.29E+07 1.17E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 3.84E+08 2.04E+07 1.52E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 1.67E+09 1.97E+08 6.32E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lTecn: 2.38E+09 2.70E+08 9.64E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I ' Child: 4.13E+09 2.19E+08 1.63E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 4.51E+09 2.21E+08 1.77E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.51E+09 4.14E+08 1.43E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 5.00E+09 5.68E+08 2.02E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 8.67E+09 4.61E+08 3.42E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 iInfcnt: 9.47E+09 4.65E.08 3.72E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
, Adult: 1.93E+05 2.28E+04 3.14E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ts;n: 2.12E+05 2.42E+04 3.42E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.04E+05 1.09E+04 3.20E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Infant: 8.21E+04 4.15E+03 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
1
.l: -ODCM Rsv.'13'
~
PagD;138
-l 5/94 Table 2-2 (Continued)
INDIVIDUAL ~ DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zr95 '. :For! Pathway: Plume
. . T. BODY GI-TRACT BONE .
LIVER KIDNEY THYROID LUNG SKIN
. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-
.TGSn t - 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 LInfant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00LL For Pathway: Ground T. BODY. GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN e Adult: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06
-Tasnt 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Child: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06
,Infcnt: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 ,
For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '
. Adult: 6.46E+03 3.03E+07 2.98E+04 9.55E+03 1.50E+04 0.00E+00 0.00E+00 0.00E+00
, TOGns 1.01E+04 3.37E+07 4.63E+04 1.46E+04 2.15E+04 0.00E+00 0.00E+00 0.00E+00 Child: 2.07E+04 2.43E+07 1.06E+05 2.33E+04 3.33E+04 0.00E+00.0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID . LUNG SKIN. *
' Adult: 7.26E+03 3.40E+07 3.34E+04 1.07E+04 1.68E+04 0.00E+00 0.00E+00 0.00E+00 Tocn 5.81E+03 1.95E+07 2.68E+04 8.45E+03 1.24E+04 0.00E+00 0.00E+00 0.00E+00f .
Child: 9.30E+03 1.09E+07 4.75E+04 1.05E+04 1.50E+04 0.00E+00 0.00E+00 0.00E+00 j Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 ; For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.65E+00 1.71E+04 1.68E+01 5.40E+00 8.47E+00 0.00E+00 0.00E+00 0.00E+00
~Tecn: 6.39E+00 2.14E+04 2.94E+01 9.29E+00 1.36E+01 0.00E+00 0.00E+00 0.00E+00 ,
Child: 1.34E+01 1.57E+04 6.84E+01 1.50E+01 2.15E+01 0.00E+00 0.00E+00 0.00E+00 Infant: 2.10E+01 1.47E+04 1.21E+02 2.96E+01 3.19E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' ' Adult: 4.39E-01 2.05E+03 2.02E+00 6.48E-01 1.02E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 7.66E-01 2.57E+03 3.53E+00 1.11E+00 1.64E+00 0.00E+00 0.00E+00 0.00E+00 Child: 1.61E+00 1.88E+03 8.20E+00 1.80E+00 2.58E+00 0.00E+00 0.00E+00 0.00E+00
. Infant: 2.52E+00 1.77E+03 1.46E+01 3.55E+00 3.83E+00 0.00E+00 0.00E+00 0.00E+00
- For Pathway: Inhalation i
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.38E+02 4.77E+03 3.40E+03 1.09E+03 1.72E+03.0.00E+00 5.60E+04 0.00S+00 Tsen: 9.99E+02 4.72E+03 4.62E+03 1.45E+03 2.14E+03 0.00E+00 8.52E+04 0.00E+00 < Child: 1.17E+03 1.94E+03 6.02E+03 1.33E+03 1.89E+03 0.00E+00 7.07E+04 0.00E+00
' Infant: 6.44E+02 6.88E+02 3.66E+03 8.83E+02 9.85E+03 0.00E+00 5.55E+04 0.00E+00 i
- i o ,
i 1
. .- n, +- - _ _ . - . . _ _ . _ . _ _ _ _ _ - _ _ _ _- ..--% _ m. - -- ,e,1 - w
l ODCM Rsv. 13 Page 139 [ 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sb124 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfCnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T :n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ; Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ; Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Meat i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tc;n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Cow Milk i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I T; n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l InfCnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I ( I i
4LJ 9&~ ei._my.5- f +JIL 9-aJ.M--4m-.44 e -# -M.- -h 4 i21.-g ,--i.1-.--.4,J. ~ l ODCM Rsv.-13 Paga 140
-l. 5/94 Table 2-2 (Continued)
-INDIVIDUAL DOSE FACTORS FOR' GASEOUS EFFLUENTS -- FOR ISOTOPE: I131-For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T2Gn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-
' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
,,. Adult: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 Tecn: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 Child:- 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05
' Infant: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG . SKIN Adult: 4.43E+05 2.04E+05 5.41E+05'7.74E+05 1.33E+06 2.54E+08 0.00E+00 0.00E+00 Tsing 4.02E+05 1.48E+05 5.35E+05 7.48E+05 1.29E+06 2.18E+08 0.00E+00 0.00E+00 '
Child: 5.83E+05 9.13E+04 1.02E+06 1.03E+06 1.68E+05 3.39E+08 0.00E+00 0.00E+00
-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat
- T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult
- 8.70E+04.4.01E+04 1.06E+05 1.52E+05 2.60E+05 4.98E+07 0.00E+00 0.00E+00 Tecn 6.64E+04 2.44E+04 8.82E+04 1.24E+05 2.13E+05 3.60E+07 0.00E+00 0.00E+00 Child: 9.35E+04 1.46E+04 1.64E+05 1.65E+05 2.70E+05 5.44E+07 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk . .
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-Adult: 2.39E+06 1.10E+06 2.92E+06 4.17E+06 7.16E+06 1.37E+09 0.00E+00 0.00E+00'
. Toen 3.98E+06 1.47E+06 5.30E+06 7.42E+06 1.28E+07 2.16E+09 0.00E+00 0.00E+00 Child: 7.34E+06 1.15E+06 1.28E+07 1.29E+07 2.12E+07 4.27E+09 0.00E+00 0.00E+00 , Infant: 1.39E+07 1.13E+06 2.68E+07 3.16E+07 3.69E+07 1.04E+10 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.87E+06 1.32E+06 3.50E+06 5.01E+06 8.59E+06 1.64E+09 0.00E+00 0.00E+00-
'Tecn: 4.78E+06 1.76E+06 6.36E+06 8.90E+06 1.53E+07 2.60E+09 0.00E+00 0.00E+00 . Child: 8.81E+06 1.38E+06 1.54E+07 1.55E+07 2.55E+07 5.13E+09 0.00E+00 0.00E+00 Infant: 1.67E+07 1.35E+06 3.22E+07 3.79E+07 4.43E+07 1.25E+10 0.00E+00 0.00E+00' 'For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN .;
6.49E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.78E+05 0.00E+00 0.00E+00 Adult:
.Tesn: 8.37E+02 2.06E+02 1.12E+03 1.56E+03 2.66E+03 4.64E+05 0.00E+00 0.00E+00 ; -Child: 8.64E+02 9.01E+01 1.52E+03 1.52E+03 2.50E+03 5.15E+05 0.00E+00 0.00E+00 Infant: 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.70E+04 0. 00E+00 0. 00E4 00
l ODCM R v. 13 Pago 141 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTOPS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe131m l For Pathway: P]ume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 ' TOCn 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 Child 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 , InfOnt 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 Far Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN lAdult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
'For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' 'Tssn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I l IFor Pathway: Meat ] T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Trant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnts 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 'Infcnts 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsent 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
ODCM R v. 13 l Pags 142 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: I133 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Tecn: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Child: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Infcnt: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.07E+03 2.08E+04 1.33E+04 2.32E+04 4.05E+04 3.41E+06 0.00E+00 0.00E+00 T n: 6.41E+03 1.59E+04 1.24E+04 2.10E+04 3.69E+04 2.93E+06 0.00E+00 0.00E+00 E Child: 1.06E+04 1.13E+04 2.26E+04 2.79E+04 4.65E+04 5.19E+06 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.01E-03 5.93E-03 3.79E-03 6.60E-03 1.15E-02 9.70E-01 0.00E+00 0.00E+00 Tecn: 1.64E-03 4.07E-03 3.17E-03 5.38E-03 9.44E-03 7.52E-01 0.00E+00 0.00E+00 Child: 2.76E-03 2.94E-03 5.90E-03 7.29E-03 1.22E-02 1.35E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.07E+04 6.12E+04 3.91E+04 6.81E+04 1.19E+05 1.00E+07 0.00E+00 0.00E+00 Trsn: 3.70E+04 9.17E+04 7.15E+04 1.21E+05 2.13E+05 1.69E+07 0.00E+00 0.00E+00 Child: 8.12E+04 8.65E+04 1.74E+05 2.15E+05 3.58E+05 3.99E+07 0.00E+00 0.00E+00 Infant: 1.56E+05 9.03E+04 3.67E+05 5.34E+05 6.28E+05 9.71E+07 0.00E+00 0.00E+00 For Pathway; Goat Milk T. BODY GI-TRACT DONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.49E+04 7.34E+04 4.69E+04 8.17E+04 1.42E+05 1.20E+07 0.00E+00 0.00E+00 i Tc n: 4.44E+04 1.10E+05 8.57E+04 1.45E+05 2.55E+05 2.03E+07 0.00E+00 0.00E+00 Child: 9.75E+04 1.04E+05 2.08E+05 2.58E+05 4.29E+05 4.79E+07 0.00E+00 0.00E+00 Infcnt: 1.88E+05 1.08E+05 4.40E+05 6.41E+05 7.53E+05 1.16E+08 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l l Adult: 1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.19E+02 6.82E+04 0.00E+00 0.00E+00 l Tecn: 1.97E+02 3.27E+02 3.85E+02 6.49E+02 1.14E+03 9.26E+04 0.00E+00 0.00E+00 f Child: 2.44E+02 1.74E+02 5.25E+02 6.44E+02 1.07E+03 1.22E+05 0.00E+00 0.00E+00 1 Infant: 1.78E+02 6.83E+01 4.20E+02 6.08E+02 7.10E+02 1.13E+05 0.00E+00 0.00E+00 i
l ODCM RSv. 13 j Pago 143 l 5/94 Table 2-2 (Continued) _ INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe133 For P2thway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 T0rn: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Childs 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Infant: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Fcr POthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TsOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ^ T0nn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tean: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfGnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l For Pathway: Inhalation j T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
< Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 )
Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ( Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l i a
ODCM Rsv. 13 l Page 144 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe133m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 TOsnt 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Child: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Infcnt: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc5ns 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0 10E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcans 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1 I Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
l ODCM Rtv. 13 Pa go 145 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs134 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfCnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 TO:n 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Child: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Infant: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 l For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN , Adult: 2.50E+08 5.34E+06 1.28E+08 3.05E+08 9.88E+07 0.00E+00 3.28E+07 0.00E+00 Tsan: 2.21E+08 5.93E+06 2.03E+08 4.77E+03 1.52E+08 0.00E+00 5.79E+07 0.00E+00 l Child: 1.60E+08 4.10E+06 4.63E+08 7.60E+08 2.36E+08 0.00E+00 8.46E+07 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For P:thway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.38E+07 5.10E+05 1.22E+07 2.91E+07 9.43E+06 0.00E+00 3.13E+06 0.00E+00 Tc n: 1.06E+07 2.35E+05 9.74E+06 2.29E+07 7.28E+06 0.00E+00 2.78E+06 0.00E+00 Child: 5.94E+06 1.52E+05 1.72E+07 2.82E+07 8.73E+06 0.00E+00 3.13E+06 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult: 2.05E+08 4.38E+06 1.05E+08 2.50E+08 8.11E+07 0.00E+00 2.69E+07 0.00E+00 Tc n: 2.00E+08 5.35E+06 1.83E+08 4.30E+08 1.37E+08 0.00E+00 5.22E+07 0.00E+00 Child: 1.46E+08 3.73E+06 4.22E+08 6.92E+08 2.14E+08 0.00E+00 7.69E+07 0.00E+00 Infcnt: 1.28E+08 3.44E+06 6.79E+08 1.27E+09 3.26E+08 0.00E+00 1.34E+08 0.00E+00 For Pathway: Goat Milk ) T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 6.14E+08 1.32E+07 3.16E+08 7.51E+08 2.43E+08 0.00E+00 8.07E+07 0.00E+00 ! Tcen: 5.99E+08 1.61E+07 5.48E+08 1.29E+09 4.10E+08 0.00E+00 1.57E+08 0.00E+00 l Child: 4.38E+08 1.12E+07 1.26E+09 2.08E+09 6.43E+08 0.00E+00 2.31E+08 0.00E+00 ) Infcnt: 3.84E+08 1.03E+07 2.04E+09 3.80E+09 9.78E+08 0.00E+00 4.01E+08 0.00E+00 l For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 0.00E+00 3.09E+03 0.00E+00 TO:n 1.74E+04 3.09E+02 1.59E+04 3.58E+04 1.19E+04 0.00E+00 4.64E+03 0.00E+00 Child: 7.12E+03 1.22E+02 2.06E+04 3.21E+04 1.05E+04 0.00E+00 3.84E+03 0.00E+00 Infant: 2.36E+03 4.23E+01 1.26E+04 2.23E+04 6.04E+03 0.00E+00 2.53E+03 0.00E+00 1
ODCM R v. 13 l PagD 146 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe135m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 TO:n: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Child: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Infcnt: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tstn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk , T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TsOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 f For Pathway: Goat Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tstn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
l' ODCM'Rav. 13 Page 147 , j 5/94 i l Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe135 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 TO n: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02
'Childs 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 ' Infant: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Totna 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T@snt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 t -Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
[ ODCM R3v. 13 P;gs 148 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs136 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TcCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 TsOns 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 . C' d: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 II int: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 F(r Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.99E+05 3.15E+05 7.01E+05 2.77E+06 1.54E+06 0.00E+00 2.11E+05 0.00E+00 Tccn: 2.14E+06 2.57E+05 8.10E+05 3.19E+06 1.74E+06 0.00E+00 2.74E+05 0.00E+00 Child: 2.88E+06 1.57E+05 1.62E+06 4.46E+06 2.37E+06 0.00E+00 3.54E+05 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.53E+05 1.03E+05 2.30E+05 9.08E+05 5.05E+05 0.00E+00 6.92E+04 0.00E+00 Tsen: 4.74E+05 5.68E+04 1.79E+05 7.05E+05 3.84E+05 0.00E+00 6.05E+04 0.00E+00 Child: 5.50E+05 2.99E+04 3.09E+05 8.50E+05 4.53E+05 0.00E+00 6.75E+04 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+07 2.26E+06 5.03E+06 1.99E+07 1.10E+07 0.00E+00 1.51E+06 0.00E+00 TGOn: 2.26E+07 2.71E+06 8.56E+06 3.37E+07 1.83E+07 0.00E+00 2.89E+06 0.00E+00 Child: 3.44E+07 1.87E+06 1.93E+07 5.31E+07 2.83E+07 0.00E+00 4.22E+06 0.00E+00 Infcnt: 4.14E+07 1.69E+06 3.77E+07 1.11E+08 4.42E+07 0.00E+00 9.05E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.29E+07 6.77E+06 1.51E+07 5.96E+07 3.31E+07 0.00E+00 4.54E+06 0.00E+00 Tctn: 6.79E+07 8.13E+06 2.57E+07 1.01E+08 5.50E+07 0.00E+00 8.67E+06 0.00E+00 Child: 1.03E+08 5.60E+06 5.80E+07 1.59E+08 8.49E+07 0.00E+00 1.27E+07 0.00E+00 Infant: 1.24E+08 5.06E+06 1.13E+08 3.33E+08 1.33E+08 0.00E+00 2.71E+07 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.50E+03 3.70E+02 1.24E+03 4.64E+03 2.71E+03 0.00E+00 3.80E+02 0.00E+00 TO ns 4.34E+03 3.45E+02 1.63E+03 6.14E+03 3.50E+03 0.00E+00 5.63E+02 0.00E+00 Child: 3.68E+03 1.33E+02 2.06E+03 5.42E+03 3.03E+03 0.00E+00 4.61E+02 0.00E+00 Infant: 1.68E+03 4.53E+01 1.53E+06 4.26E+03 1.79E+03 0.00E+00 3.73E+02 0.00E+00
j ODCM Rnv. 13 l Pago 149 j l 5/94 l Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs137 I Fcr Pathway: Plume ! T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Tacn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ! Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Ts n: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 q Child: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 i Infant 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 For Pathway: Vegetable i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.88E+08 5.56E+06 2.10E+08 2.87E+08 9.75E+07 0.00E+00 3.24E+07 0.00E+00 Tsen: 1.61E+08 6.57E+06 3.47E+08 4.62E+08 1.57E+08 0.00E+00 6.11E+07 0.00E+00 Child: 1.17E+08 4.97E+06 8.29E+08 7.94E+08 2.59E+08 0.00E+00 9.31E+07 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Meat ) T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ) Adult: 1.63E+07 4.80E+05 1.81E+07 2.48E+07 8.42E+06 0.00E+00 2.80E+06 0.00E+00 l TO:n 6.98E+06 2.85E+05 1.51E+07 2.00E+07 6.82E+06 0.00E+00 2.65E+06 0.00E+00 j Childs 3.92E+06 1.66E+05 2.77E+07 2.66E+07 8.65E+06 0.00E+00 3.11E+06 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 1.38E+08 4.07E+06 1.54E+08 2.10E+08 7.13E+07 0.00E+00 2.37E+07 0.00E+00 Tecn: 1.29E+08 5.27E+06 2.78E+08 3.70E+08 1.26E+08 0.00E+00 4.90E+07 0.00E+00 Child 9.48E+07 4.02E+06 6.71E+08 6.42E+08 2.09E+08 0.00E+00 7.53E+07 0.00E+00 , Infant: 8.88E+07 3.92E+06 1.07E+09 1.25E+09 3.36E+08 0.00E+00 1.36E+08 0.00E+00 l For Pathway: Goat Milk ; T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l l Adult: 4.13E+08 1.22E+07 4.61E+08 6.30E+08 2.14E+08 0.00E+00 7.11E+07 0.00E+00 Tecn: 3.87E+08 1.58E+07 8.35E+08 1.11E+09 3.78E+08 0.00E+00 1.47E+08 0.00E+00 Child: 2.84E+08 1.21E+07 2.01E+09 1.93E+09 6.28E+08 0.00E+00 2.26E+08 0.00E+00 , Infcnt: 2.66E+08 1.18E+07 3.21E+09 3.76E+09 1.01E+09 0.00E+00 4.09E+08 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN , Adult: 1.36E+04 2.66E+02 1.52E+04 1.97E+04 7.05E+03 0.00E+00 2.38E+03 0.00E+00 Tcent 9.87E+03 2.69E+02 2.13E+04 2.69E+04 9.64E+03 0.00E+00 3.83E+03 0.00E+00 Child: 4.07E+03 1.15E+02 2.87E+04 2.62E+04 8.95E+03 0.00E+00 3.30E+03 0.00E+00 Infant: 1.44E+03 4.23E+01 1.74E+04 1.94E+04 5.46E+03 0.00E+00 2.26E+03 0.00E+00
-l. ODCM R v. 13' Pags 150 l 5/94 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe137 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ~ Adult: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 TOcns 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Child: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Infcnt: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOcn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 hild: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
.nfcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0,00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
ODCM Rsv. 13 l l Page 151 l 5/94 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe138 For Pnthway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 T;cn 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Child: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Infcnt: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 q ton: 0.00E+00 0.00E+00 0.00E+C0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 , Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 !
'Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn 0.00E+00 0.CSE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I l
Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I For Pathway: Cow Milk ) T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l . Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 IChild: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inf nt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 fAdult: 0.00E+00 (Tecn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t . . . _ _ _ _ _ _ _ _ _ _ _ _ - _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _________________________________o
'j. ODCM Rsv. 13 Pago 152 l 5/94 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Baldo For Pathway: Plume T. BODY .GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
. T3:nt Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt:.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground
-T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05'6.27E+05 6.27E+05 7.16E+05-l Tasnt 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05
' Child: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Infant:'6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 ;
For~ Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.36E+05 4.29E+06 2.08E+06 2.62E+03 8.89E+02 0.00E+00 1.50E+03 0.00E+00 Tesn: 1.62E+05 3.88E+06 2.52E+06 3.09E+03 1.05E+03 0.00E+00 2.07E+03 0.00E+00 Child: 3.13E+05 2.72E+06 5.36E+06 4.69E+03 1.53E+03 0.00E+00 2.80E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat , , T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 3.61E+04 1.13E+06 5.50E+05 6.91E+02 2.35E+02 0.00E+00 3.96E+02 0.00E+00 Tesnt 2.93E+04 7.02E+05 4.55E+05 5.58E+02 1.89E+02 0.00E+00 3.75E+02 0.00E+00 Child: 4.90E+04 4.25E+05 8.40E+05 7.36E+02 2.40E+02 0.00E+00 4.39E+03 0.00E+00 e Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN r Adult: 3.37E+04 1.06E+06 5.15E+05 6.47E+02 2.20E+02 0.00E+00 3.70E+02 0.00E+00 Tesnt 5.99E+04 1.43E+06 9.29E+05 1.14E+03 3.86E+02 0.00E+00 7.66E+02 0.00E+00 ; Child: 1.31E+05 1.14E+06 2.24E+06 1.97E+03 6.40E+02 0.00E+00 1.17E+03 0.00E+00 Infant: 2.38E+05 1.13E+06 4.62E+06 4.62E+03 1.10E+03 0.00E+00 2.83E+03 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.05E+03 1.27E+05 6.18E+04 7.76E+01 2.64E+01 0.00E+00 4.44E+01 0.00E+00 Tecn 7.18E+03 1.72E+05 1.12E+05 1.37E+02 4.63E+01 0.00E+00 9.19E+01 0.00E+00 Child: 1.57E+04 1.36E+05 2.69E+02 2.36E+02 7.68E+01 0.00E+00 1.41.E+02 T 0.00E+00 i Infcnt: 2.85E+04 1.36E+05 5.54E+05 5.54E+02 1.32E+02 0.00E+00 3.4L.+02 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.14E+01 6.92E+03 1.24E+03 1.55E+00 5.30E-01 0.00E+00 4.03E+04 0.00E+00 Tecn: 1.12E+02 7.25E+03 1.73E+03 2.13E+00 7.23E-01 0.00E+00 6.44E+04 0.00E+00 ; , Child: 1.37E+02 3.23E+03 2.35E+03 2.05E+00 6.70E-01 0.00E+00 5.52E+04 0.00E+00 Infant: 9.19E+0" 1.22E+03 1.78E+03 1.78E+00 4.26E-01 0.00E+00 5.06E+04 0.00E+00 ;
- .. .. -- . _ - _. - . - - . . .. .~ . .. - -.
i- [ ODCM Rav.:13 Page 153
'[ 5/94 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce141 For Pathway: Plume T. BODY GI-TRACT BONE LIVER- KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Tsant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infantt 0.00E+00 0.00E+00 0.00E+00 0.00E+00~0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Tosnt 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05: : Child: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 t Infant: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 ; For Pathway: Vegetable , T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG. SKIN l Adult: 3.55E+02 1.20E+07 4.63E+03 3.13E+03 1.45E+03 0.00E+00 0.00E+00 0.00E+00 Tosn: 5.57E+02 1.39E+07 7.26E+03 4.85E+03 2.28E+03 0.00E+00 0.00E+00 0.00E+00 ; Child: 1.29E+02 1.08E+07 1.74E+04 8.67E+03 3.80E+03 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 1.95E+01 6.56E+05 2.54E+02 1.72E+02 7.97E+01 0.00E+00 0.00E+00 0.00E+00 " Toen: 1.53E+01 4.07E+05 2.13E+02 1.42E+02 6.70E+01 0.00E+00 0.00E+00 0.00E+00 Child: 2.97E+01 2.50E+05 4.01E+02 2.00E+02 8.77E+01 0.00E+00 0.00E+00 0.00E+00 ! Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY- THYROID LUNG SKIN ' Adult: 6.71E+00 2.26E+05 8.75E+01 5.92E+01 2.75E+01 0.00E+00 0.00E+00 0.00E+00 Tsan: 1.23E+01 3.06E+05 1.60E+02 1.07E+02 5.04E+01 0.00E+00 0.00E+00 0.00E+00 4 Child: 2.93E+01 2.46E+05 3.95E+02 1.97E+02 8.64E+01 0.00E+00 0.00E+00 0.00E+00 _r Infant: 5.62E+01 2.47E+05 7.83E+02'4.78E+02 1.47E+01 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.06E-01 2.72E+04 1.05E+01 7.10E+00 3.30E+00 0.00E+00 0.00E+00 0.00E+00 ,
'Toon 1.48E+00 3.68E+04 1.93E+01 1.29E+01 6.05E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.51E+00 2.95E+04 4.74E+01 2.37E+01 1.04E+01 0.00E+00 0.00E+00 0.00E+00'
- Infant: 6.75E+00 2.96E+05 9.40E+01 5.73E+01 1.77E+01 0.00E+00 0.00E+00.0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '
Adult: 4.84E+01 3.80E+03 6.31E+02 4.29E+02 1.99E+02 0.00E+00 2.46E+05 0.00E+00 Taan: 6.87E+01 4.01E+03 9.00E+02 6.01E+02 2.81E+02 0.00E+00 4.24E+05 0.00E+00-Child: 9.13E+01 1.79E+03 1.24E+03 6.19E+02 2.71E+02 0.00E+00 3.79E+05 0.00E+00 Infant: 6.30E+01 6.83E+02 8.79E+02 5.28E+02 1.66E+02 0.00E+00 3.12E+05 0.00E+00
ODCM Rsv. 13 l Pago 154 5/94 l Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce144 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Tccn: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Child: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Infant: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.63E+04 2.91E+08 8.62E+05 3.60E+05 2.14E+05 0.00E+00 0.00E+00 0.00E+00 T n: 7.73E+04 3.62E+08 1.44E+06 5.95E+05 3.56E+05 0.00E+00 0.00E+00 0.00E+00 Child: 1.87E+05 2.87E+08 3.51E+06 1.10E+06 6.10E+05 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.41E+03 8.90E+06 2.63E+04 1.10E+04 6.53E+03 0.00E+00 0.00E+00 0.00E+00 Tenn: 1.19E+03 5.58E+06 2.22E+04 9.18E+03 5.43E+03 0.00E+00 0.00E+00 0.00E+00 Child: 2.23E+03 3.42E+06 4.18E+04 1.31E+04 7.26E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 3.47E+02 2.18E+06 6.46E+03 2.70E+03 1.60E+03 0.00E+00 0.00E+00 0.00E+00 Tssn: 6.39E+02 2.99E+06 1.19E+04 4.92E+03 2.94E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.56E+03 2.40E+06 2.93E+04 9.19E+03 5.09E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 2.35E+03 2.41E+06 4.20E+04 1.72E+04 6.95E+03 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 4.16E+01 2.62E+05 7.75E+02 3.24E+02 1.92E+02 0.00E+00 0.00E+00 0.00E+00 Toen: 7.67E+01 3.59E+05 1.43E+03 5.90E+02 3.53E+02 0.00E+00 0.00E+00 0.00E+00 Child: 1.88E+02 2.88E+05 3.52E+03 1.10E+03 6.11E+02 0.00E+00 0.00E+00 0.00E+00 Infant: 2.82E+02 2.89E+05 5.04E+03 2.06E+03 8.34E+02 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.83E+03 2.59E+04 1.09E+05 4.54E+04 2.69E+04 0.00E+00 2.46E+05 0.00E+00 Tcan 8.32E+03 2.74E+04 1.55E+05 6.42E+04 3.83E+04 0.00E+00 4.24E+05 0.00E+00 Child: 1.15E+04 1.23E+04 2.15E+05 6.71E+04 3.72E+04 0.00E+00 3.79E+05 0.00E+00 Infant: 5.59E+03 4.70E+03 1.01E+05 3.84E'04 1.70E+04 0.00E+00 3.12E+05 0.00E+00 1
l ODCM Rav. 13 Paga 155 l
- j. 5/94 TABLE 2-3 Assumptions Used in Limerick Gaseous Effluent Dose Evaluation Index Description Value 1 Fraction of produce from local garden 0.76 2 Fraction of leafy vegetable from local garden 1.00 3 Soil density in plow layer (kg/m**2) 240.0 4 Fraction of deposited particulates retained on vegetation 0.20 5 Fraction of deposited iodines retained on vegetation 1.0 l 6 Shielding factor of residential structures 0.7 7 Period of buildup of activity in soil (hr) 175200.0 i 8 Period of pasture grass exposure to activity (hr) 720.0 9 Period of crop exposure to activity (hr) 1440.0 10 Transport time milkman (hr) 48.0 11 Delay time for ingestion of grass by animals (hr) 0.0 12 Delay time for ingestion of stored feed by animals (hr) 2160.0 13 Delay time for ingestion of leafy vegetable by man (hr) 24.0 14 Delay time for ingestion of other vegetable by man (hr) 1440.0 15 Time between slaughter and consumption of meat animal (hr) 480.0 16 Grass yield, wet wt (kg/m**2) 0.7 17 Other vegetation yield, wet wt (kg/m**2) 2.0 18 Weathering rate constant for activity on veg (1./hr) 0.0021 19 Milk cow feed consumption rate (kg/ day wet) 50.0 20 Beef cattle consumption rate (kg/ day wet) 50.0 21 Goat feed consumption rate (kg/ day wet) 6.0 22 Plume exposure adult (hr/yr) 8760.0 23 Plume exposure teen (hr/yr) 8760.0 24 Plume exposure child (hr/yr) 8760.0 25 Plume exposure infant (hr/yr) 8760.0 26 Ground exposure adult (hr/yr) 8760.0 27 Ground exposure teen (hr/yr) 8760.0 28 Ground exposure child (hr/yr) 8760.0 29 Ground exposure infant (hr/yr) 8760.0 30 Inhalation exposure adult (m**3/yr) 8000.0 31 Inhalation exposure teen (m**3/yr) 8000.0 32 Inhalation exposure child (m**3/yr) 3700.0 33 Inhalation exposure infant (m**3/yr) 1400.0 34 Leafy veg exposure adult (kg/yr) 64.0 35 Leafy veg exposure teen (kg/yr) 42.0 36 Leafy veg exposure child (kg/yr) 26.0 37 Leafy veg exposure infant' (kg/yr) 0.0 38 Non-leafy veg exposure adult (kg/yr) 520.0 39 Non-leafy veg exposure teen (kg/yr) 630.0 40 Non-leafy veg exposure child (kg/yr) 520.0 41 Non-leafy veg exposure infant (kg/yr) 0.0 42 Root veg consumption rate adult (kg/yr) 0.0 43 Root veg consumption rate taen (kg/yr) 0.0 44 Root veg consumption rate child (kg/yr) 0.0
I ODCM Rr.v.-13
~Pega 156 '
~lT 5/94' TABLE 2-3.(Continued)
Assumptions Used in~ Limerick Gaseous Effluent Dose. Evaluation IndOx Description ' Value 45- Root veg consumption rate infant (kg/yr)
~
0.0 1 46' ' Cow milk consumption rate adult (1/yr) 310.0 ) 47 . Cow. milk consumption rate teen-(1/yr)- _400.0
'48 Cow milk consumption rate child (1/yr) 330.0z 49' Cow milk consumption rate-infant (1/yr) 330.0 50 Goat _ milk consumption-rate adult-(1/yr) 310.0 51 Goat milk consumption rate teen (1/yr) 400.0 52 Goat milk-consumption: rate child (hr/yr) 330.0-53 Goat milk consumption rate infant-(hr/yr) 330.0 54 Meat consumption rate adult- (hr/yr) '110.0 55' Meat consumption rate. teen - (hr/yr) 65.0 56- -Meat consumption rate child (hr/yr) 41.0 57 Meat consumption rate infant (hr/yr) 0.0 58 Fraction of year animals on pasture 0.75 59 Fraction-of feed from pasture when on pasture 0.88 60 Fraction of year leafy veg grown 0.42 61 Atmosphere hydrogen concentration (gm/m**3) 8.0 ,
l
-r
[ ODCM RGv. 13 Pcgo'157. L ll 5/94 TABLE 2-4 Nearest Gaseous Effluent. Dose Receptor Distances (Meters)
-Plume' I Ground Inhalation Vegetation Meat Cow Goat 'birdction Pathways Pathway Pathway. Pathway Pathway N 805 2414 3414 .7562' O.
NNE 805 1609 1585 .0 'O-NE 965 3218 1097 4183 0 'l
,ENE 965 2414 3871 0 0 ;E' 805 1770 1890 6758 0 ESE .965- 805 4511 1770 1770 SE 1609 3862 7241 7241 0 SSE 1609 1609 7224 7241 0 S 1287 1931 3018 3701. 5654 SSW 1609 1609 1433 2896- 0 -SW 965- 1287. 2835 4827 .0 WSW 1287 1287 2134 2255 0 .W 965 2574 4084 0 0 WNW 1126 1440 0 0. '0 NW 1126 2574 6660 0 7401 NNW 1448 1931 6325 0 0 l-l'
su -- ll- ODCM R:v. 13 P g3 158 l 5/94 APPENDIX A j i t-i l l l l
l- :l) ODCM R0v. 13' Pag 3 159 l 5/94 5 TABLE A-1 Technical Specification /ODCM Matrix ODCM ODCM
' .TCchnical' Section I Equation gaggification*, Recuirement Section II
.3.3.7.11 3.2.1 1-1 1-2 1-3 1-4' P
23.3.7.12 3.3.1 2-1 (or 2-9) 2-2 (or 2-9) 2-4 (or 2-10)- 2-5 (or 2-10)- 3.11.1.1 3.2.2 1-1 1-2 1-3 1-4 3.11.1.2 3.2.3 1-5 1-6 1-7 3.11.1.3 3.2.4 1-8 1-9 3.11.2.1 3.3.2 2-22 2-23 3.11.2.3 3.3.4 2-26 2-27 2-28
-- 3 .11. 2 . 2 3.3.3 2-24 2-25 3.11.2.4 3.3.5 2-33 3.11.2.7 3.3.6 2-4 2-5 CTransferred to ODCM via T.S. amendment # 48 for Unit 1 and 11 for Unit 2.
i
l; ODCM'R;v. 13 Pagan 160
- - l -
. 5/94
-TABLE A-1.
Technical Specification /ODCM Matrix '= ODCM ODCM
, -Tcchnical Section I Equation
' Specification * ' Requirement- Section II'-
6.9.1.8 3.6 1-5 1-6 1-7 2-24' 2 2-26 2-27 2-28 3.11.4 3.3.7 3-1
-3.12.1 3.4.1 Section II App. B 6.9.1.7 3.5 1 '3.12.3. 3.4.3 1-6 1-7 2-29 2-30 2-31 2 3-2
- Transferred to ODCM via T.S. amendment # 48 for Unit 1 and 11 for Unit 2.
-+ re -
,, ,.. . . . _ . . . _ . . . . . _ - . _ ~ . . . - . _ . .. . . _ . . __ . . . . . .
' (l. -
ODCM R;v. 13 Pags 161 >
.-:f .
, ).ll 5/94 1.-
APPENDIX B RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM - SAMPLE TYPE, LOCATION, AND ANALYSIS ; e a I 1 L f I
~
a c l ~ ODCM R v. 13l y'. .J P gs 162' - E 8 5/94 Page 1 oft 4. , . TABLE B-1
~
DCM - Limerick Generating' Station Radiological Environmental Monitoring Program' Pathway Station Code Location Collection Method Analyses! I. Direct 36S2 0.6 miles N of site 1 set of four (4) TLDs Gamma dose o t- 2E1 5.1 miles NNE of site from-each location at~ quarterly _ , i 3S1 0.6 miles NNE of site least quarterly j 4E1 4.6. miles NNE of site i SS1 0.4 miles NE of site-
- SH1 C 25.8 miles NE of site~
l 6C1 2.1 miles ENE of site 7S1 0.5 miles ENE of site - 7El 4.2 miles ENE of site 9C1 2.2 miles E of site 10S3 0.5 miles E-of site 10E1 3.9 miles E of site 10F3 5.5 miles ESE of site 11S1 0.5 miles ESE of site 13Cl- 2.9. miles SE of site 13E1 ' 4.3-miles SE of site 14S1 0.6 miles-SE of' site , 15D1 3.2 miles SE-of site 16S2 0.6 miles SSE of site ! 17B1 1.6 miles S~of site 18G1 C 12.9 miles S 1 of site i l 18S1 - 0.3 miles S of site , -19D1 3.6'ailes S of site ' 20D1 3.1'ailes SSW of site ~ 20F1 5.2 miles'SSW of site-21S1- 0.5. miles SSW'of site-
- 23S2 0.5 miles WSW of. site- -
C = Control Stations 1 T- f +v6 w e 4-- e-- e t- 4 m e en
ODCN Rsv.113L
-I
' Pngs-163~ '
'5/94 Page'2:of-4 TABLE B-1 Collection Method- Analyses Pathway Station Code Location Collected quarterly Gamma dose I. Direct 24D1 3.9 miles SW of site quarterly' (cont.) 25S1 0.5 miles SW of site 25D1 4.0 miles.WSW of site 26S3 0.4 miles W of site 28D2 3.8 miles W of site 29S1 0.5 miles WNW of site 29El 4.9 miles WNW of site 31D1 3.0 miles NW of site -i 31D2 3.9 miles NE of site 32S1 0.6 miles NW of site.
34S2 0.6 miles NNW of site 34E1 4.6 miles NNW of site , 35F1 4.2 miles N of site 0.5 miles E of site Approximately 1 cfm Gross beta analysis II. Airborne 10S3 'on each weekly sample. continuous flow through Particulates 11S1 0.5failes ESE.of site : Gamma spectrometry' 14S1 0.6 miles-SE of' site glass fiber filter which 13C1 2.9 miles SE of site is collected weekly. 'shall be done when 22G1 C 17.6 miles SW of site gross beta exceeds ten: , times.the yearly mean. of control station value.
- V
- -____...___.___m -
_ _ _ _ . __ _ _ _ _ - . , . - -- ~ ., , y ~.- . _ , , , , , . , ,., , m
l l ODCM Rav. 13 Paga 164 l 5/94 Page 3 of 4 l TABLE B-1 l Pathway Station Code Location Collection Method Analyses II. Airborne (cont.) Particulates (cont.) Gross beta analysis i done 224 hr after sampling to allow for Radon and Thoron daughter decay. Gamma isotopic analysis on monthly composite. Iodine 10S3 0.5 miles E of site A TEDA impregnated flow- Iodine 131 11S1 0.5 miles ESE of site through cartridge is con-l 14S1 0.6 miles SE of site nected to air sampler and 13C1 2.9 miles SE of site is collected weekly at 22G1 C -17.6 miles SW of site filter change. III. Water 24S1 C 0.3 miles SSW of site Sample collected from a Gamma isotopic continuous water sampler, analysis monthly; Surface 13B1 1.8 miles ESE of site monthly. In event sampler H-3 on quarterly l is inoperable, weekly grab composite. samples will be collected until sampler returned to l service. Sediment 16C4 Vincent Dam, down- A sediment sample is taken Gamma isotopic stream of discharge semi-annually. analysis. I
i l* ODCM R v. 13 Pcg3 165 l 5/94 l~ Page 4 of 4 TABLE B-1 Pathway Station Code Location Collection Method Analyses IV. Incestion Milk 22F1 C 9.8 miles SW of site Sample of fresh milk is Gamma isotopic and' , 10B1 1.1 miles ESE of site collected from each farm I-131 analyses on.each i I 25B1 1.3 miles WSW of site biweekly when cows are on sample. l 21B1 1.8 miles SSW of site pasture (April through October) , monthly at other j times. Drinking i 15F7 5.2 miles SSE of site Sample collected from a Gross beta and gamma 28F3 C 5.9 miles WNW of' site continuous water sampler isotopic monthly, 15F4 7.8 miles SE of site monthly. In event sampler H-3 on quarterly 16C2 2.4 miles SSE of site in inoperable, weekly grab composite. samples will be collected until sampler returned to service. Fish Gamma isotopic 16C5 1.9 miles SSE of site Two species of recrea- analyses on edible 29C1 C 3.2 miles WNW of site tionally important fish portions. (Predator and bottom feeder) sampled in season i or semiannually if not seasonal. Food Gamma isotopic and Products Two offsite locations of highest Samples of three (3) dif- analysis. 1 predicted annual average ground ferent kinds of broad leaf level D/Q and one location vegetation monthly when (15-30 km distance) in the least available if milk sampling prevalent wind direction as deter- is not performed mined using the results of the most recent annual Landuse Survey. 1 l 1
FIGURES l I
)
l
UNIT 2 ' - Ilmante;r tincL: '
~
j "%
..linst limlintest '
Illteok til .IIer ll M
~
7000 clan-l'articulato/ Incline j'. . Itatlinilent Monllor k , - - _ . .
, .,z,
-l. \+*
g !._ - l f- - lleenn ~ nten
.\ : ~'
llag 1:llistr , (typical) V-t
.4
~
l'!allnifall ililn I!!actric Consp.
- 1.lmatich . (lanetaling '!1talloti
' Gonoral 11epnir Aron - l Ifrile_tj :!
- unannua IIllluant '.
. = l'Inw Dintynm
___ !!'J!_Mii!!ilalt!!!!sa Ulitis! -
'.' *.6 ' I . ,., , -' 1:11 Tilll '
liXilAl'IGil l'AN - .
. l}D . ~ ..
.p.
.: .__-jyy';
ODCM,.-Rev.13' Page 166~ 5/94 .
. . . . . . . _ . . 'I a 1"-' h__.m_______ _m.um_,a _m.u,_.,_ _ _ _ _ _ _ _ _ _ _ , ,,. _ _ _
1 } . y . t '
) .
South Vent South Vent - Partlettlate Unit t ' Unit 2 Partleulate , lodine and El 411' 38"' ""d El. 41 t' - Noble Gas Continuous Continuous Noble Gas
- Monitor (2) Monitor (2) -
(2][ _ _ _ _ (2) 234,000 234,000 D' ~ CFM CFM ' M a w. Max. tiefueling Floor liefueling Floor Enhaust i 2 131 h . Enhaust lkG (3) l - 11earter Enclosure Exhaust [ l -> 4 ts)
) . ;
Ileactor Enclosure
' is) 54,000 54,000 Exhaust CFM CFM Min. Min.
Equtpment Compartment ' p b - Equipment (2; 12) Compartment (2) Philadelphia Electric Comp. Limerick Generating Station Units 1 & 2 Gaseous Effluent Flow Diagram South Stack. ODCM, Rev.13 Page 167-5/94 v
I . , Oa venri , North veni -Wido - unn. I a N _y _l Mang0 Ein. 4H
/ d y, g ,,3,,, ,
nenge Accident. 3 - re,ueuteio to ne ae
- y. Monitor Contianese Fittet Pasticulate, lodine & *'"'*
Noble Gee Nosmal - g -' Range Monitore
/ ,
Oas Monitor p,,p
~
Imbhia rnelnema Enhaust
~
+-- --l D . . _ . . . .. . ... - ~ -
8- "' ne..ona cru 4y tu.a.ina r.. epa.ina Esgulp. Coanpail Enfinust Y (p) turbine Encloewe Eshouel I3I / b
+ W Igy) Meeliseleal Vac. Pump Tusbtne Enclosure Estulp. Cosnpart Enhaveg I II -
+ I23 Datteer noon.Enhauel Jk nasa.
Cleem Pachtn0 E*hauel*r
" * * ' ' ' *** I""P nadoeste Enct. Enhaust Steam Peek. Enhauster 4
- nadwnste Enct. Equiri.
Compnetment Enfieuelet II[ - Y IN- Ganeous nadenet. Teentment Slendby Gee Treet. Sye. sees 4 Uedt I Condenses Offges Unit condenset Offges
. g 4 ,,
Fume flood Enheuet G , (2) Phtlaitolplila Electric Comp, i 4 Umellck Generating Station control Area Enhavet _ y - Il!'!I8..I & 2 (2) Hannotis Etitismits Flow Otagram flotth Sinck ODCM, Rev.13
. unn 1 chmecome sr elem Page 168
{,I Exhaust Fan g Filter " u.. che, cost sveiem 5/94
ll; ,1 p y g a en n t'n .n pio iM
, , 4 O
E D g L n e P n' e n I mta ot - n i CS 2 394 n o o w s m-u icg& t 169 o d u Csoa n nm . 1/ Cre owd o tr i t c a 1 e a u r v 5 E o wlB( n I nts ler e s n g t a ee Rg F T To Eni t n Ei D a a e U d iG iu wo P
,I h
ph q l M i M - tn c i L F C I I D
'g I
G .d ne O U )m
! m ht .
0o P L
~ 0N 2(
E 2
. L #
DP K FMA N A S T
) . h n EA L
E L D m n DPK o DPK N *i EMN EMN (
~
t s e AA AA i , M ag ST ST P wiu t
,V G oS t
> )
[ o N i . I
- ._ 4
- t DM F E ~ k o
o D - n M
- ~
~
. T a O 2
> ta e t o
E L K - ~ a g wdu 3 - 5 3 DP N t 0- i6 - aS 3 t L- ATMA G N T 8 st S I En _ D M > F*
' E *
- D -
E1 k L # n a DP K o T b FM N t s e k n A S A T a o 'T a Wdu t
a eg
_ oS
- t Wd lu TaS p
.R n _ t t
D E D E T D. TLE FL T E L T LI I F I F C F U F y ' d
' T oi i'~
I [g ) t d - g - ~d
- r
' r -
~
j K K "" nc E a N N m E A A o G K i K oK K T T D r t Un NA DcN nN WN F ' J n FuT S E eA t T uAT C AT D D ' N s o S L L I4 " u c I
> , g'
- ~ ~
mkn ea hT C e t e t t ) s _ ) Dm ms ) De m a m oa nDM eE s e Lt e y( s FrW Ft ( s m( W t s d r y ns y pns y y ns r ! s qriab ni onb i i
)b uab u or u u Wu LADS r
lF DS EDS CS ( l . ' ' . ,4 - t~ < .
- l{ll\Ijll
ocM asy,13 ll FIGURE B-1 Page 170 5/94 M* ENVIRONMENTAL SAMPLING LOCATIONS ON-SITE OR NbAM
. THE LIMERICK GENERATING STATION N
NNW,7 NNE .
- d. mee.
N W <::
-?..._ s
.y . S2
- NE
.u
;;.Q. ~.;
A. 5:- me' l : ... \
*. ;,. 't; ?13
.E.n.=
s .. . wir.,:34S2.w:z,.x e.. . . . . . L.f 5!,k' ;,:. ~ N 'f ,_j .f WNW 2 3 2'S 1 &=e Wx #. E . S ~
.:e
'\ENE 1
/.N;5d...
c-r T :.1 - h } r..e
- P.a ,
2 9 S 1 =JJ,4 w=. "
= ,? 'v
.a: g_s n;; w ..
g Q. %
, 7 jQ
~ '
/p 1
*k \'
\,.\
1 "c1 l ;
\ 23.S2 h I- !
WSW IM /ESE i Nas.1 ' . . -. . / . e U S 1 W ' _ W~SE
!i .
,, W .l (
SW /2-,r
< S. _:_ e. 4 V w::=:s Yd~E: . ,
exn j M& '~ % SSW SSE S ; I SITE EOUNDARY j 20S1 L35 CISCHARGE AEEA l 3832 EVERGEEEN & S AN AT0GA R::. S AN ATCG A E:. 2151 LGS !?.1 POUNCING I AS:N 251 225: TRANS?.t!SSiCN 7:: Win
$$1 F C S S U?.1 H C L'.':W R O.
L35 TRA N:NG CINTER 2451 L33INTAXE 751 2551 SW S ECTO R 1053 XIEN KO. 2553 f.iET. TCWER :: 1151 LG S IN FC Rt.! AT:C N CNTR. 22S1 WNW SECTOR 1151 LCNGVIEW R: . 3:51 HW SECTOR 1832 LONGVIEW R::. 3432 !.t!T. TOWE R, 1 1251 RA:LRO AO TRA XS . e, /e* *
; 7, ; ODCM R;v'.13 f
i.
* . FIGURE B ~ p g3 171
' 5/94-YAIRBORNE.' AND TLD ENVIRONMEN'TAL SAMPLING LOCATIO'NSi AT:lNTERMEDIATE DISTANCES FROM LIMERICK GENERATING STATION ;
N NNW' NNE NW- NE 5F1 2E1 34E1 WNW
- 4E1 *- ENE 1D2e.
e
- 31
- 5B1
- SEl e 7El 2B 621 e )
29
- W 28D2 e 2 1 f E 9C1 25D1 * !.
7.B1 3 10E1 J e -10F3
- p.
- 24D1 e 15D e 20D1 e E1 ESE WSW 19D1
~
20F1 e T 6F*1 - SW SE SSW SSE S ten mile radius 4 251 SAN ATCGA SUESTATION 13E1 VAUGHN ROAD 28B1 QLD SCHUYLKILL RD - 1501 SPRING CITY SUh. 4 TION 28D2 W. CEDARV!LLE RD
'2E1 L LAUGHING WATERS CSC 18F1 PIKELAND SUBSTATION 2SB1 YCST RCAD 4E1 NEIFFER ROAD 17B1 LINFIELD SUBSTATION 2SE1 HIGH SUBSTATICN .
SC1 POTTSTOWN AIRPCRT 19D1 SNOWDEN SUBSTATION 31D1 LINCOLN SUBSTATICN 7Et PHEASANT ROAD sc1 REED ROAD 2001 ELLl3 WCCCS ROAD 31D2 PCPLAR SUBSTATION 20F1 SHEEDER SUBSTATION 34E1 YARNELL RC AD
."10E1 ROYERSFCRD RC AD 24D1 PORTERS MILL SUBSTATION 3551 PLEASANTVILLE RD 10F3 TRAPPE 5UBSTATICN 25D1 HOFFECKER & KEIM ST. 35F1 RINGING ROCKS SUB 1301 KING ROAD
.. ,2===>
z
,.#,.. . .,,,.,,.m ,_%,
** emmeme-
- w~+==.... ,
___-_-__ ___________._______________m __._._.__.________m=-__-..m_ _
ODCM~REV.13 Paga 172 SM FIGURE B-3 '
~
AQUATIC AND TERRESTRIAL ENVIRONMENTAL SAMPLING LOCATIONS AT lNTERMEDIATE DISTANCES FROM LIMERICK GENERATING STATION
- N >
NNW NNE NE NW SE1 e ENE WNW 28F3 13 2' .\ 2ect . ioF2 E W l 21 % c - y 2ec1. g,'83f,'16C4
. ua. /ESE WSW 4 18C1 2- SF7 e
35p4
- SE SW SSW g SSE ten mile radius 19B1 FARM IN SSW SECTOR 1081 FARM IN ESE SECTOR 21B1 FARM IN SW SECTOR 10F2 PERKIOMEN CREEK 22C1 FARM IN SW SECTOR 1381 VINCENT DAM 22F1 FARM IN SW SECTOR 15F4 PHIL. SUB. WATER CO.
f 25C1 FARM IN WSW SECTOR { 15F7 PHOENIXVILLE WATER CO. 28F3 POTTSTOWN WATER AUTH. j 16B2 LINFIELD BRIDGE 2SC1 PCTTSTOWN VICINITY
. 16C2 CITIZENS HOME WATER CD.
33A2 UPSTREAM OF LGS
' 16C4 VINCENT POOL 36E1 FARM IN N SECTOR i 16C5 VINCENT POOL 18C1 FARM IN S SECTOR l = _ _ _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ _ . _ _ _ . _ _ _ ._ _. . - - _ . -.
+m t
ODCM R v.13- ' ' Paga 173 Ll? FIGURE B-4 5/94-
.g; ENVIRONMENTAL SAMPLING LOCATIONS AT REMOTE DISTANCES FROM LIMERICK GENERATING STATION N-NNW -
.NNE ;
NW .NE e 5H1 WNW 'ENE g) o
/
W e gG1 E~
.;. y
, e :ax WSW 22G1 18G1 13H21 '~f-' M H4 t'
SW SE
. SSW ssg g
fif ty mile resius . EH1 BIRCH SUESTATION
. SG1 FARM IN E SECTOR 13H2 EELMONT WATER WORKS 13H4 PEco EUILOING iEG1 FLANEEROOK SUESTATION
. 22G1 MANOR SUESTATION 32G1 FRIEDENBERG SUBSTATION
" " * ' " N+ m =ame - 4en. # % #g - -
e ,
l ODCM R v.13 Paga 174 l 5/94 REFERENCES l
- 1. Regulatory Guide 1.109, " Calculation of Annual Doses to Man from l Routine Releases of Reactor Effluents for the Purpose of Evaluating {
Compliance with 10 CFR Part 50, Appendix I," Revision 1, U.S. Nuclear l Regulatory Commission, Washington, D.C. 20555, October 1977. l l
- 2. Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, July 1977.
- 3. Regulatory Guide 1.112, " Calculation of Releases of Radioactive l Materials in Gaseous and Liquid Effluents from Light-Water-Cooled i Power Reactors," U.S. Nuclear Regulatory Commission, Washington, D.C.
20555, April 1976.
- 4. Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents I from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1977.
- 5. U.S. Nuclear Regulatory Commission, " Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Boiling Water Reactors (BWR-GALE Code)," USNRC Report NUREG-0016, Washington, D.C. 20555, April 1976.
- 6. U.S. Nuclear Regulatory Commission, "XOQD0Q, Program for the Methodological Evaluation of Routine Effluent Releases at Nuclear Power Stations," USNRC Report NUREG-0324, Washington, D.C. 20555, September, 1977.
- 7. Title 10, " Energy," Chapter I, Code of Federal Reaulations; Part 20, Appendix B, U.S. Government Printing Office, Washington, D.C. 20402, !
I January 1, 1977.
- 8. Title 10, " Energy," Chapter I, Code of Federal Reaulations; Part 100, U.S. Government Printing Office, Washington, D.C. 20404, January 1, j 1977. 1 f
- 9. Title 40, " Protection of Environment," Chapter I, Code of Federal )
Reculations, Part 141, U.S. Government Printing Office, Washington, ) D.C. 20402, January 1, 1977.
- 10. Regulatory Guide 1.21, " Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, June 1974.
1
\
j ODCM Rsv.13 Pcga 175 l 5/94 REFERENCES
- 11. Title 40, " Protection of Environment," Chapter I, Code of Federal Reculations, Part 190, Federal Register, Vol. 42, No. 9, Washington, D.C. 20402, January 13, 1977.
- 12. U.S. Nuclear Regulatory Commission, "Short Term Diffusion Estimates,"
Section 2.3.4, Standard Review Plan for the Review of Safety Analysis ReDorts for Nuclear Power Plants - LWR Edition, USNRC Report NUREG-75/087, Washington, D.C. 20555, November 1975. l 13. U.S. Nuclear Regulatory Commission, " Preparation of Radiological
- Effluent Technical Specifications for Nuclear Power Plants," USNRC l
Report NUREG-0133, Washington, D.C. 20555, October 1978. l
- 14. Letter From Thomas E. Marley, Director Office of Nuclear Reactor Regulations, To Thomas E. Tipton Vice President and Director i
operations, Nuclear Management and Resources Council, 6/30/93. l 15. ANSI N42.14-1991 (Revision of ANSI N42.14-1978) " Calibration and Use l of Germanium Spectrometers For the Measurement of Gamma-Ray Emission Rates of Radionuclides", Sect. 6.2.2
- 16. EML Procedures Manual, H.L. Volchok and G. dePlangue, Editors, U.S.
Dept. Of Energy (Revised Annually)
- 17. L.A. Currie, " Limits For Qualitative Detection and Quantitative l Determination - Application to Radiochemistry", Analytical Chemistry, l Vol. 40, pp. S86-593 (TABLE II), 1968
- 18. NUREG/CR-4007, " Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements", prepared by NRC by L.A. Currie (Chapter II, Sect. D.2; Chapter III, Sect. C.1), September 1984 l
- 19. Tech. Spec. Section 1.24 (Definitions)
- 20. USNRC Generic Letter, 89-01
( t
. _ . . - - . _ _ _ _ _ _ _ _ . - _ . - - - _ . - - - _ - _ - _ _ _ - - _ . _ _ _ _ . . - - _ _ - - _ _ - -}}